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Abstract 
 
Searching for Novel  
Neural Inducing Signals 
 
 
Irene Marta De Almeida 
 
 
 
Neural induction marks the beginning of vertebrate nervous system formation, 
consisting of an interaction between the organizer, which emits inducing signals, and the 
ectoderm, which responds by giving rise to the neural plate.  
In the present study we explored the role of FGF signals, Wnt inhibition and 
BMP inhibition in chick neural induction. Contrasting with previous work, in vivo 
studies in the extraembryonic ectoderm revealed that FGF signals, even together with 
inhibition of Wnts and BMPs are not capable of causing the surrounding cells to acquire a 
neural character. Inhibition of BMPs can, however, extend the border of the neural plate.  
To uncover possible missing factors secreted by the organizer, a screen to isolate 
cDNAs encoding for secreted proteins was carried out. 442 clones were obtained and, 
after blast analyses, 137 were selected to be put through an in situ hybridization screen, 
narrowing down the number of candidate molecules to 23. Of these, and based on their 
expression in the node and/or anterior primitive streak, 3 were studied further, 
including cloning, molecular characterization and functional analysis in the context of 
neural induction in the chick embryo. 
Fibulin2 belongs to the Fibulin family of extracellular matrix proteins.  Our 
results suggest that is not directly involved in neural induction.  
Calreticulin is largely present in the endoplasmic reticulum, and widely studied 
as an intracellular calcium regulator. We report that it can be secreted and acts like a BMP 
inhibitor, extending the border of the neural plate and rescuing the effect of BMP 
overexpression. It cannot, however, induce neural character in the competent  
extraembryonic ectoderm.  
Nhbr90 seems not to be translated but act as a RNA. It is the first molecule 
identified with the ability of inducing the neural marker Sox2 in the extraembryonic 
ectoderm. 
The work presented emphasises the complexity of the neural induction process 
and that we are only beginning to understand how the molecular players interact to form 
an early neural plate.  
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Chapter 1 
General Introduction 
 
 
 
 
Neural Induction – and the organizer 
 
Induction was defined by Gurdon as the “interaction between one (inducing) tissue and 
another (responding) tissue as a result of which the responding tissue undergoes a 
change in its direction of differentiation" (Gurdon, 1987).  
 
Neural induction marks the beginning of the vertebrate nervous system formation and 
results from an interaction between the organizer (a population of cells emitting signals) 
and the ectoderm (the induced tissue), which responds by giving rise to neural tissue.  
 
Through the seminal work of Hilde Mangold, it was found that the dorsal blastopore lip 
of the gastrulating Triturus (newt) embryo “exerts an organizing effect on its 
environment in such a way that, following its transplantation to an indifferent region of 
another embryo, it there causes the formation of a secondary embryo” (Gerhart, 2001; 
Spemann and Mangold, 1924). This secondary embryo, fused to the host at the ventral 
midline, had two complete heads, two hearts, two of each of the main dorsal structures 
(the notochord, neural tube and somites) and one gut. Very crucially, and because 
Mangold used differently pigmented species of newts as grafts and as hosts, early lineage 
tracing experiments were possible and revealed that, while the notochord of the 
secondary axis was derived from the progeny of the graft, the nervous system (with the 
exception of the floor plate) was derived from the host. This clearly demonstrates that 
there is an instruction from the graft on cells, causing the latter to change their fate and 
become neural instead of epidermal: a small region of the dorsal mesoderm can initiate 
the formation of an entire nervous system. Furthermore, close examination revealed that 
the secondary axis was patterned anterior-posterioly and dorso-ventrally. Because the 
dorsal lip of the blastopore is able to both induce and organize a fully patterned 
secondary axis, it was named the organizer.  
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Spemman and Mangold’s work marked the onset of the field of neural induction and 
many groups started to study the organizer and the molecular nature of its signals.  
 
 
 
The organizer in other species 
 
Soon the functional equivalent of the amphibian organizer was found in other species. 
The dorsal tip of the primitive streak, Hensen’s node, was put forward as the organizer 
centre in the chick (Hunt, 1929) and later shown to have, in fact, neural inducing ability 
(Waddington, 1930; Waddington, 1933a; Waddington, 1933b; Waddington, 1934; 
Waddington and Schmidt, 1933b).  Hensen’s node was found to induce a secondary axis 
both in the prospective epidermis (the avian non neural ectoderm of the area pellucida) 
and in the extraembryonic ectoderm of the area opaca (Cuevas and Llorca, 1974; Dias and 
Schoenwolf, 1990; Gallera, 1970a). 
 
Equivalent regions were soon described in other vertebrate classes: Hensen’s node in the 
duck (Waddington, 1930; Waddington, 1932), rabbit (Waddington, 1934; Waddington, 
1936; Waddington, 1937) and mouse (Beddington, 1994) and the embryonic shield in the 
fish (Oppenheimer, 1936).  
 
Many grafting experiments demonstrated that the organizer induces neural tissue when 
transplanted ectopically, not only within the same species but also across vertebrate 
classes. To name some examples, chick Hensen’s node grafts can induce neural tissue in 
Xenopus (Kintner and Dodd, 1991), rabbit (Waddington, 1934) and zebrafish (Hatta and 
Takahashi, 1996). Rabbit nodes can induce neural tissue in both chick and duck 
(Waddington, 1936; Waddington, 1937); the mouse or rabbit node act as organizers in 
Xenopus (Blum et al., 1992) and in chick (Knoetgen et al., 2000). These amazing 
experiments do not provide any clue to the organizer’s molecular nature, but as a whole, 
are a clearly indication that, whatever the signals, whatever the mechanism, neural 
induction is conserved across species.  
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The organizer neural inducing ability and the 
competence of the responding tissue 
 
The idea of competence was first introduced by Waddington (Waddington, 1932) and 
was later defined as “the physiological state of a tissue which permits it to react in a 
morphogenetically specific way to a determinative stimuli” (Holtfreter, 1955). 
 
  
1. The chick as a system to study neural induction 
Organizer grafting experiments in the chick have revealed that both the extraembryonic 
epiblast of the area opaca and non-embryonic ectoderm of the area pellucida of the 
gastrulating embryo are competent to respond by giving rise to secondary axis (Dias and 
Schoenwolf, 1990; Gallera, 1972; Gallera and Ivanov, 1964). In the present study, the 
epiblast of anterior inner third of the area opaca (just laterally to the host node) is used for 
most experiments because it represents a comparatively neutral environment in which to 
study neural induction: the epiblast of the area opaca does not contribute to any 
embryonic tissues and only gives rise to extra-embryonic membranes but, crucially, it is 
able to respond to neural inducing signals. The secondary axes formed in the area opaca 
remain separate from the host axis, so that a cellular contribution from the host can be 
ruled out (Hornbruch et al., 1979).  Because of the relatively large distance from the host 
embryo, it is very unlikely that the induced neural structures will be influenced by 
signals from the host embryo (Dias and Schoenwolf, 1990; Shieh, 1963; Storey et al., 1992; 
Tsung et al., 1965). 
 
2. The inducing ability of the node and neural competence of the 
epiblast: changes over time  
Node grafting experiments (reviewed by (Gallera, 1971; Nieuwkoop, 1985) suggest that 
the developmental age and orientation of the grafted Hensen's node, the age of the host 
epiblast and the position of the graft all influence whether and to what extent new axes 
are induced and how their patterning is affected. By transplanting nodes into host 
embryos of different developmental stages, Storey and colleagues (Storey et al., 1992) 
identified the time frame during which neural inducing signals are present in Hensen’s 
node and the stage by which the epiblast loses its competence to respond to neural 
inducing signals. Furthermore, the age of a transplanted Hensen's node determines the 
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extent to which new neural structures are induced and the regions of the nervous system 
that form: young Hensen's nodes (stages 2 to 4) induce both anterior and posterior central 
nervous system (CNS), while older nodes (stages 5 to 6) have a reduced inducing ability 
and progressively generate more posterior structures (Dias and Schoenwolf, 1990; 
Gallera, 1970b; Storey et al., 1992; Streit et al., 1997b; Tsung et al., 1965; Vakaet, 1965).  
 
As mentioned above, not only the age of the node, but also the age of the epiblast affect 
the extent to which posterior CNS is formed. While young epiblasts, up to stage 3+/4 can 
be induced to form a fully patterned, anterior to posterior, secondary axis, the 
competence of the host embryo to respond to neural inducing signals decreases 
substantially after stage 4 (Storey et al., 1992), disappearing completely by stage 6 
(Gallera, 1971a; Gallera and Ivanov, 1964; Woodside, 1937). It is interesting to note that 
the competence of the epiblast to respond to neural inducing signals starts to decrease 
from stage 4, which coincides with the time at which inducing signals begin to decrease 
in the node. Finally, it also appears that, while the contribution to the induced secondary 
axis by a younger node is minimal (notochord and part of the floorplate), older nodes 
have a greater tendency to differentiate into neural structures, rather than exerting an 
induction on the neighboring tissues (Dias and Schoenwolf, 1990; Gallera, 1970b; Gallera 
and Ivanov, 1964). 
 
3. L5220: A marker for neural competence 
Neural competence in the chick seems to be closely correlated with the expression of the 
carbohydrate epitope L5220 (Roberts et al., 1991; Streit et al., 1995; Streit et al., 1996; Streit 
and Stern, 1997a). Its expression begins in a broad domain that resembles the region that 
appears to be competent to neural inducing signals (Gallera, 1970b). At stages 3+/4, L5220 
is expressed in a broad domain around the node and extending to the lateral and anterior 
inner third part of the area opaca. The posterior part of both the embryonic and 
extraembryonic regions lack L5220 expression (Streit et al., 1997b). At stage 5, when the 
area opaca has lost its neural competence, L5220 is absent from this region and is only 
present in the presumptive neural plate (Roberts et al., 1991; Streit et al., 1997b; Streit et 
al., 1995). Apart from L5220 expression, two further experiments support its relation to 
neural competence. First, the chick organizer is not able to induce neural tissue when 
grafted together with cells secreting L5 antibody (Roberts et al., 1991). Second, Streit and 
colleagues (Streit et al., 1997b) demonstrated that Hepatocyte Growth Factor/Scatter 
Factor (HGF/SF) can maintain L5220 expression in the anterior area opaca to at least stage 5 
and that this also prolongs competence to respond to neural inducing signals: a grafted 
node is able to induce neural character in a stage 5 host that had previously received a 
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graft of hepatocyte growth factor/scatter factor (HGF/SF) (Stern et al., 1990) secreting 
cells (Streit et al., 1997b).  This establishes L5220 as a marker for competence and indicates 
that L5220 might also be involved in the response of the epiblast to Hensen’s node signals, 
a concept that is supported by the fact that antibodies to the L5220 epitope inhibit this 
response (Roberts et al., 1991).  
 
 
 
The long search for the chemical nature of organizer 
signals 
Although much headway was made in understanding neural induction, with the 
identification of the organizer across several species and vertebrate classes and, to some 
extent, the timing of neural induction, the identity of the inducing signal (or signals) 
remained elusive for many decades.  
 
An early finding was that neural induction could be initiated by a variety of tissues, 
ranging from the extract of a fish swim bladder to guinea pig bone marrow (for review 
see (Grunz, 1997)). Tiedemann demonstrated that the phenol phase of an extract of an 11-
day chick embryo was able to neuralize animal caps, and was the first to speculate that 
proteins were the likely candidates for the inducing signal (Tiedemann, 1956a; 
Tiedemann, 1956b). Soon after, Saxén (Saxén and Toivonen, 1962) and later Toivonen 
(Toivonen and Wartiovaara, 1976) separated organizers from juxtaposed animal caps by 
using filters that excluded cell–cell contact. Their results showed that neuralization could 
still occur in the absence of direct cell–cell contact, indicating that the signals were 
diffusible. 
 
 
The default model of neural induction: BMPs and 
their inhibitors 
 
A number of experiments performed in Xenopus involving dissociated single cells from 
blastula animal caps indicated that neural fate might be the default in the amphibian 
(Godsave and Slack, 1989; Grunz and Tacke, 1989; Sato and Sargent, 1989). Immersion of 
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the animal cap in media depleted of calcium and magnesium causes it to dissociate into 
single cells. When the ions are immediately added back, the cells re-associate. Upon 
further culture these re-aggregates differentiate into epidermis, similar to the intact cap. 
However, if the re-association is delayed, the re-aggregate acquires a neural character 
(Born et al., 1989; Godsave and Slack, 1989; Grunz and Tacke, 1989; Saint-Jeannet et al., 
1990; Sato and Sargent, 1989). These results suggested that intact blastula animal caps 
had some kind of activity that maintains non-neural character, and that this activity is 
diluted by dissociation. These experiments first suggested that during Xenopus early 
development, some factor intrinsic to the animal cap (that is lost during dissociation in 
the animal cap assays, inhibits neural differentiation (Godsave and Slack, 1989; Grunz 
and Tacke, 1989).  
 
It was only with the onset of molecular biology that the nature and the mechanism of the 
signals responsible for neural induction started to be elucidated. The main breakthrough 
on the molecular nature of neural induction happened almost by chance. Hemmati-
Brivanlou, while studying the role of activin, a member of the Transforming Growth 
Factor-β  (TGF-β) family, realized that the caps, upon injection of a truncated activin 
receptor, become neural, instead of epidermal (Hemmati-Brivanlou and Melton, 1994b). 
The RNA encoding the truncated activin receptor lacks the transducing, cytoplasmic 
domain, but had intact the extracellular and transmembrane domains, acting as a 
dominant negative (although ligand binding could occur, it was unable to elicit a 
response) (Hemmati-Brivanlou and Melton, 1992).  Perhaps activin, or another member 
of the TGF-β family, inhibits neural fate.  
 
Around the same time, Smith and Harland (Smith and Harland, 1992) isolated noggin, a 
secreted molecule able to rescue dorsal development in Xenopus embryos that had been 
ventralized by UV radiation of the vegetal pole. Noggin was found to be expressed first in 
the dorsal mesoderm and later in the notochord of the embryo. This initial study was 
only concerned with dorsalizing activity of Noggin on the mesoderm, but a subsequent 
study suggested noggin as a neural inducer.  When Xenopus animal caps are incubated in 
a solution contained purified Noggin protein (Lamb et al., 1993), the caps produce neural 
tissue without expressing mesodermal markers. 
 
The next neural inducer to be identified was follistatin, a known activin inhibitor 
(Hemmati-Brivanlou et al., 1994a), also able to induce neural, but not mesodermal, 
markers in animal caps.  Since follistatin is an inhibitor of TGF-β signalling this suggested 
that a TGF-β may be an endogenous inhibitor of neural fate. The first candidate was 
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activin, because of the similar effects of follistatin and injection of a truncated activin 
receptor (see above) (Hemmati-Brivanlou and Melton, 1994b). As it turned out, neither 
follistatin nor the construct used by Hemmati-Brivanlou and Merton are specific activin 
inhibitors, but also antagonise other members of the TGF-β family (Hemmati-Brivanlou 
and Melton, 1994b).  
 
BMP2 and BMP4, members of the TGF-β superfamily, are both expressed in the ventral 
part of the embryo (Dale et al., 1992; Jones et al., 1992). BMP4 is expressed in the non-
neural ectoderm, consistent with it being an epidermal inducer. Moreover, when BMP4 is 
added to dissociated animal cap cells, neural induction is prevented, regardless of how 
long re-association is delayed (Wilson and Hemmati-Brivanlou, 1995). Moreover, 
overexpression of BMP4 RNA on the dorsal side of the embryo reduces neural ectoderm 
and also dorsal mesoderm and expands the expression of epidermal markers (Dale et al., 
1992; Jones et al., 1992).  
 
Soon after, genetic analyses in Drosophila lead to the isolation of decapentaplegic (dpp), 
which is homologous to the vertebrate genes BMP2 and BMP4 (Holley et al., 1995). In the 
fly, eliminating dpp converts the epidermal cells into neuroectoderm; conversely, 
overexpression of dpp changes the fate of neuroectodermal cells to epidermis (Biehs et al., 
1996).  Further studies in Drosophila led to the isolation of short gastrulation (sog), an 
antagonist of dpp (Holley et al., 1995). Chordin is the vertebrate homologue of sog. In 
Xenopus, Chordin is expressed in the organizer and later in the prechordal mesoderm and 
notochord, all structures capable of neural induction (Sasai et al., 1994). 
  
By now it was starting to emerge that members of the TGF-β family act as neural 
inhibitors and that the neural inducers discovered so far, noggin, follistatin and chordin, act 
by inhibiting TGF signals. Indeed, it was soon demonstrated that chordin, noggin, and 
follistatin all bind to BMP4 and BMP2 (Iemura et al., 1998; Piccolo et al., 1996; Zimmerman 
et al., 1996). Ingenious genetic analysis in Drosophila, where chordin or noggin is 
ectopically expressed in various Drosophila mutants defective in components of the BMP 
pathway, allowed the site of action of these proteins to be placed upstream of the 
receptor, in the extracellular matrix (Holley et al., 1995; Holley et al., 1996b). 
Subsequently, other extracellular, secreted antagonists of BMP activity were found, such 
as Cerberus, Gremlin, and Xnr-3, all of which induce neural markers in Xenopus animal cap 
assays (Bouwmeester et al., 1996; Hsu, 1998; Smith et al., 1995). 
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Further support for the idea that BMP inhibition is responsible for neural induction came 
from inhibiting the intracellular components of the BMP signal-transduction pathway. As 
well as the truncated activin receptors, acting as dominant negative forms of the 
endogenous BMP receptor, negative forms of Smad molecules were also shown to 
promote neural differentiation in animal cap experiments (Bhushan et al., 1998; Liu et al., 
1998). Inhibitory versions of the transcription factors that form the nuclear response to 
BMP were also shown to neuralize Xenopus animal caps (Onichtchouk et al., 1998; 
Trindade et al., 1999). 
 
The data so far indicated that the inhibitory signal of neural induction was a member of 
the TGF-β family, more precisely BMP4 (or BMP2) and that neural inducers might inhibit 
these to allow the default, neural fate. That the inhibitory substance was BMP4 was also 
suggested by the finding that BMP4 is an effective inhibitor of neural fate while 
promoting epidermal differentiation, even in dissociated cells (Hawley et al., 1995; 
Wilson and Hemmati-Brivanlou, 1995).  
 
To summarise the findings so far: 
1. Dissociation of animal caps of gastrulating Xenopus embryos results in the 
formation of neural tissue; 
2. Missexpression of dominant negative forms of the “activin” receptor not only 
blocks mesoderm formation, but also induces neural tissue (Hemmati-Brivanlou 
and Melton, 1992; Hemmati-Brivanlou and Melton, 1994b). The activin dominant 
negative receptor used by Hemmati-Brivanlou was later found to inhibit other 
members of the TGF-β family. 
3. Other neural inducing molecules, such as follistatin (Hemmati-Brivanlou et al., 
1994a), noggin (Lamb et al., 1993; Smith and Harland, 1992; Smith et al., 1993) and 
chordin (Sasai et al., 1995; Sasai et al., 1994) were discovered and are all expressed 
in the organizer and can induce neural tissue when ectopically expressed. These 
bind and antagonise BMP signalling (Fainsod et al., 1997; Piccolo et al., 1996; 
Zimmerman et al., 1996). 
  
These observations led to the notion that neural induction may not be due to an 
instructive signal, but rather to inhibition of an endogenous inhibitor of neural fate, 
which is also an inducer of epidermis. Thus, the neural state may be an intrinsic, or 
default, property of cells in the animal cap. This is the “Default Model” of neural 
induction. The neural antagonist and epidermal inducer would be a member of the BMP 
family and the neural inducers, all expressed in the organizer, would bind to and inhibit 
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the BMP signals, allowing the surrounding ectoderm to pursue its intrinsic neural fate. 
 
 
 
Challenging the Default Model  
 
However, it soon became apparent that the patterns of expression of BMPs and their 
antagonists in the chick embryo, when compared to the timing of neural induction (see 
above) do not easily fit with the predictions of the Default Model. The next sections 
address some key findings surrounding neural induction by the node in amniote 
embryos, mainly the chick. 
 
1. Is the node absolutely necessary for Neural Induction? 
 
The role of the organizer and how fundamental it for neural induction to occur has been 
questioned. In the chick, neural induction can take place even after the node is surgically 
ablated (Waddington, 1932). This result was initially interpreted as showing that the 
Hensen’s node, though sufficient for neural induction, is not required. However, this 
view was abandoned when subsequent studies showed that after ablation, the node 
quickly regenerates into a new, functional organizer (Grabowski, 1956; Joubin and Stern, 
1999; Psychoyos and Stern, 1996; Schoenwolf and Yuan, 1995; Yuan and Schoenwolf, 
1998; Yuan and Schoenwolf, 1999). On the other hand, genetic ablation of both the node 
and notochord in the mouse, and in the fish, seems to have little effect on the induction of 
neural tissue (Gritsman et al., 1999; Klingensmith et al., 1999).  
 
Studies in the fish, and using the mutant one-eyed-pinhead (oep), where the embryonic 
shield and dorsal mesoderm do not form, showed that some chordin is still expressed and 
some neural-inducing activity still persists (Gritsman et al., 2000; Gritsman et al., 1999). 
Also, in the zebrafish chordino mutants, some nervous system still develops (Schulte-
Merker et al., 1997). 
 
Comparable results were obtained in the mouse. In the HNF-3β mutant (Ang and 
Rossant, 1994; Chen et al., 1994b; Weinstein et al., 1994) the node and axial mesoderm are 
absent, and do not express organizer markers, including chordin and noggin. However, 
the rostral streak, from which the node derives, is still capable of neural induction 
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(Klingensmith et al., 1999). Moreover, embryos mutated for either follistatin (Matzuk et 
al., 1995c), noggin (McMahon et al., 1998) or Cer1 (Cerberus related-1) (Simpson et al., 1999) 
develop a normal sized neural plate. Even in the chordin:noggin double mutants, although 
lacking the forebrain, still develop a relatively normal posterior nervous system, 
indicating that some neural induction did take place (Bachiller et al., 2000). 
 
Another explanation for why node ablation still results in neural tissue formation could 
relate to the finding that neural induction in vertebrates begins even before the 
appearance of a morphologically distinct organizer.  For example, explants of prospective 
neural ectoderm express neural markers even if isolated before the beginning of 
gastrulation (Darnell et al., 1999; Streit et al., 2000a; Wilson et al., 2000). Also in Xenopus, 
it now seems that neural induction is initiated during the late blastula stages of 
development (Faure et al., 2000; Hemmati-Brivanlou and Thomsen, 1995). This 
conclusion was a result of studies in which the downregulation of the expression of 
components of the BMP pathway was used as the time point for when neural induction 
was taking place (Faure et al., 2000; Hemmati-Brivanlou and Thomsen, 1995). 
  
 
 
2. Is BMP Inhibition Sufficient for Neural Induction? 
 
Experiments performed in the chick started to question the idea of BMP inhibition 
mediating neural induction. The expression patterns of the BMP inhibitors noggin, 
follistatin, and chordin (Connolly et al., 1997; Connolly et al., 1995; Streit et al., 1998) do not 
correlate well with the spatio-temporal patterns of inducing ability of the node or 
responses of the epiblast.  
 
Streit and colleagues showed that neural tissue could not be induced by either chordin or 
noggin expressing cells when placed in the competent epiblast of the extraembryonic area 
opaca (Streit et al., 1998). Moreover cells expressing BMP2 or BMP7 failed to inhibit neural 
plate formation (Streit et al., 1998). However, in chick pre-gastrula epiblast explants, fated 
to become neural ectoderm, and cultured for 40 hours, BMP4 induces expression of 
epidermal markers (Wilson et al., 2000). The mostly likely explanation for the difference 
in the results may reside in the timing in the experimental set-up as a more recent study 
(Linker and Stern, 2004), revealed that BMP overexpression in the chick does indeed 
inhibit Sox2 expression but only at a later stage of neural plate formation. 
 
 11 
Mouse double mutants for noggin:chordin still have neural tissue (Bachiller et al., 2000), 
whereas null mutants of BMP2 (Zhang and Bradley, 1996), BMP4 (Winnier et al., 1995), or 
BMP7 (Wawersik et al., 1999) do not have a massively expanded neural plate. However, 
the possibility remains of some functional redundancy between different BMPs and 
different antagonists, with one compensating for the loss of another (Dudley and 
Robertson, 1997); And other inhibitors of BMP signalling may also account for some 
aspects of neural induction (Munoz-Sanjuan and Brivanlou, 2002; Scott et al., 2001; von 
Bubnoff and Cho, 2001). 
 
On the other hand, there is evidence suggesting an important conserved role for BMP 
inhibition, together with Nodal inhibition, in establishing the neural tissue in the mouse 
embryo. Importantly, recent work found that loss of the BMP receptor Alk3 (Di-Gregorio 
et al., 2007) or of Nodal (Camus et al., 2006) each result in a dramatic and precocious 
conversion of almost the entire epiblast into anterior neural tissue that expresses Otx2 
and Sox1 as well as markers of anterior forebrain such as Six3, Dlx5, and Hesx1. These 
results have been interpreted as indicating that Nodal and BMP signalling are required 
before gastrulation to prevent the entire embryo becoming neuralised and to maintain a 
pluripotent epiblast that can also form epidermis, mesoderm, and endoderm. 
 
 
In the chick there is other evidence supporting the idea that BMP inhibition accompanies 
neural induction in the embryo. This comes from experiments in which the level of 
phosphorylated Smad1, Smad5 and Smad8 (intracellular regulators of BMP signalling) 
was assessed. By using antibodies that recognize activated forms of the above Smads, it 
was shown that there is no BMP activity in the forming neural plate (Faure et al., 2002). It 
now appears that BMP inhibition is a late step in the neural induction process: BMP 
inhibition has a function of stabilizing and reinforcing neural cell fates, and that other 
molecules will be the primary neural inducers (Streit and Stern, 1999). In support of this, 
Linker and Stern (Linker and Stern, 2004) showed that BMP can inhibit the maintenance 
of neural marker expression at late gastrulation/early neurulation stages but does not 
affect the onset of expression of these markers. 
 
 
3. BMP inhibition at the border of the neural plate 
 
Experiments in the chick first raised the possibility that not all of the ectoderm, as the 
default model predicts, but only cells close to the neural/epidermal border are sensitive 
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to BMP and its antagonists (Streit et al., 1998; Streit and Stern, 1999; Streit and Stern, 
1999a). The prospective neural plate, delimited by the border, is not inhibited by BMP4 or 
BMP7 and the non-neural ectoderm outside the border is not induced by chordin or 
noggin. However, when BMP-4 is misexpressed, by means of pellets of expressing cells, at 
the edge of the prospective neural plate, the domain of expression of the early neural 
marker Sox3 becomes narrower. This narrowing of the neural plate is further supported 
by the lateral shift of msx1, a border marker. Conversely, downregulation of BMP signals, 
at the border, using BMP antagonists, leads to a widening of the neural plate (Linker and 
Stern, 2004; Streit et al., 1998; Streit and Stern, 1999a). 
 
In Xenopus, the reason by which animal caps are so easily neuralized by misexpression of 
BMP antagonists, might reside on the fact that they contain some neural plate and/or 
border cells. In fact, Linker and colleagues (Linker et al., 2009), through systematic fate 
mapping of animal caps of a wide range of sizes, revealed that even the smallest caps 
contribute cells to the anterior neural plate itself in as many as 60% of cases, and nearly 
all caps contribute to the prospective placodal domain at the border of the anterior neural 
plate. Furthermore, isolated animal caps express both anterior neural (Otx2) and border 
(XAG1/XCG1) markers (Knecht et al., 1995; Lamb and Harland, 1995; Lamb et al., 1993). 
Although these data are consistent with previous fate maps made at the 16 cell stage 
(Moody, 1987a) and at the 32 cell stage (Dale and Slack, 1987b; Moody, 1987b), Linker’s 
results (Linker et al., 2009) provide the first demonstration that virtually all animal caps 
excised at stage 8 contain cells fated to became neural plate border. 
 
In Xenopus BMP2 and BMP4 are expressed ubiquitously in the entire ectoderm before 
gastrulation, and then cleared from the prospective neural plate at the time when the 
organizer appears (Fainsod et al., 1994). On the other hand, in the chick embryo, neither 
BMP2, BMP4 or BMP7 is expressed in the future neural plate at the early primitive stage 
(Streit et al., 1998). However, by early neurulation, the expression of BMPs in both Chick 
and Xenopus becomes strongly localized to the border of the neural plate. This seems to 
mean that, even though the expression patterns differ at the early stages, they converge 
just after the appearance of the neural plate, suggesting that a role for BMP at the border 
is important and has been conserved in evolution. 
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The role of other players and signaling molecules in 
neural induction 
 
This section will provide a short overview on some molecular players and signalling 
molecules currently studied in relation with neural induction.  
 
1. Fibroblast Growth Factors (FGFs) in neural induction 
FGF, a mesodermal inducer (Isaacs et al., 1994; Slack, 1994a; Slack, 1994b; Slack and 
Isaacs, 1994) has been reported to have direct neural inducing ability in several species. In 
ascidians, several lines of evidence indicate that FGF signalling initiates the formation of 
the nervous system (Bertrand et al., 2003; Hudson et al., 2003; Hudson and Lemaire, 2001; 
Kim and Nishida, 2001), suggesting an ancient role for this family of signalling molecules 
in neural induction. In Xenopus, FGF can induce neuralization of animal cap cells that 
have undergone brief dissociation (Kengaku and Okamoto, 1993). Furthermore, in animal 
cap experiments, blocking FGF signalling with dominant negative FGF receptor prevents 
induction of neural markers by BMP antagonists noggin (Launay et al., 1996) and chordin 
(Sasai et al., 1996). An alternative view suggests that FGF signalling provides the 
ectoderm with competence to become defined as neural, by analogy to the observations 
(Cornell et al., 1995) that FGF contributes to define the competence of the ectoderm to 
respond to mesoderm induction by TGF-β signals in Xenopus. 
 
FGF may induce neural tissue by a mechanism independent of BMP inhibition. 
Experiments in Xenopus with Smad10, a Co-Smad, component of the BMP signalling 
pathway, revealed that it induces neural tissue within the animal cap (LeSueur et al., 
2002). More surprisingly, by removing Smad10 protein using antisense oligonucleotides, 
neural tissue is never formed in the affected embryos and, using co-injection studies, the 
authors found that Smad10 cannot inhibit the BMP pathway, indicating some other 
mechanism for its function. The authors further identify one site in the Smad10 protein 
that becomes phosphorylated and activated as a result of FGF signalling (LeSueur et al., 
2002). 
 
In the chick embryo, the role of FGF in neural induction has received considerable 
attention. Storey and colleagues (Storey et al., 1998) provided the first comprehensive 
study examining the role of FGF signalling in the induction of neural tissue in the 
amniote embryo. Using chick embryos, the authors showed that FGFs, which are 
expressed in the node and anterior primitive streak, induce a subset of genes associated 
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with the laying down of the posterior nervous system.  FGF can also maintain and/or 
induce the expression of the early neural marker L5 in the extraembryonic epiblast and 
may, therefore, maintain the competence of this tissue to respond to other neural 
inducing signals (Streit et al., 1997b; Streit et al., 1995; Streit and Stern, 1997a). 
 
A few years later, Streit and co-workers (Streit et al., 2000a) reported that the gene Early 
Response to Neural Induction (ERNI) starts to be expressed very early in the pre-streak 
epiblast. ERNI is induced by a grafted node in as quickly as 1 hour, and this is mimicked 
by FGF8. The induction of ERNI by the node can be inhibited by the FGF receptor 
antagonist SU5402 or by a chimaeric secreted FGF receptor construct in vivo. The same 
treatment also abolished induction of Sox3 and Sox2 by the node, strongly suggesting an 
absolute requirement for FGF signalling not only in the early stages of neural induction 
but also for later marker expression (Streit et al., 2000a). During normal development, 
ERNI is expressed in a large domain of the pre-streak stage epiblast – at this stage, the 
underlying hypoblast expresses FGF8. These observations first suggested that the earliest 
neural inducing signals may arise early, from the hypoblast (Streit et al., 2000a). At the 
same time, another study, also using SU5402, also showed that neural differentiation is 
blocked in chick epiblast explants obtained from the central region of pre-streak stage 
chick embryos (Wilson et al., 2000).  In the chick FGF8 induces, amongst other markers, 
the early neural marker Sox3 but not Sox2, a later, more definitive neural plate marker (de 
Almeida et al., 2008; Linker et al., 2009; Linker and Stern, 2004; Pinho et al., 2011; Streit 
and Stern, 1999a). This, together with the ability quickly and robustly to induce ERNI 
(Streit et al., 2000a) suggests that FGF signals initiate the process of neural induction, but 
additional signals are further required for the establishment of a fully committed neural 
plate.  
 
 
Despite some initial controversy, it is now generally accepted that FGF signalling is 
absolutely required for neural induction to take place not only in Xenopus (Delaune et al., 
2005; Hardcastle et al., 2000; Launay et al., 1996; Linker and Stern, 2004; Pera et al., 2003; 
Sasai et al., 1996; Strong et al., 2000; Xu et al., 1997) and chick (Linker and Stern, 2004; 
Streit et al., 2000c; Wilson et al., 2000), but also in zebrafish (Kudoh et al., 2004) and 
ascidians (Bertrand et al., 2003; Hudson et al., 2003; Hudson and Lemaire, 2001; Kim and 
Nishida, 2001). 
 
There is also strong evidence for interactions between FGF and BMP signaling. It was 
proposed that FGF signaling aids the clearance of BMP activity from the neural plate, and 
 15 
downstream effectors of the FGF pathway have been shown to inhibit the nuclear 
accumulation of the R-Smad/Co-Smad complex (Kretzschmar et al., 1997a; Kretzschmar 
et al., 1999; Kretzschmar et al., 1997b). 
 
An important effector of BMP signals is the transcription factor Smad1, which becomes 
phosphorylated at three conserved carboxy-terminal serine residues upon activation by 
the BMP receptor (BMPR) serine/threonine kinase (Massague and Chen, 2000). It has 
further been shown (Kretzschmar et al., 1997b) that Smad1 also undergoes 
phosphorylation by MAPK in the central linker region. Whereas phosphorylation by 
BMPR promotes nuclear translocation and transcriptional activity of Smad1, 
phosphorylation by MAPK in the linker region has the opposite effect, causing 
cytoplasmic localization and inhibition of transcriptional activity (Kretzschmar et al., 
1997b; Massague and Chen, 2000). 
 
A conclusive study, performed in Xenopus, has clearly demonstrated that FGF8, through 
the MAPK cascade, causes phosphorylation in the linker region of Smad1, acting as an 
effective inhibitor of BMP signals (Pera et al., 2003). This has been proposed to be an 
explanation for the requirement of FGF signalling in Xenopus neural induction (Pera et 
al., 2003). However this does not account for all the findings implicating FGF, because 
some of its actions appear independent of BMP inhibition (see (de Almeida et al., 2008; 
Linker et al., 2009; Linker and Stern, 2004). 
 
 
2. Wnts in neural induction 
The role of the Wnt family has been investigated in the context of neural induction. In 
chick explant experiments, Wnt overexpression induces epidermal markers in epiblast 
from the prospective neural domain of pre-streak embryos (Wilson et al., 2001). 
Conversely, in presumptive epidermal tissue from the same stage, Wnt inhibition 
induces neural markers. In the same study it was shown that at a certain concentration of 
Wnt inhibitors, below the level required for neural induction in the epidermal epiblast 
explants, a combination of BMP inhibition and FGF could induce neural ectoderm. The 
authors’ proposed mechanism is that Wnt signalling causes an upregulation of BMP 
expression and, therefore, induces the epidermal fate (Wilson and Edlund, 2001; Wilson 
et al., 2001).  Contradicting this view are results from Xenopus, suggesting that expression 
of Wnts downregulates that of BMPs (Baker et al., 1999; Gomez-Skarmeta et al., 2001). 
However also in Xenopus, Delaune and colleagues (Delaune et al., 2005) obtained 
evidence supporting the view of Wilson et al. (Wilson et al., 2001). 
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Results in chick embryos in vivo, however, do not easily fit with the model of Wilson et al. 
(Wilson et al., 2001). Inhibition of Wnt signals, even together with FGFs and BMP 
inhibition do not induce the neural marker Sox2 in the competent epiblast of the 
extraembryonic area opaca (de Almeida et al., 2008; Linker et al., 2009; Linker and Stern, 
2004b, this study).  There are many possible reasons for the differences between these 
results but among them is the fact that explants are cultured in medium containing the 
supplement N2, which contains insulin, a factor that acts through the MAPK pathway 
common to FGFs. Moreover, there is evidence implicating insulin or insulin-like growth 
factor (IGF) in neural induction in Xenopus (Pera et al., 2003) 
 
It was also proposed that Wnt signalling can modulate the strength of the transduced 
BMP signal via activation of the calmodulin/Ca2+! pathway (Scherer and Graff, 2000; 
Zimmerman et al., 1998). This may explain why BMP inhibition cannot induce neural 
tissue in epidermal epiblast explants. If the level of inhibition of BMP signalling is not 
complete, the sensitized transduction pathway can still receive an input, resulting in 
epidermal cell fates. If, however, Wnt signalling is also inhibited, reception is 
desensitized and when combined with BMP inhibition, can lead to neural cell fates. In 
agreement with this view, it is interesting to note that two naturally occurring inhibitors 
of Wnt signalling, FrzB and Sfrp-2, are expressed in the chick presumptive neural plate at 
around the stages that neural induction is taking place (Ladher et al., 2000).  
 
 
3. Calcium in neural induction 
Most information regarding Ca2+ signalling during neural induction comes from studies 
in amphibians. As early as 1974, it was suggested that Ca2+ is important in triggering 
neuralization in Rana pipiens ectoderm (Barth and Barth, 1974a; Barth and Barth, 1974b). 
More recently, the dissociation of animal caps in Ca2+ and Mg2+-free medium has been 
shown to direct the cells toward a neural fate (Grunz and Tacke, 1989; Saint-Jeannet et al., 
1989; Saint-Jeannet et al., 1993). Frequently, the explanation given for this neuralization 
by dissociation phenomenon is that the epidermal inductors (BMPs) are being diluted 
from their receptors. This theory was taken as fact for many years because it was 
reported that when BMP4 is added at a high concentration during dissociation, the 
expression of neural markers is totally abolished (Wilson et al., 1997). Recently, it has 
been shown that cell dissociation induced a sustained activation of the Ras/MAPK 
pathway, which causes the phosphorylation of Smad1 at sites that inhibit the activity of 
this transcription factor. This demonstrates that BMP ligands continue to signal in 
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dissociated cells (Kuroda et al., 2005). In addition, it has been shown that the dissociation 
of animal caps in Ca2+-free medium triggers an increase in [Ca2+]i and that this increase is 
due to an efflux of Ca2+ from internal stores resulting from the inversion of the gradient of 
concentration in Ca2+ between intra- and extracellular compartments (Leclerc et al., 2001). 
To distinguish whether, during cell dissociation, the increase in [Ca2+] i is a cause or a 
consequence of neural induction, animal cap cells were loaded with the Ca2+ chelator 
BAPTA: under these conditions, the neuralization by dissociation is blocked (i.e., the 
neural marker NCAM is not expressed) (Leclerc et al., 2001). This demonstrates that, at 
least in animal caps, a Ca2+-dependent signal is necessary to trigger neuralization of the 
ectoderm and to inhibit epidermal determination. 
 
Many more studies have suggested that calcium fluxes (Leclerc et al., 1997; Leclerc et al., 
1999; Leclerc et al., 2003; Leclerc et al., 2000; Leclerc et al., 2008; Lee et al., 2009; Moreau et 
al., 1994; Moreau et al., 2008) or associated Protein Kinase C signalling (Otte and Moon, 
1992; Otte et al., 1989) may play a role in the specification of the embryonic nervous 
system in Xenopus.  But how these fluxes are regulated and how they relate to the neural 
induction cascade are only now starting to become understood. In a recent study 
(Papanayotou et al., submitted), Calfacilitin, a novel transmembrane protein was 
identified and characterized as a regulator of calcium signalling and as a new player in 
neural induction. It is a calcium channel facilitator that increases calcium flux by 
generating a larger window current and slowing the inactivation of the L-type Cav1.2 
channel. It is required early, downstream of initial FGF signals, to induce Geminin, and 
defines an essential step for the later acquisition of Sox2 expression and neural plate 
formation. The authors demonstrate that Calfacilitin acts by modulating intracellular Ca2+ 
levels, providing a long-sought mechanism for how L-type calcium channels are 
involved in neural induction. 
 
 
5. Insulin-Like Growth Factor (IGF) in neural induction  
It has been shown that the insulin-like growth factor (IGF) family can play a role in 
neural induction. Experiments performed in Xenopus show that animal caps are 
neuralized by IGFs (Pera et al., 2001; Van Obberghen et al., 2001). The necessity for IGF 
signalling has also been shown using a truncated IGF receptor. In these embryos, neural 
induction mediated by noggin is inhibited. The authors propose that the IGF pathway 
may act downstream of BMP inhibition during neural induction, and that as well as a 
passive role for BMP inhibition, neural induction may not be a default as previously 
thought. Instead, it may also require an active signal, induced as a result of BMP 
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inhibition (Pera et al., 2001). As mentioned above, these findings may be relevant to the 
interpretation of the chick explant results (Wilson et al., 2000; Wilson et al., 2001) since 
these are cultured in the presence of medium supplement N2, a major component of 
which is insulin. 
 
 
6. Retinoic acid (RA) and Notch in neural induction 
Retinoic acid (RA) and Notch are signalling molecules which, although they have 
attracted considerable attention in neural development, have not been studied 
extensively in the earlier process of neural induction.  
 
RA is a signalling molecule widely studied as involved in neuronal patterning, neural 
differentiation and axonal outgrowth. As a patterning factor, it contributes to both the 
anteroposterior and dorsoventral patterning of the neural plate and neural tube. In the 
anteroposterior axis of the neural plate, RA, along with Wnts and FGFs, is specifically 
responsible for the organization of the posterior hindbrain and the anterior spinal cord 
(Liu et al., 2001; Maden, 2002; Melton et al., 2004). In the absence of RA signalling, the 
posterior hindbrain is missing and the anterior spinal cord is abnormal (Maden et al., 
1996; Wilson et al., 2004). As RA is synthesized in the posterior mesoderm and the RA 
catabolizing enzyme CYP26C1 is expressed in the anterior mesoderm, a gradient of RA 
that is able to pattern the overlying presumptive hindbrain of the neural plate is 
generated (Reijntjes et al., 2004; Wilson et al., 2004).   
 
Despite an early report in the chick embryo that ectopic RA can induce neural tissue, and 
that the response differs between left and right sides of the embryo (Chen et al., 1992; 
Chen and Solursh, 1992), this has barely been studied further. It is relevant to note that, in 
cultured NT2/D1 carcinoma cells, RA can activate Sox3. The authors further identify a 
novel positive regulatory element within the Sox3 promoter responsible for this RA-
dependent activation of Sox3 (Nikcevic et al., 2008).  
 
Another study, this time performed in chick embryos, explored the role of the hypoblast 
in neural induction (Albazerchi and Stern, 2007), showing that it plays a role in 
establishing an initial “pre-neural/ pre-prosencephalic” territory in the epiblast. The 
signals involved include a combination of FGF and RA signalling, perhaps together with 
Wnt and BMP antagonists. This induction is transient, but can be stabilized by RA and 
continued Wnt and BMP inhibition. However, a definitive neural state requires 
additional factors remaining to be identified. Interestingly, FGF and RA, generally 
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considered as caudalizing factors, are shown in Albazerchi’s study to play a role in the 
induction of a transient “pre-neural/pre-forebrain” state (Albazerchi and Stern, 2007). 
 
And finally, a recent study demonstrated an interaction between BMP signaling and 
RA/RA receptor (RAR) pathway (Sheng et al., 2010). The authors show that RA represses 
the duration of BMP signals by reducing the level of phosphorylated Smad1 (pSmad1).  
Through its nuclear receptor-mediated transcription, RA enhances the interaction 
between pSmad1 and its ubiqitin E3 ligases, promoting pSmad1 ubiquitination and 
subsequent proteasomal degradation (Sheng et al., 2010). 
 
Notch has been extensively studied on neurogenesis in Drosophila embryos. In the absence 
of Notch, the embryo forms too many neuroblasts at the expense of the hypodermal cell 
layer (Artavanis-Tsakonas, 1988; Campos-Ortega, 1988). Even though Notch appears to 
play a role in deciding the fate of neural/hypodermal cells, it is expressed ubiquitously in 
early embryos in the neurogenic region (Hartley et al., 1987; Kidd et al., 1989). 
 
The Xenopus homolog of Notch, Xotch, is very similar to Drosophila Notch in structure and 
shares some similar features in its developmental expression (Coffman et al., 1990). A 
study in which Xotch was truncated by a deletion in its extracellular domain, XotchΔE, 
shed some light on its function in Xenopus (Coffman et al., 1993). Broad overexpression 
causes the loss of dorsal structures and the expansion and disorganization of the brain, 
whereas injections of XotchΔE into a single blastomere induce neural and mesodermal 
hypertrophy in the descendants of the injected cell. XotchΔE further inhibits the early 
expression of epidermal and neural crest markers and yet enhances and extends the 
response of animal caps to mesodermal and neural induction. The authors suggest that 
Notch might be working on delaying differentiation and leaving undetermined cells 
competent to respond to later inductive signals (Coffman et al., 1993).  A more recent 
study, also performed in Xenopus, has suggested that Notch signalling modulates the 
nuclear localization of carboxy-terminal-phosphorylated Smad2 and controls the 
competence of ectodermal cells for activin (Abe et al., 2005). Further studies will be 
needed to access if Notch signalling can also crosstalk with other TGF-β family members.  
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The requirement for more players upstream of BMP 
signals  
In the chick embryo, BMP inhibitors alone (or in combinations) are unable to induce Sox2, 
a late, stable neural marker, unless mesoderm is also induced (de Almeida et al., 2008; 
Linker et al., 2009; Linker and Stern, 2004; Streit et al., 1998) A graft of Hensen’s node into 
the inner third of the area opaca induces the pre-neural marker Sox3 within 3 hours. 
However, if the graft is removed before 12 hours, the induced expression is lost and no 
neural plate develops (Streit et al., 1998). However, expression of Sox3 can be maintained 
if Chordin expressing cells are added following the removal of the node at 5 hours, but 
not earlier (Streit et al., 1998). These results suggest the requirement for other signals 
upstream of BMP inhibition to initiate neural induction.  
 
To identify the molecular events taking place in the first 5 hours of induction by the node, 
a differential screen was performed between area opaca epiblast cells that had been 
exposed to a graft of Hensen’s node for 5 hours and control cells from the contralateral 
side of the same embryo. The expression of about 10 genes was found to differ between 
the two conditions; these have now been characterized functionally and their regulation 
by secreted factors investigated. All the isolated genes are expressed in the prospective 
neural plate and are induced by a node graft in the area opaca within 5 hours. When it 
comes to the regulation of the genes isolated, it was revealed that a significant subset can 
be induced by FGF8: ERNI (Streit et al., 2000a), Churchill (Sheng et al., 2003), Calfacilitin 
(Papanayotou et al, submitted), Dad1, polyubiquitin (UbII) and ferritin heavy chain (Fth) 
(Gibson et al., 2010) and Asterix (Pinho et al., 2011). However, another subset is not 
regulated by FGF: Obelix and TrkC (Pinho et al., 2011). These genes are also not regulated 
by BMP antagonits or by other factors previously implicated in neural induction.  
 
These results indicate that FGF is the major, but not the only, signal involved in the early 
steps of neural induction, and that other signals remain to be identified. Examination of 
the timing of induction of all of these response genes after a node graft revealed that they 
are expressed as three distinct temporal waves, or “epochs” (Pinho et al., 2011): genes 
induced within 3 hours of a node graft (ERNI, Sox3, Calfacilitin and Geminin) are normally 
expressed in the epiblast of pre-primitive-streak stage embryos; genes induced within 5 
hours of a node graft (Churchill, UbII, Dad1, Fth, TrkC, Asterix and Obelix) are normally 
expressed in the prospective neural plate from the late primitive streak stage; a third 
wave of expressed genes comprises those induced after about 12 hours of a node graft 
such as Sox2 and BERT (Papanayotou et al., 2008). In normal development, these genes 
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start to be expressed in the very early neural plate when the axial mesoderm starts to 
form, at stage 4+/5. Apart from TrkC and Obelix (Pinho et al, 2011) from the first two 
waves, BERT (Papanayotou et al., 2008) is also not regulated by FGFs. These results 
suggest that at least one, and probably more, signals from the node remain unidentified. 
This conclusion is further supported by the observation that neither FGF together with 
BMP antagonists, nor exposure to Hensen’s node for 5 hours followed by BMP 
antagonists, is sufficient to induce expression of Sox2 or the formation of a neural plate. 
 
 
The search for neural inducing signals from the node 
The conclusions from the previous sections suggest that it is now critically important to 
identify the missing signals involved in neural induction. This is the aim of the work 
reported in the present thesis. 
 
Here, we start by reassessing the role of BMP inhibition during neural induction in the 
chick embryo. We find that BMP inhibition, even together with FGF and Wnt signals, is 
unable to induce neural markers in competent epibast of the area opaca; and the only 
region capable to respond to BMP inhibition is the border of the neural plate (see also 
(Streit et al., 1998; Streit and Stern, 1999a).  
 
Next, we used a technique to isolate putative secreted factors (Jacobs et al., 1997) to look 
for novel factors expressed in the chick Hensen’s node at stages 3+- 4. A genetic screen 
was carried out, resulting in the isolation of 137 sequences, which were studied by in situ 
hybridisation; 22 were found to have defined expression patterns.  
 
Based on their time and pattern of expression three genes were chosen and further 
studied. Their full-length cDNAs were cloned and characterized in the context of neural 
induction. 
 
Fibulin2, a previously described extracellular protein, did not display any activity in 
neural induction assays: Fibulin2 misexpression does not induce the neural markers Sox3 
or Sox2 and a combination of FGF8 and Fibulin2 is unable to induce Sox2 in the competent 
epiblast of the area opaca. 
 
Calreticulin, a previously well characterized endoplasmic reticulum protein, was cloned 
and studied in connection with neural induction. It is unable to induce neural markers in 
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the area opaca but can extend the border of the neural plate when ectopically expressed 
by electroporation. This activity resembles that of BMP antagonists. 
 
Nhbr90, a previously undescribed 2Kb sequence, seems not to encode a protein, but may 
function as a long non-coding RNA. It is expressed early in development in the hypoblast 
and later in the node. Surprinsigly, nhbr90 is able to induce both Sox3 and Sox2 in the 
extraembryonic epiblast of the area opaca. 
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Chapter 2 
General Methods 
 
 
 
 
This chapter is dedicated to material and methods commonly used throughout the work 
presented in this manuscript. Specific methodologies will be introduced at the beginning 
of each subsequent chapter, as appropriate.  
 
Chick embryology 
Fertile hens’ eggs (White Leghorn: SPAFAS, U.S.A.; Henry Stewart &Co., UK) were 
incubated at 38ºC to the desired stages. For electroporation and grafts embryos were 
cultured using a modified New Culture Method (Stern and Ireland, 1981). 
 
Electroporation 
Chick embryos at stage 3+ were placed in an acrylic chamber with Pt cathode embedded 
in the bottom, exposed to the saline through a 1.5mm window. The embryo was 
positioned over the window (dorsal side up) and the DNA (pCAβ-IRES-GFP construct) 
was applied between the dorsal side of the embryo and an adjustable anode (Pt or Cu 
wire). Three 50 ms pulses of 5-6 volts were applied with a TSS10 pulse generator 
(Intracel). Embryos were then placed in New culture (Stern and Ireland, 1981) and grown 
to the desired stages. 
 
FGF beads 
Heparin-coated acrylic beads (Sigma) were washed several times in phosphate buffered 
saline (PBS) and then soaked in purified recombinant human FGF-4 (Sigma) or mouse 
FGF-8b (R&D systems and Sigma) at 10µg/µl in PBS for 3 hours on ice. Control beads 
were soaked in PBS alone. Beads were then washed in PBS and implanted in the 
embryos. 
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Transfected cells 
COS cells were grown in DMEM containing 10% new born calf serum and 1µg DNA 
transfection was performed using Lipofectamine Plus (Gibco). Control cells were “mock 
transfected” with 1µl water instead of the DNA. 24 hrs after transfection, pellets of about 
1 000 cells each were generated by setting up hanging drop cultures. 24 hrs later the 
hanging drops were ready for being placed in the embryos. 
The following expression constructs were used for transfection: Dkk1 (kind gift from E. 
Laufer), Crescent (kind gift from E Laufer and M Marvin) and soluble Nfz8 (Deardorff et 
al., 1998)(kind gift from S. Sokol). 
 
Whole mount in situ hybridization 
Whole mount in situ hybridization was performed using DIG- or fluoresceine-labeled 
probes. Below is a table with all the DNAs used for transcription: 
DNA 
Restriction/ 
transcription Kind gift from  
BMP4 BamHI/T3 Karel Liem (Liem et al., 1995)  
Bra Xba/T3 Jim Smith (Kispert et al., 1995) 
Cash4 BamHI/T3 Kate Storey (Henrique et al., 1997) 
cNR1 NotI/T7 Michael Kuehn (Levin et al., 1995) 
CCRT BamHI/T3  (present work) 
CFbln short ClaI/T7  (present work) 
Chd EcoRI/Sp6 (Streit et al., 1998) 
Dlx5 NcoI /T7 Gail Lizarraga (Ferrari et al., 1998) 
ERNI KpnI/T3 (Streit et al., 2000a) 
FCrt XbaI/T7 Marnie Halpern (Rubinstein et al., 2000) 
FGF8 Not1/T3 Izpisua-Belmonte (Vogel et al., 1996) 
follistatin ClaI/T3 Laura Paganess (Hemmati-Brivanlou et al., 1994a) 
GATA2 NdeI/T7 (Sheng et al., 1997) 
GATA3 NdeI/T7 (Sheng et al., 1997) 
Geminin EcoRI/T3 (Papanayotou et al., 2008) 
Hoxb9 HindIII/T7 Linda McNaughton (Grapin-Botton et al., 1995) 
msx1 BglII/T3 Karel Liem (Liem et al., 1995) 
Nhbr90 ClaI/T7 (present work) 
noggin XhoI/T3 Karel Liem (Connolly et al., 1997) 
Pax6 EcoRI/T7 M Goulding (Goulding et al., 1993) 
Pax7 SalI/T7 (Kawakami et al., 1997) 
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Sax1 Asp718/T7 Kate Storey (Spann et al., 1994) 
Slug XhoI/T3 David Wilkinson (Nieto et al., 1994) 
Smad6 Xba/T7 Ed Laufer (Yamada et al., 1999) 
Smad7 Xba/T7 Ed Laufer (Unpublished) 
Sox2 PstI/T7 Paul Scotting (Uwanogho et al., 1995) 
Sox3 PstI/T7 Paul Scotting (Uwanogho et al., 1995) 
 
 
The plasmids were linearized with the enzyme indicated above, extracted with 1:1 
phenol:chloroform, ethanol precipitated and ressuspended in clean water. Transcriptions 
were performed using 1µg of linearized plasmid, the appropriate enzyme and either 
Digoxigenin-nucleotide mix (Boerhinger) or fluorescein isothiocyanate-(FITC) nucleotide 
mix (Boerhinger) for  2 hours at 37ºC. RNase-free DNase (1µl/µg) was then added to 
destroy the DNA template and the resulting RNA was ethanol precipitated with 4M LiCl. 
In order to reduce the background in the in situs, the precipitations were carried out twice 
and in the case of Sox2 and Sox3, three times. The resulting RNA was resuspended in 
RNase-free water and stored in hybridization buffer (50% formamide, 1.3x SSC pH5.3, 
5mM EDTA, 50µg/ml yeast tRNA, 100µg/ml Heparin, 0.2% Tween-20 and 0.5% 
CHAPS). 
 
The embryos were collected at the required stages or time after manipulation in calcium-
magnesium-free PBS (CMF) and fixed in fresh 4% formaldehyde in CMF containing 2mM 
EGTA overnight at 4ºC. Embryos were then transferred to absolute methanol and stored 
at –20ºC for up to a week.  
 
Embryos were progressively rehydrated in 75%, 50% and 25% methanol in PBS 
containing 0.1% Tween (PTW). Following two more washes in PTW, the embryos were 
treated for 15 minutes with 1µg/µl Proteinase K, rinsed in PTW and post-fixed in 4% 
formaldeheyde containing 0.1% glutaraldehyde for 20 to 30 minutes at room 
temperature. Embryos were then washed again in PTW, transferred to hybridization 
solution and pre-hybridized at 70ºC for 4 hrs.  Hybridization solution was replaced by 
the labelled RNA probe and hybridization proceeded overnight at 70ºC. 
 
The following day, the embryos were washed at 70ºC in hybridization solution (3x 30 
minutes) and in 1:1 hybridization solution: TBST (TBS with 1% Tween) for 20 minutes. 
Embryos were then brought to room temperature, washed in TBST alone (3x 30 minutes) 
and then blocked with 5% heat inactivated goat serum and 1mg/ml bovine serum 
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albumin in TBST (blocking buffer) for 3 hours at room temperature.  Embryos were 
incubated in anti-Digoxigenin-AP antibody (Roche) 1:5000 in blocking buffer or in anti-
fluorescein-AP (Roche) 1:2000 in blocking buffer. 
 
Embryos were extensively washed in TBST for a minimum of 5 hours with frequent 
changes of washing solution.  Sox2 and Sox3 in situs benefited if the post antibody washes 
were extended until the following day at 4ºC.For the detection of alkaline phosphatase, 
embryos were rinsed in NTMT (0.1M NaCl, 0.1M Tris-Hcl pH9.5, 0.05M MgCl2, 1% 
Tween; 2x 10 minutes) and then incubated in one of the following solutions: 
- 1.5 ml NTMT containing 4.5 µl NBT (Sigma) and 3.5 µl BCIP (Roche)  - 
develops into a dark blue colour; 
- 1 ml NTMT containing 7 µl NBT – develops into a light blue colour; 
- 1 ml NTMT containing 7µl INT/BCIP (Roche) – develops into a brick red 
colour. 
 
When double in situs were to be performed, the two probes FITC-labelled and DIG-
labelled were combined for the hybridization step. Embryos were washed as described 
above and the anti-DIG and anti-FITC antibodies, both coupled with alkaline 
phosphatase were then detected sequentially.  The anti-DIG antibody was normally 
detected first (either with NBT alone or with INT/BCIP) and the remaining alkaline 
phosphatase activity was inactivated by fixing the embryos overnight and then 
transferring them to TBST (containing 0.01% Tween) for 2 hours at 70ºC. Detection of the 
anti-FITC antibody was normally carried out with NBT/BCIP. After the in situs were 
developed embryos were kept in 4% formaldehyde. 
 
Immunostaining 
GFP protein in the electroporated embryos was detected with antiGFP antibody. The 
embryos were washed in PTW (3x 1 hour), placed in blocking buffer for 3 hours at room 
temperature and left in mouse anti-GFP (Molecular Probes) antibody 1:2000 in blocking 
buffer overnight at 4ºC. The following day, embryos were washed with PTW (5x1hour) 
and incubated in the secondary antibody, GαR HRP (Santa Cruz) 1:5000 in blocking 
buffer, overnight at 4ºC. After three washes for one hour each, HRP was detected using 
DAB in 1mMTris pH 7.4. Oxidation was aided by adding H2O2 and the reaction stopped 
when a brown precipitated was detected.  
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Histology 
After post-fixing, the embryos were incubated for 5 minutes in absolute methanol and 10 
minutes in propan-2-ol (2-isopropanol), followed by clearing in absolute 
tetrahydronaphthalene for 30 minutes. The embryos were infiltrated in 1:1 
tetrahydronaphthalene:paraffin wax for 30 minutes at 60ºC, followed with 3 changes (30 
minutes) of pure wax at 60ºC and placed into a mould. The wax was then left to set and 
8-10µm sections were performed in a microtome. The sections were placed on gelatin-
albumen subbed glass slides and dried overnight at 37ºC.  Sections were then de-waxed 
in Histoclear and mounted in Canada Balsam.  
 
Photography 
Whole mounts were normally photographed from the dorsal side using a dissecting 
microscope and oblique lighting from a fibra optics source.  Photographs were taken with 
a digital camera (Zeiss Axiovision) attached to a computer with Axiovsion software.  
Sections were photographed on an Olympus Vanox-T compound microscope with 
Nomarski Differential Interference Contrast or bright field optics. 
 
Library screening and isolation of full length clones 
The initial partial length clones nhbr34, nhbr90 and nhbr307 were used to screen a stage 
2-4 chick cDNA library (kind gift of Juan Carlos Izpisua-Belmonte), directly cloned in 
Uni-Zap (Stratagene), under stringent conditions (0.1xSSC, 65°C). The radioactive probes 
were synthesized with Prime IT II labelling kit (Stratagene) using 20ng of the template 
DNA fragment and 5µl (50µCi) [α-32P]dCTP. Incorporated nucleotides were removed 
using a Probe Quant G-50 Micro Column (Pharmacia Biotech). 1 mg salmon sperm DNA 
(Sigma) was added to the probes and the mixtures were boiled for 5 minutes, allowed to 
cool on ice for 5 minutes and then added directly to the pre-hybridization solution. About 
2x105 clones were screened. Up to 5 positive phage plaques were replated and a 
secondary screen performed using the same radiolabelled probes, under the same 
conditions (0.1xSSC, 65°C). The positive plaques were in vitro excised and cloned into 
pBlueScript plasmids using ExAssist™ Interference-Resistence helper Phage (Stratagene). 
Clones were then PCR amplified with T3 and T7 primers (94°C, 1 min.; 55°C, 2 min.; 
72°C, 2 min.; 30 cycles) and the longest clones were sequenced.   
 
Northern Blot 
Total RNA was isolated from approximately 30 embryos each at stage 3, 5 and 7-8. 
Embryos were collected in PBS and the area opaca removed. The embryos were rapidly 
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transferred to GUA-SCN (4M guanidinium thiocyanate, 26mM Na-citrate, 0.5% Na-
Sarcosyl, 0.7% mercaptoethanol), phenol extracted (pH4.0) once and chloroform extracted 
twice. After ethanol precipitation, the pellets were resuspended in GUA-SCN, re-
precipitated and resuspended in 0.1% SDS. 10µg total RNA at each stage (3, 5 and 7-8) 
was run on a 1.5% agarose gel containing 2.2M formaldehyde, for about 3 hours at 85V. 
The gel was then soaked in 0.05M NaOH (20 minutes) and neutralized in 10xSSC (45 
minutes). The RNA was transferred overnight and the blot was pre-hybridized  (0.4M 
Sodium Phosphate buffer pH7.2, 1mM EDTA pH8.0, 1% BSA, 7% SDS) and hybridized at 
65°C with radiolabelled probes [α-32P]dCTP made from both the initial partial clones and 
the full length clones obtained after the library screnning  (mentioned above).  The filters 
were exposed to X-ray film (Fuji) overnight   at –80°C and developed using an X-O-Mat.  
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Chapter 3 
Challenging the Default Model of Neural 
Induction 
 
 
 
 
 
Introduction 
 
Around the time of gastrulation in vertebrate embryos, the nervous system is induced 
from part of the ectoderm under the influence of signals emanating from the organizer. 
This interaction is known as neural induction (Hemmati-Brivanlou and Melton, 1997a; 
Hemmati-Brivanlou and Melton, 1997b; Munoz-Sanjuan and Brivanlou, 2002; Stern, 2005; 
Streit and Stern, 1999). The discovery of neural induction in 1924 by Spemann and 
Mangold (Spemann and Mangold, 1924) generated considerable interest in identifying 
the signals responsible. Little progress was made until some 15 years ago when it was 
proposed that Bone Morphogenetic Proteins (BMP), expressed ubiquitously in the early 
embryo, act as epidermal inducers and that they need to be inhibited in the prospective 
neural plate for this structure to form (Harland, 2000; Hemmati-Brivanlou and Melton, 
1997a; Hemmati-Brivanlou and Melton, 1997b; Munoz-Sanjuan and Brivanlou, 2002). 
However, there has been considerable controversy concerning whether or not this 
“default” model provides an adequate explanation for this phenomenon, as there 
appears to be considerably more complexity to the cell interactions that lead to 
establishment of a functional neural plate  (Linker and Stern, 2004; Streit and Stern, 1999). 
  
BMPs are members of the transforming growth factor β (TGF-β) family of secreted 
proteins and the main pathway for TGF-β signals is mediated by heterodimeric receptors 
with serine/threonine receptor kinases and cytoplasmic proteins called Smads (Derynck 
et al., 1998; Heldin et al., 1997; Massague and Chen, 2000; Nakao et al., 1997a). TGF-β 
binds to serine/threonine kinase receptors, consisting of both type I (TβRI) and type II 
(TβRII). The activated type I receptor transmits the intracellular signals through the 
phosphorylation of receptor-regulated Smad proteins (R-Smads), Smad1, Smad2, Smad3, 
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Smad5 and Smad8. Smad1, Smad5 and Smad8 serve as substracts for the BMP receptors 
whereas Smad2 and Smad3 function to transduce for the TGFβ, activin and nodal signals. 
Activated R-Smads form heteromeric complexes with a common partner, Smad4 (Co-
Smad) and translocate into the nucleus (Chen et al., 1998; Hata et al., 1998; Heldin et al., 
1997; Kretzschmar et al., 1997b; Lagna et al., 1996; Liu et al., 1997a; Liu et al., 1997b; 
Macias-Silva et al., 1998; Massague and Chen, 2000). Once localized within the nucleus, 
the Smad heterocomplex recruits either transcriptional activators or co-repressors to 
target their action upon a specific subset of target genes (Massague and Chen, 2000; 
Massague and Gomis, 2006). 
 
The transduction of the TGF-β signals is tightly regulated by the inhibitory Smads (I-
Smads), Smad6 and Smad7 (Imamura et al., 1997; Nakao et al., 1997b). Smad6 
preferentially inhibits BMPs, whereas Smad7 inhibits signalling by all TGF-β family 
members including TGF-β, activin and BMP (Ishisaki et al., 1999; Itoh et al., 1998).  Both I-
Smads compete with R-Smads for binding to activated type I receptors and therefore 
inhibiting the phosphorylation of the R-Smads (Shi and Massague, 2003). Furthermore, 
they both recruit Smurf ubiquitin ligases and induce degradation of the receptors (Wicks 
et al., 2006). Smad6 also inhibits BMP signalling by competing with Smad4 for binding 
with phosphorylated Smad1, yielding inactive Smad1—Smad6 complexes (Hata et al., 
1998). Recent studies further suggest that Smad7 also inhibits TGF-beta signalling in the 
nucleus, by disrupting the formation of the TGF-beta-induced functional Smad-DNA 
complex (Zhang et al., 2007).  
 
 
Whether or not the default model provides a good enough explanation for neural 
induction, it is clear that BMP inhibition plays some part in the process. In this chapter 
we aim to re-address the role of BMP and BMP antagonism during neural induction. 
Misexpression of BMP transcripts inhibits the expression of the definitive neural marker 
Sox2, confirming BMP inhibition as a necessary step in neural induction. However, 
inhibition of BMP signals alone is not sufficient to neuralise competent the ectoderm: by 
manipulating the BMP pathway intracellularly, using the inhibitory Smads, Smad6 and 
Smad7, we show that inhibiton of BMP signals does not result in neural induction. Even a 
combination of Smad6, Smad7 and other BMP antagonists together with FGF, Cerberus and 
Wnt antagonists is unable to induce neural markers in competent epiblast. Finally we 
reveal that the only cells that can be made to express neural markers in response to BMP 
antagonists are at, or connected with, the border of the neural plate. 
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Material and Methods 
 
Fertilized hens eggs (Brown Bovan Gold; Henry Stewart and Company) were incubated 
at 38ºC to reach the desired stages. 
 
All the factors used in the present work were introduced to the area opaca of the chick 
embryo at stage3+/4 by electroporation, by grafting cells expressing factors or as proteins 
in heparin-coated beads. Electroporations were performed as previously described 
(Sheng et al., 2003). The coding region of xSmad7 (Casellas and Brivanlou, 1998), cSmad6 
(Yamada et al., 1999), cChordin (Streit et al., 1998), Xenopus truncated BMP receptor 
(Suzuki et al., 1994) and cCerberus (Zhu et al., 1999) were cloned into pCAβ-IRES-GFP.  
FGF8 (R&D systems, at a concentration of 50µg/ml) was delivered bound to heparin 
beads, as previously described (Streit et al., 2000a). Secreted proteins Noggin (Streit and 
Stern, 1999a) and the Wnt inhibitors Dkk1 (kind gift of E. Laufer), Crescent (Kind gift of 
M. Marvin and E. Laufer) or soluble NFz8 (Deardorff et al., 1998) were used to transfect 
COS cells, as previously described (Streit et al., 1998) 
 
The Sox2 enhancer N2, in ptKEGFP (a kind gift fromH.  Kondho, (Uchikawa et al., 2003), 
was subloned into ptkLacZ (a kind gift from O. Voisculescu). 
 
Node grafts were performed as previously described (Streit et al., 2000a). In situ 
hybridization and whole mount immunocytochemistry were carried out as described in 
Chapter 2. Clones for chick Smad6 and chick Smad7 were a kind gift from Ed Laufer; Sox2 
and Sox3 were provided by R. Lovell-Badge and P. Scotting (Uwanogho et al., 1995) and 
chick Brachyury was provided by Jim Smith (Kispert et al., 1995). Following in situ 
hybridization with Sox2, grafted cell pellets produce background staining. In those cases, 
sections were performed in order to access for Sox2 epiblast expression. 
 
More detailed description of the procedures followed can be found on Chapter 2. 
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Results 
 
Neural induction: the inhibitors, the inducers and the readouts - fitting 
almost neatly with the default model 
This chapter explores the role of BMP inhibition in neural induction and, albeit 
extensively studied in various reports (Connolly et al., 1997; Connolly et al., 1995; 
Graham et al., 1994; Houston et al., 1994; Rex et al., 1997a; Rex et al., 1994; Streit et al., 
1998; Uwanogho et al., 1995), it seemed appropriate to re-analyse the expression pattern 
of some of the BMPs, BMP2 and BMP4, the “neural inducers” Chordin, Noggin and 
Follistatin, and the “readouts” of neural induction, Sox3 and Sox2, during the 
developmental stages neural induction is believed to be taking place.  
 
At stage 3/3+ Chordin transcripts concentrate in the anterior tip of the primitive streak 
(Fig 3.1 D). At stage 4+ (Fig 3.1 K) and thereafter (Fig 3.1 R) Chordin is restricted to the 
Hensen’s node and the entire length of the notochord (node derivative). 
 
Regarding noggin, it has been reported that it is first detected in the anterior part of the 
primitive streak at stage 3 (Connolly et al., 1997). Our results, however, reveal that noggin 
only starts to be expressed, very weakly (and if at all) at stage 4/4+ (Fig 3.1 J) and its 
signal becomes stronger by stage 5 and 6 (Fig 3.1 Q) with transcripts in the notochord 
and forming neural plate. 
 
In the original paper (Connolly et al., 1995) where chick follistatin expression was first 
described, the authors detected expression at stage 4 in the anterior part of the node. This 
is in contrast with mouse expression, where the primitive streak and not the node express 
the gene (Albano et al., 1994). In our results, however, chick follistatin only starts to be 
detected at stage 5 (Fig 3.1 S) with strong expression in the head process and the regions 
lateral to the node. Expression is never seen in the node or in the primitive streak (Fig 3.1 
E, L and S). 
 
Sox2 and Sox3 present a very similar expression pattern, confined to the prospective 
neural plate and neural plate (Fig 3.1 F, G, M, N, T and U). But whereas Sox3 starts to be 
expressed even before primitive streak formation (not shown), Sox2 transcripts only start 
to be detected at around stage 4 (Fig 3.1 N).  
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The expression of BMP genes after the full primitive streak stage in the chick has been 
described (Liem et al., 1995; Schultheiss et al., 1997; Watanabe and Le Douarin, 1996)Here 
we decided to re-analise the expression of BMP2 and BMP4 during the developmental 
stages neural induction is occurring. At stage 3/3+, BMP2 expression is present in the 
posterior area pellucida epiblast, including the primitive streak (Fig 3.1 A), then expands 
until it surrounds the forming neural plate, where expression persists throughout most of 
the non-neural ectoderm (Fig 3.1 H and O). BMP4 transcripts start to be detected, very 
weakly, at stage 3, in the most posterior epiblast of the area pellucida (Fig 3.1 B). By stage 
4, expression expands anteriorly, forming a ring of epiblast cells surrounding the future 
neural plate (Fig 3.1. I) and then condenses into a line of cells at the boundary between 
neural and non-neural ectoderm (Fig 3.1 P). 
 
Some of the expression patterns presented above correlate with the default model. 
However, it is important to note that, there is no overlap of expression between the BMPs 
and the neural inducers Chordin, noggin and Follistatin. Furthermore, Noggin just starts to 
be expressed in the node when the neural inducing ability of the node starts to decrease 
(Storey et al., 1992; Storey et al., 1995) and its expression persists after the node has lost 
the ability to induce neural tissue (Connolly et al., 1997). This is also the case for follistatin 
(Connolly et al., 1995). 
 
 
The Inhibitory Smads (I-Smads), Smad6 and Smad7 are expressed at the 
border of the neural plate 
In vertebrates, Smad6 and Smad7 function as intracellular inhibitors of BMP, TGF-β and 
activin signalling pathways (Imamura et al, 1997; Topper et al, 1997; Hata et al, 1998, 
Kleeff et al, 1999). Whereas Smad6 inhibits specifically the BMP pathway (Hata et al., 
1998; Imamura et al., 1997) and the BMP pathway involving TCF3/Lef1/β-catenin (von 
Bubnoff and Cho, 2001), Smad7 inhibits signals of all TGF-β family members (Hayashi et 
al., 1997; Nakao et al., 1997a). 
 
Despite being largely studied, the Inhibitory Smads expression pattern is not very well 
documented in the chick embryo, at least not at gastrula stages of development (Yamada 
and colleagues (Yamada et al., 1999) have reported the cloning and expression of chick 
Smad6, focusing mainly on heart development stages). In order to determine the 
spatiotemporal expression of Smad6 and Smad7 during neural induction, whole mount in 
situ hybridization was performed in chick embryos form pre-streak stages to the 
appearance of the first somites. cSmad6 expression (Fig 3.2 A-G) is first detected at stage 4 
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in the posterior most part of the embryo, including the primitive streak and at the margin 
of the embryo and excluding the prospective neural plate (Fig 3.2 B, E-G); As 
development proceeds, the Smad6 mRNA remains excluded from the neural plate, but 
accumulates at the border and expands into the blood mesoderm in the area opaca (Fig 3.2 
C,D). Smad7 expression follows a very similar pattern (Fig 3.2 H-N), with the exception 
that its transcript is detected earlier, very weakly at stage 3 embryos, in a crescent type 
expression around the future neural plate (Fig 3.2 H). By stage 4, the expression becomes 
strongly localized to the border of the neural plate and very posterior streak (Fig 3.2 I, L-
N).   
 
Like in the case of BMP expression, Smad6 and Smad7 are expressed predominantly at the 
border of the neural plate, more consistent with their possible roles in positioning the 
neural plate border than of acting in the process of neural induction. 
 
Smad7 can activate the N2 Sox2 enhancer 
Sox2 expression in the chick embryo was recently found to be controlled by a large 
number of different enhancers, of which two (N1 and N2) are responsible for the initial 
domain of expression in the prospective neural plate of stage 4+-5 embryos (Uchikawa et 
al., 2003). N2 directs Sox2 expression to the largest and earliest, anterior domain, whereas 
N1 activates Sox2 in the paranodal region, destined to give rise to posterior hindbrain 
and the entire spinal cord (Takemoto et al., 2006; Uchikawa et al., 2003). Uchikawa and 
colleagues (Uchikawa et al., 2003) also demonstrated that N1 is induced by a graft of 
Hensen’s node in the area opaca. To test weather a node can activate the N2 enhancer, a 
N2-GFP construct was electroporated, together with a node graft, in the area opaca of a 
chick stage 3+ host (Fig 3.3 A). After 18-22 hours of culture, the activation of the N2 
enhancer could be detected by fluorescence (Fig 3.3 B). The embryos were then probed 
for Sox2, with expression in the induced secondary axis in all the cases tested (12/12), of 
which, 9 revealed activation of the N2 enhancer as shown by the GFP antibody staining 
(Fig 3.3 C and D). Further evidence that the N2 construct is functional is provided when 
N2-TK-GFP is electroporated into a large domain of the neural and prospective neural 
plate at stage 3+ (Fig 3.3 E), revealing the accumulation of GFP as shown by fluorescence 
(Fig 3.3 F) and by antibody staining (Fig 3.3 H) in all of the 12 embryos tested. 
 
Smad7, a multifunctional Smad antagonist which inhibits not only Smad1/5/8 (BMP 
effectors) but also Smad2/3 (Nodal/Activin effectors; (Bhushan et al., 1998; Casellas and 
Brivanlou, 1998; Pogoda and Meyer, 2002), is reported to be a potent neural inducer in 
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Xenopus (Bhushan et al., 1998; Chang and Harland, 2007). We decided, therefore, to test if 
Smad7 could act as a neural inducer in our chick experiments. 
 
To check if Smad7 could mimic the effect of a node graft in activating N2, the  N2-TK-
LacZ and pCAβ-Smad7-ires-GFP constructs were co electroporated in a broad domain of 
the area opaca of stage 3+ chick embryos (Fig 3.3 I). LacZ staining after O/N culture 
confirmed the ability of Smad7 for activating N2 in 7 out of the 12 embryos tested (Fig 3.3 
J and K). In control experiments where the N2 construct was co-electroporated with an 
empty pCAβ-GFP, no LacZ staining was obtained (0/5; not shown).  
 
 
Inhibition of TGF-β  signalling is not sufficient for neural induction in 
the chick 
Smad7 alone can activate the N2 enhancer, but is it sufficient to cause competent epiblast 
cells to acquire Sox2 expression? In order to test this, pCAβ-Smad7-IRES-GFP was 
electroporated in a small domain of the area opaca of stage 3+ chick embryos (Fig 3.4 A). 
Following incubation for 18-20 hours, no expression of the mesodermal marker Brachyury 
or the neural marker Sox2 was observed (0/12; Fig 3.4 P-R). It is conceivable that the 
amount of Smad7 introduced is insufficient to block all BMP signalling in this assay, or 
that Smad7 is not sufficiently potent. To investigate this, other BMP antagonists were 
tested in the same assay, alone or in combination, resulting in no Sox2 or Brachyury 
induction in all the experiments performed for the different factors: Noggin (0/6; Fig 3.4 
B and C), Chordin (0/10; Fig 3.4 D-F), dnBMPR (0/5; Fig 3.4 G-I), Cerberus (0/4; Fig 3.4 J-
L), Smad6 (0/12; Fig 3.4 M-O) or all the factors together (0/9; not shown). 
 
These results confirm previous observations (Linker and Stern, 2004; Streit et al., 1998) 
that inhibition of BMP is not sufficient to induce Sox2 in competent chick epiblast. We 
also show that, even though Smad7 is unable to induce Sox2, it does activate the isolated 
N2 enhancer of Sox2, suggesting the existence of silencer elements outside of the N2 
enhancer. 
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Inhibition of TGF-β  signalling is not sufficient for neural induction in 
the chick even when combined with Wnt antagonists and FGF  
It has been recently reported that neural induction is initiated by FGF signals (Streit et al., 
2000a) and that this, together with the inhibition of Wnt signals, can induce the neural 
marker Sox2 (Wilson and Edlund, 2001; Wilson et al., 2001). This later experiments were 
conduced in cell culture and the results could not be reproduced when performed in vivo, 
in the chick embryo, even when BMPs where inhibited together with FGFs and Wnt 
antagonists (Linker and Stern, 2004). Further repeating those experiments, we obtained 
similar results (Fig 3.5 I, J, J’, Q, R and R’). FGF8 alone is able to induce the early neural 
marker Sox3 in the extraembrionic area opaca in all the embryos tested (11/11; Fig 3.8 D 
and E). No Brachyury or Sox2 (0/10; Fig 3.5 A and B) were induced by FGF8 alone or 
FGF8 combined with either Smad6 (0/7; not shown), or with Smad7 (0/7; not shown) or 
with both together (0/9, Fig 3.5 C-E). Different combinations of the BMP-Smad and TGF-
β/activin pathways inhibitors together with the inhibition of Wnts and with FGF signals 
always resulted in no Brachyury or Sox2 induction: FGF8+Smad6+Smad7+αWnt (0/5; Fig 
3.5 F-H and H’); FGF8+Smad6+αWnt+cerberus+noggin+dnBMPR+Chordin (0/6, Fig 3.5 K-
M and M’); FGF8+Smad7+αWnt+cerberus+noggin+dnBMPR+Chordin (0/10, Fig 3 N-P 
and P’) or all the factors together 
FGF8+Smad7+Smad6+αWnt+cerberus+noggin+dnBMPR+Chordin (0/15, Fig 3.5 S-U and 
U’).  
 
These results confirm the previous conclusion (Linker and Stern, 2004; Streit et al., 1998) 
that BMP antagonism is insufficient to induce Sox2 expression, even when combined with 
Wnt-antagonists and FGF. 
 
 
BMP inhibition is required for the formation of the neural plate 
The experiments performed so far suggest that BMP inhibition is not sufficient for neural 
induction, but is it necessary? A previous study (Linker and Stern, 2004) demonstrated 
that overexpression of BMP4 into the prospective neural plate of stage 3+ embryos does 
not have an effect on the early neural marker Sox3 in the first 15 hours of the experiment, 
while Sox2 is strongly downregulated. At 20 hours both Sox3 and Sox2 are 
downregulated and the neural plate morphology is lost in the electroporated region. Is 
the neural plate border shifted laterally in the electroporated side of the embryos?  
To address this, Xenopus BMP4 (pCAβ-XBMP4-IRES-GFP) was electroporated into the 
prospective neural plate of stage 3+ embryos. After 18-20 hours, the expected reduction of 
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the neural plate was observed in all the embryos tested (35/35; Fig 3.6 A, D, G and J), 
together with a lateral shift of the domain of expression of the border markers Dlx5 (8/8; 
Fig 3.6 B and C), msx1 (9/9; Fig 3.6 E and F), Pax7 (9/9; Fig 3.6 H and I) and Slug (9/9; 
Fig 3.6 K and L). 
 
This results, together with previous observations (Linker and Stern, 2004), show that 
BMP inhibition is necessary for expression of the definitive neural plate marker Sox2 and 
for neural plate formation. Moreover, BMP modulation plays a role in positioning the 
border of the neural plate. 
 
 
The border of the neural plate is uniquely sensitive to BMP antagonists 
In the chick embryo, it was previously shown, using grafts of pellets of heterologous cells 
secreting BMP4 or its antagonists (Chordin or Noggin), that only the border of the neural 
plate (prospective neural crest and placode region) is sensitive to BMP signalling: in this 
region, misexpression of BMP4 narrows the neural plate while misexpression of Chordin 
or Noggin expands it into the prospective epidermis (Streit et al., 1998; Streit and Stern, 
1999a; Streit and Stern, 1999b). To test whether intracellular BMP antagonists exert the 
same effect, expression constructs were electroporated as a line extending from the 
prospective neural plate to the edge of the area opaca in chick embryos at stages 3+-4 (Fig 
3.7 A). Electroporation of Smad7 produced a marked extension in the expression domains 
of Sox3 (14/15; Fig 3.7 D and E) and Sox2 (16/19; Fig 3.7 F and G and Fig 3.9 G and H). 
Under the same conditions, we also reported the expansion of the expression domains of 
the neural plate border markers Pax7 (11/11; Fig 3.7 L and M) and Slug (9/9; Fig 3.7 N 
and O) and of msx1 (10/10; Fig 3.7H and l), Dlx5 (10/10; Fig 3.7 J and K) and also BMP4 
(8/8; Fig 3.7 B and C) into the non-neural ectoderm.  
 
We carried out a similar experiment but using Smad6 instead, obtaining comparable 
results (Fig 3.8). Smad6 overexpression dramatically expands the domain of expression of 
Sox2 in the electroporated region (60/61; Fig 3.8 A, D, G and J; Fig 3.9 J and K) as well as 
of msx1 (15/16; Fig 3.8 E and F), Pax7 (18/18; Fig 3.8 H and I) and Slug (11/12; Fig 3.8 K 
and L). 
 
We went further and tested several other BMP inhibitors on their ability to extend the 
border of the neural plate and found that all the factors tested were able to extend the 
domain of Sox2 expression (4/5 for dnBMPR; Fig 3.9 M and N; 6/6 for Cerberus; Fig 3.9 P 
and Q; 7/9 for Chordin; Fig 3.9 S and T).  
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It is important to note that in all of the experiments performed, in which there was 
expansion of Sox2 or Sox3 domains, no mesoderm was ever induced (0/29; Fig 3.9; Bra 
expression in light blue). 
 
Control experiments had no effect on any of the markers tested (0/5 for BMP4; 0/8 for 
Sox3; 0/8 for Sox2; 0/4 for msx1; 0/6 for Dlx5; 0/6 for Pax7 and 0/7 for Slug; not shown). 
 
 
BMP inhibition induces border markers in cell populations not in 
contact with the neural plate 
While the experiments above were being carried out, a colleague in the lab reported that 
Pax7 expression was not cell-autonomous to the Smad-electroporated cells: it extended 
many cell diameters away from transfected cells, but always extended as a continuous 
line from the normal neural plate even if the line of electroporated cells was 
discontinuous (Linker et al., 2009). This observation raised the possibility that cells from 
the host neural plate are stimulated to migrate laterally when BMP signalling is inhibited. 
This idea has been refuted in a recent report (Linker et al., 2009) where cell movements 
between the electroporated side and the contralateral side (which had been marked with 
DiI) were compared by time-lapse video microscopy and no differences were observed in 
the patterns of cell movements between the two sides.  
 
Can BMP inhibition in the non-neural ectoderm, and in an area discontinuous with the 
neural plate, still result in the expression of neural and border markers? To test this, 
(pCAβ-Smad6-IRES-GFP) was electroporated into the non-neural ectoderm of stage 3+ 
embryos, away from the prospective neural plate. While this experiment resulted in no 
induction of Sox2 (0/57; Fig 3.10 A, D, G and J), we observed an induction of all the 
border/neural crest markers tested (12/12 for Dlx5; Fig 3.10 B and C; 6/15 for msx1; Fig 
3.10 E and F; 15/18 for Pax7; Fig 3.10 H and I; 10/12 for Slug; Fig 3.10 K and L). No effect 
was observed in control experiments where pCAβ-GFP was electroporated (0/8 for Sox2; 
0/8 for Dlx5; 0/7 for msx1; 0/6 for Pax7; 0/7 for Slug; not shown). 
 
This experiment confirms that the expansion of neural plate and border markers caused 
by inhibiting BMP signalling is due to an induction of these markers in the lateral 
epidermis and not to an alteration of cell movements. 
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Discussion 
 
Neural induction by inhibitory Smads cannot be separated from 
mesendoderm formation in Xenopus or chick 
Two previous studies showed that a combination of eFGF (FGF4; (Isaacs et al., 1992) 
signalling together with BMP inhibition is sufficient to induce neural tissue in the ventral 
epidermis of Xenopus embryos in the absence of expression of a set of endodermal or 
mesodermal markers (de Almeida et al., 2008; Delaune et al., 2005; Linker et al., 2009; 
Linker and Stern, 2004) On the other hand when a similar experiment (FGF4+Smad6) is 
performed in chick, brachyury a marker for mesendoderm precursors, is induced along 
with neural markers, suggesting that the induction of neural markers is an indirect 
consequence of mesendoderm induction (Linker and Stern, 2004). This difference is 
puzzling. One possible explanation for the absence of mesendodermal marker expression 
in the Xenopus experiment is that the set of markers chosen in Xenopus excludes markers 
for some very early mesendodermal state, or for a particular cell type, which is 
responsible for emitting the presumed neural inducing signals. To address this, and 
based on the finding that Nodal signalling is required for mesendoderm formation 
(Conlon et al., 1994; De Robertis and Kuroda, 2004; Driever, 1995; Jones et al., 1995; 
Kuroda et al., 2004; Perea-Gomez et al., 2001; Weng and Stemple, 2003), a recent study 
(Linker et al., 2009) examined the effect of blocking this with the specific inhibitor CerS 
(Piccolo et al., 1999) in combination with eFGF+Smad6 in the A4 blastomere of Xenopus. 
Indeed, this abolishes the expression of Sox2 and greatly reduces Sox3, more consistent 
with the results from chick (Linker and Stern, 2004; Streit et al., 2000a). Virtually identical 
results were obtained with a different cell-autonomous BMP inhibitor, ΔSmad7 (a 
Smad1-specific truncated version of Smad7, which otherwise inhibits all Smads; 
(Wawersik et al., 2005), was co-injected with eFGF, with and without CerS. In contrast, 
when the full-length Smad7 was injected, dorsal mesoderm (brachyury/chordin-expressing 
cells) was induced alongside neural markers (Sox3 and Sox2). As expected (because 
Smad7 should already block Nodal), CerS did not block the induction of dorsal 
mesoderm in this assay. In the chick, however, Smad7 did not induce either mesodermal 
(brachyury) or neural (Sox3, Sox2) markers. One possible explanation for this is that the 
chick experiments are conducted at the mid-/late gastrula stage, when competence for 
mesendoderm induction by activin/nodal signalling is rapidly declining (Dias and 
Schoenwolf, 1990; Gallera and Ivanov, 1964; Storey et al., 1992; Streit and Stern, 1997a). 
The type of FGF may also be important – in the chick it was shown that when combined 
with Smad6, FGF4, but not FGF2, -3 or -8, can induce brachyury as well as neural markers 
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(Linker and Stern, 2004). All of these results make it impossible to separate 
mesendodermal induction from induction of neural markers: neural markers are only 
expressed in both species when mesendoderm is also induced. Taken together these 
results suggest that both in Xenopus and in chick, FGF signalling together with BMP 
inhibition triggers a mesendodermal tissue (or state), which in turn is able to induce the 
expression of neural markers as a secondary effect. 
 
 
Mechanism of regulation of Sox2 expression 
In the chick embryo, the three genes of the SoxB1 class are expressed in a precise 
temporal sequence: Sox3 is activated before gastrulation in a broad domain that includes 
the prospective neural plate, followed by Sox2 in the entire presumptive nervous system 
at late primitive streak stages (stage 4+/5) and finally by Sox1 in a similar domain to the 
latter (Rex et al., 1997a; Rex et al., 1994; Rex et al., 1997b; Uwanogho et al., 1995). Grafts of 
Hensen’s node induce Sox3 within 3 hours, Sox2 after 9 hours and Sox1 later still (Streit et 
al., 2000a; Streit et al., 1998; Streit and Stern, 1999a). This timing of Sox2 activation 
corresponds approximately to the time when the grafted node can be removed and the 
responding tissue will still continue to develop into a mature neural plate – for this 
reason Sox2 is considered as a marker for induced neural plate in the chick. 
 
Sox2 expression is regulated by a complex array of 25 separate enhancer elements 
situated both up- and downstream of the coding sequence (Uchikawa et al., 2003; 
Uchikawa et al., 2004). Of these, two account for the early expression of this gene in its 
earliest domain in the chick embryo: N2 drives expression in a large region anterior to the 
tip of the primitive streak (which eventually gives rise to forebrain, midbrain and the 
most rostral hindbrain) while N1 is activated in a small paranodal domain at the same 
stage and will eventually give rise to the remaining hindbrain and spinal cord (Takemoto 
et al., 2006; Uchikawa et al., 2003; Uchikawa et al., 2004). Uchikawa (Uchikawa et al., 
2003) demonstrated that N1 can be activated by a graft of Hensen’s node. Here we show 
that N2 can also be activated by a similar graft, consistent with the fact that such grafts 
can induce a complete CNS (Dias and Schoenwolf, 1990; Storey et al., 1992). 
 
More puzzling is our finding that Smad7 activates N2, but not expression of the 
endogenous Sox2 gene. This result strongly suggests the existence of undescribed silencer 
elements outside of the N2 enhancer, which contribute to regulate the expression of Sox2. 
This is especially surprising considering that the combined activity of N1+N2 
recapitulate the entire initial domain of expression of Sox2, and suggests that Smad7 
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induces N2 through a mechanism that does not entirely correspond to the normal process 
of neural induction in the embryo or by a graft of Hensen’s node. Moreover (and unlike 
N1), the N2 enhancer lacks obvious FAST1 binding sites, which might be expected to 
respond to the BMP pathway (data not shown). These findings suggest again that the 
node, as well as the normal embryo environment responsible for generating the early 
neural plate, must contain signals that are not identical to those activated by Smad7, and 
reinforces the idea that signals in addition to inhibitors of TGFβs must be involved. 
 
 
BMP-inhibited cells express neural markers only when they form a 
continuous trail to the neural plate or its border 
The default model proposes that BMP inhibition is the only signal necessary for neural 
induction. Although its simplicity made it very attractive, there has been considerable 
debate about whether this mechanism is sufficient to explain neural induction (Stern, 
2005; Stern, 2006; Streit and Stern, 1999). The current prevailing view is that additional 
factors are required, and in particular that FGF signaling is important. At least in the 
chick, BMP inhibitors alone have not been shown to induce any markers (neural or 
otherwise) in vivo to date.  What was previously reported was hat the secreted BMP 
antagonists Chordin and Noggin can expand the neural plate only when applied directly 
to the neural/epidermal border, and likewise that BMP4 can only narrow the neural plate 
when applied to the same region (Streit and Stern, 1999a). Here we have observed a 
similar effect with the cell-autonomous BMP antagonists Smad6 and Smad7: the neural 
markers Sox2 and Sox3 and the border markers Slug and Pax7, as well as msx1 and Dlx5 
and BMP4 can be induced to extend away from their normal domains when Smad6 or 
Smad7 are electroporated as a line between the neural plate and the lateral non-neural 
ectoderm.  
 
We also show that BMP inhibition induces border markers in the non-neural ectoderm, 
but neural induction in the same cells only occurs if the BMP-inhibited cells form a 
continuous trail connecting them to the neural plate and/or its border. These findings 
suggest that neuralizing factors emanating from the neural plate spread through the 
ectoderm (“homeogenetic induction”, or induction of neural plate by neural plate 
(Mangold, 1929; Servetnick and Grainger, 1991), but only between BMP-inhibited cells. 
 
We propose a relay mechanism by which homeogenetic signals can spread from the 
neural plate only through cells in which BMP signaling is inhibited. Over-expression of 
BMP inhibitors in cells adjacent to the neural plate or its border allows these cells to 
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respond to homeogenetic neural inducers emanating from the neural plate, resulting in 
an expansion of the neural territory. In contrast, cells distant from the endogenous neural 
plate (e.g. the distant epiblast cells in chick, which are competent to make neural tissue in 
response to an organizer graft) cannot receive homeogenetic inducing signals unless they 
are connected to it by a continuous trail of BMP-inhibited cells. However, these results 
also generate a paradox. BMP inhibition in prospective epidermis induces border 
markers but not neural markers, while inhibition of BMP at the border does induce 
neural markers. Despite this, increasing the amount of BMP inhibition (even by a 
combination of Smad6 + Smad7 + dnBMPR + Noggin + Chordin + Cerberus, together with 
FGF and Wnt inhibitors) outside the border is not sufficient to induce neural markers. 
This suggests that the border markers induced by BMP inhibitors alone (Slug, Pax7, Dlx5, 
Msx1) are not indicative of induction of a full-fledged border, and that other factors must 
also be important. This is consistent with one model of neural crest induction proposing 
that signals from the underlying mesoderm are required along with BMP-inhibition for 
neural crest to be specified (Meulemans and Bronner-Fraser, 2004; Steventon et al., 2005; 
Streit and Stern, 1999a). 
 
What could be the missing signals, present in the neural plate, which can only travel 
between BMP-inhibited cells? A possible candidate is the Notch pathway, which has been 
implicated in establishing the border of the neural plate (Cornell and Eisen, 2002; Endo et 
al., 2002; Glavic et al., 2004; Kintner, 1992) and as well as generating boundaries between 
adjacent domains in many other systems (Bray, 1998; Bray, 2006; Sanson, 2001) and this 
idea requires further investigation. 
 
 
Conclusion  
This study reveals that the only cells that can be made to express neural markers in 
response to BMP antagonists are at, or connected with, the border of the neural plate.  
We further extend previous observations suggesting that BMP inhibition is not sufficient 
for neural induction. In the chick, inhibition of BMP signalling, even together with Wnt 
antagonists and FGF, is not sufficient to induce neural markers in competent epiblast. We 
therefore challenge the Default Model and propose that neural induction does not take 
place “by default” but involves a sequence of signalling events, where some players are 
yet to be identified. 
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Fig 3.1. Expression patterns of BMP2, BMP4, noggin, Chordin, follistatin, Sox3 and Sox2 in 
the early chick embryo. At stage 3/3+, BMP2 is expressed in the posterior area pellucida 
epiblast, including the primitive streak (A); the domain of expression then expands until it 
surrounds the forming neural plate where transcripts are present throughout most of the 
non-neural ectoderm (H and O). BMP4 transcripts start to be detected, very weakly, at 
stage 3, in the most posterior epiblast of the area pellucida (B); by stage 4, expression 
expands anteriorly, marking a ring of epiblast cells surrounding the future neural plate (I) 
and then condenses into a line of cells at the boundary between neural and non-neural 
ectoderm (P). Noggin transcripts seem to be absent up to stage 4+ (C and J); by stage 5, 
expression is present in the notochord (Q). Chordin is strongly expressed in the node and 
anterior streak at stage 3 (D) and 4+ (K); from stage 5, Chordin expression is present in 
the node and notochord (R). Follistatin transcripts are not detected at stage 3+ (E) or 4+ 
(L); by stage 5, expression is present in the head process and the regions lateral to 
the node (S). Sox3 and Sox2 follow a similar expression in the prospective neural 
plate and neural plate (F, M, N, T and U), with the exception that, while 
expression of Sox2 only starts to be detected at stage 4/4+ (N), Sox3 transcripts 
are detected earlier (F). 
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Fig 3.2. Expression pattern of Smad6 and Smad7 in the early chick embryo. Whole-
mount in situ hybridisation was performed with DIG-labelled probes for Smad6 (A-G) and 
Smad7 (H-N).  cSmad6 transcripts are not detected up to stage 3+ (A); At stage 4 
expression is  detected at the posterior most part of the embryo, including the primitive 
streak and at the margin of the embryo and excluding the prospective neural plate (B, E-
G); As development proceeds, the Smad6 mRNA remains excluded from the neural 
plate, but accumulates at the border and expands into the blood mesoderm in the area 
opaca (C,D). cSmad7 expression follows a very similar pattern (H-N), with the exception 
that its transcript is detected earlier, very weakly at stage 3 embryos, in a crescent type 
expression around the future neural plate (H); By stage 4, the expression becomes 
strongly localized to the border of the neural plate and very posterior streak (I, L-N).   
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Fig 3.3. Smad7 activates the N2 enhancer of Sox2. Control experiments show that the N2 enhancer 
is active when a node graft is placed in the area opaca (A-D). Similarly, when N2-GFP construct is 
electroporated in a broad domain in the prospective neural plate, N2 is activated (E-H). Smad7 
activates the N2 enhancer when electroporated in the competent epiblast of the area opaca (I-K); 
LacZ marks the cells with the enhancer active (J). 
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Fig 3.4. BMP inhibition is not sufficient for neural induction. Experiments were 
performed in the competent epiblast of the area opaca (A). Inhibition of BMP by 
missexpression of Noggin (B and C), Chordin (D-F), dnBMPR (G-I), Cerberus (J-L), 
Smad6 (M-O) and Smad7 (P-R) is not sufficient to induce Sox2 (or Brachyury, light blue 
in all the panels). All cell pellets produce background staining after Sox2 in situ 
hybridization and sections through the embryos, at the level indicated, were performed to 
show absence of expression in the epiblast (D). 
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Fig 3.5. Inhibition of BMP and Wnt, together with activation of FGF signaling, does 
not induce neural or mesodermal tissue in the chick. None of the following 
combinations induces either Brachyury (A, C, F, I, K, N, Q and S) or Sox2 (B, D, G, J, L, 
O, R and T): FGF alone (A and B); FGF + Smad6 + Smad7 (C-E); FGF + Smad6 + 
Smad7 + Wnt antagonists (Dkk1+NFz8+Crescent) (F-H); Wnt antagonists alone (I and J); 
FGF + Smad6 + Wnt antagonists + Noggin + dnBMPR + Cerberus + Chordin (K – M); 
FGF + Smad7 + Wnt antagonists + Noggin + dnBMPR + Cerberus + Chordin (N - P); 
FGF + Wnt antagonists (Q and R); FGF + Smad6 + Smad7 + Wnt antagonists + Noggin + 
dnBMPR + Cerberus + Chordin (S – U). Electroporated cells were recognized by GFP 
expression (E, H, M, P and U). In situ hybridization with Sox2 always produces 
background staining in the grafted cell pellets and sections were performed to show the 
absence of Sox2 expression in the epiblast (the plane of section is indicated by a black 
line) (H’, J’, M’, P’, R’ and U’).   
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Fig 3.6. BMP overexpression inhibits the formation of the neural plate. BMP4 was 
electroporated as a patch in the prospective neural plate at stage 3+.  18-20 hours later, a 
reduction in the domain of the neural plate is observed in the electroporated side, as seen 
by the narrowing of the domain of expression of Sox2 (A, D, G and J). This is followed by 
a lateral shift in the expression of the border markers Dlx5 (B and C), msx1 (E and F), 
Pax7 (H and I) and Slug (K and L); The electroporated region is marked by α-GFP 
antibody staining, in brown (C, F, I and L).  
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Fig 3.7. Smad7 overexpression extends the domain of the neural plate. 
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Fig 3.7. Smad7 overexpression extends the domain of the neural plate. Experiments 
were performed at stage 3+, when Smad7 was electroporated in a line spanning from the 
prospective neural plate into the area opaca (A). This resulted in the expansion of the 
neural plate, as marked by Sox3 (D and E) and Sox2 (F and G); Induced expression was 
also seen for BMP4 (B and C), msx1 (H and I) Dlx5 (J and K), Pax7 (L and M) and Slug 
(N and O); Electroporated cells are shown in brown, after α-GFP antibody staining (C, E, 
G, I, K, M and O). 
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Fig 3.8. Smad6 overexpression extends the domain of the neural plate. Experiments 
were performed at stage 3+, when Smad6 was electroporated in a line spanning from the 
prospective neural plate into the area opaca. This resulted in the expansion of the neural 
plate, as marked by Sox2 (A, D, G and J); Induced expression was also seen for Dlx5 (B 
and C), msx1 (E and F) Pax7 (H and I) and Slug (K and L); Electroporated cells are 
shown in brown, after α-GFP antibody staining (C, F, I and L). 
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Fig 3.9. The border of the neural plate is uniquely sensitive to BMP antagonists. 
Experiments were performed at stage 3+, when the BMP inhibitors were electroporated in 
a line spanning from the prospective neural plate into the area opaca (F). This procedure 
always resulted in the extension of the domain of expression of Sox2 (shown in dark 
blue), without induction of Brachyury (shown in light blue): Smad7 (G and H), Smad 6 (I – 
K), dnBMPR  (L – N), Cerberus (O – Q) and Chordin (R – S); Electroporated cells are 
shown in brown, after α-GFP antibody staining. Some positive controls for this chapter 
are also presented: Noggin expressing cells are active as, when grafted together with a 
piece of primitive streak (A) induce paraxis (B); FGF8 used in this study is active as it is 
able to induce the early neural marker Sox3 whithin 5 hours (C and D); this can be clearly 
seen, through a section, in the epiblast exposed to the FGF bead (E).  
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Fig 3.10. BMP inhibition induces border markers in cell populations not in contact 
with the neural plate. Experiments were performed at stage 3+, when Smad6 was 
electroporated, as a small patch, in the non-neural ectoderm, not in contact with the 
neural plate. This resulted in no induction of the neural marker Sox2 (A, D, G and J) and 
in the induction of the border and/or neural crest markers Dlx5 (B and C, see inset in B), 
msx1 (E and F, low level of induction, inset in E), Pax7 (H and I, see inset in H) and 
Slug (K and L, see inset in K); Electroporated cells are shown in brown, after α-GFP 
antibody staining (C, F, I and L).  
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Chapter 4 
Screen for secreted molecules from the 
Organizer 
 
Introduction  
 
The organizer and neural induction 
The formation of the vertebrate nervous system is generally thought to start at gastrula 
stages of development when signals from the organizer induce neural development in 
the ectoderm (Spemann and Mangold, 1924). Some of the molecular players involved 
have been identified based mainly on work in amphibians, and a model proposed – the 
Default Model (Sasai et al., 1995; Wilson and Hemmati-Brivanlou, 1995).  The model 
states that neural inducing signals function by inhibiting epidermis and that, in the 
absence of these signals, cells acquire neural fate as a default. Several lines of evidence 
support this general idea. The BMP antagonists Chordin (Piccolo et al., 1996; Sasai et al., 
1994), noggin (Lamb et al., 1993; Smith and Harland, 1992; Zimmerman et al., 1996), 
follistatin (Hemmati-Brivanlou et al., 1994a) and Xnr3 (Hansen et al., 1997; Smith et al., 
1995) are expressed by the amphibian organizer at an appropriate stage and share the 
property of inhibiting BMP signals, allowing the surrounding ectoderm to differentiate 
into neural (for review see (Harland, 2000; Streit and Stern, 1999; Weinstein and 
Hemmati-Brivanlou, 1999; Wilson and Hemmati-Brivanlou, 1995; Wilson and Edlund, 
2001). However, other work, performed in various species suggest more complexity. 
 
In the mouse, follistatin mutants have no neural defects (Matzuk et al., 1995c) and noggin 
mutants do not have an early phenotype, developing a normal neural plate (McMahon et 
al., 1998). BMP4 mutants, although early embryonic lethal, seem to have both a nervous 
system and epidermis (Winnier et al., 1995) and BMP7 deficient mice do not exhibit a 
neural phenotype (Dudley and Robertson, 1997). 
 
In the chick, as presented in the previous Chapter, the time of expression of the neural 
inducing molecules does not correlate with the default model. Noggin just starts to be 
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expressed in the node when the neural inducing ability of the node starts to decrease 
(Storey et al., 1992; Storey et al., 1995) and its expression persists after the node has lost 
the ability to induce neural tissue (Connolly et al., 1997). This is also the case for follistatin 
(Connolly et al., 1995). 
 
Furthermore, ectopic expression of either Chordin or noggin fails to induce an ectopic 
neural plate in a region of the area opaca that is competent to respond to neural inducing 
signals from the node (Streit et al., 1998; Streit and Stern, 1999; Streit and Stern, 1999a; 
Streit and Stern, 1999b). Furthermore, although Chordin cannot induce neural tissue 
when ectopically expressed, it can stabilize Sox3 expression in cells that have been 
exposed fro 5 hours to neural inducing signals from the node (Streit et al., 1998). 
 
Taking together, these observations suggest that, at least in the chick, BMP inhibition is 
not the only component in neural induction and that other upstream signals from the 
organizer may also be required.  
 
Secreted molecules have a signal sequence 
Proteins destined to cross the cell membrane, including both transmembrane  (eg. cell 
surface, transmembrane receptors) and secreted (eg. hormones, growth factors) 
components, contain a characteristic hydrophobic sequence (Signal Sequence). The 
presence of this signal sequence was first detected by Blobel and Dobberstein (Blobel and 
Dobberstein, 1975a; Blobel and Dobberstein, 1975b) and later confirmed by others that 
further added that although these signal sequences are unique, they are largely 
interchangeable among secreted proteins and even between different organisms (Brown 
et al., 1994; Hitzeman et al., 1990; Miller et al., 1994; Walter and Johnson, 1994). It has also 
been demonstrated that there is considerable functional interchangeability between some 
components of the eukaryotic and prokaryotic protein secretion pathways (Hallenberger 
et al., 1993; Hartman et al., 1994).  
 
A method for isolating secreted molecules 
Jacobs and colleagues (Jacobs et al., 1997) have designed a rapid method for isolating 
large numbers of cDNAs encoding secreted proteins. Their strategy consists of a genetic 
selection performed in a strain of Saccharomyces cerevisiae that is deleted for its 
endogenous invertase gene. When the yeast is grown in a medium containing either 
sucrose or raffinose, it has to secrete invertase to break down these sugars and survive.  A 
cDNA cloning vector (“yeast signal sequence trap vector”) carries a modified invertase 
gene lacking the signal sequence and is introduced into this strain.  Heterologous 
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secreted genes that correctly fuse upstream of the defective invertase provide the 
necessary signals to restore invertase secretion and yeast survival in restrictive media. 
 
This chapter describes a screen performed to isolate secreted molecules expressed in 
Hensen’s node or anterior primitive streak of stage 3+-4 chick embryos.  The initial screen 
was performed in collaboration with the original authors of this method (Edward 
Lavallie and Lisa Collins-Racie) at the Genetics Institute in Boston (later acquired by 
Wyeth Pharmaceuticals) and resulted in the isolation of 442 clones. Sequence analyses 
revealed a 70% contamination with mitochondrial and Ribosomal DNA and the 
remaining 137 clones were used to perform an in situ hybridization screen on chick 
embryos from stage 3 to stage 7-8. Most genes seem to be expressed ubiquitously, with 
the exception of 23 that are discussed in more detail.  
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Material and methods 
 
Molecular screen for Hensen’s node secreted factors 
Hensen’s nodes were dissected from about 1200 chick embryos at stage 3+/4 and total 
RNA extracted using the GUA-SCN method (Chomczynski and Sacchi, 1987)  (Chapter 
II). PolyA+ mRNA was then isolated with the PolyATtract mRNA isolation system 
(Promega) and converted to double-stranded cDNA using the Superscript Choice System 
(Gibco) and the oligo/random primer 5’-
TCCCGATTGAATTCTAGACCTGCGTCGACNNNNNN-3’. EcoRI adaptors were ligated 
onto the cDNA which was then digested with SalI; The resulting 300-600 base pair 
fragments (aproximately) were ligated into pSUC2T7M13ORI pre-digested with EcoRI 
and XhoI. Electrocompetent DH10B cells (Gibco) were transformed and 5x106 were 
pooled to prepare the amplified plasmid cDNA library (Sambrook et al., 1989).  
 
A Saccharomyces cerevisiae mutant for invertase (SUC2-) was used for the selection. SUC2- 
yeast, transformed using lithium acetate, were selected by growth on complete minimal 
plates lacking triptophan (CMD-W) (Ausubel et al., 1995) for three days before being 
replicated onto YPR plates (1% yeast extract, 2% peptone, 2% raffinose, 2 µg/ml 
antimycin A) to select for plasmids encoding signal sequences. Seven days later, yeast 
colonies were purified by streaking onto new YPR plates. Individual colonies were 
grown overnight on  CMD-W plates and the used to inoculate duplicates into deep-well 
trays with CMD-W medium. After overnight incubation, glycerol was added (1:1) to one 
of the sets and frozen (Yeast glycerol stocks). The other set was used to prepare plasmid 
DNA as previously described (Blanchard and Nowotny, 1994) and the cDNA inserts 
sequenced. 
 
Bioinformatics 
The sequences obtained were compared against the NCBI database  for Homo sapiens  and 
Gallus gallus using BLAST.  For prediction of a signal peptide in DNA sequences the 
Signal P3.0 software was used (http://www.cbs.dtu.dk/services/SignalP/) 
(Bendtsen et al., 2004; Nielsen et al., 1997a; Nielsen et al., 1997b; Nielsen et al., 1996).  
 
PCR amplification from yeast stocks 
Yeast glycerol stocks containning the clones were defrosted and 25µl of each stock was 
used to inoculate 300µl of CMD-W medium with 15% glycerol. The overnight cultures 
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were resuspended and 5µl of each lysed with 20µl Lysis buffer (1% Triton X-100, 20nM 
Tris-HCL pH8.9, 2mM EDTA) at 100°C for 10 minutes, followed by a 7 minute spin at 
11500 RPM at 4°C. Clones were amplified by PCR using 2µl of lysis product per reaction 
and the primers COLPCR3 (5‘-GGTGTGAAGTGGACCAAAGGTCTA-3‘) and  INV-UNI 
(5‘-CCTCGTCATTGTTCTCGTTCCCTT-3‘) (94°C, 1 minute; 55°C, 45 seconds, 68°C, 5 
minutes; 30 cycles).  
 
In situ hybridization  
In situ hybridization was performed as described in Chapter 2. DIG labelled RNA probes 
were transcribed using the yeast PCR products and T7 Polymerase (Promega) (The 
pSUC2T7M13ORI vector contains a T7 polymerase recognition site and the cloning was 
directional). 
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Results 
 
The molecular screen resulted in the isolation of 442 sequences  
To isolate sequences that code for secreted proteins a Yeast Sequence Trap Screen (Jacobs 
et al., 1997) was performed using cDNAs isolated from stage 3+-4 Hensen’s nodes from 
chick embryos. Two rounds of screening were performed, resulting in the isolation of 227 
clones and 215 clones in the other set, denominated nhbr and nhbw respectively.  
 
Sequence analyses revealed that of the total 442 clones, 4 (0.9%) correspond to 18S RNA 
genes (accession numbers AF173612 and SCA419876) and 301 clones (69.9%) were 
mitochondrial DNA sequences (either homologous to Gallus gallus mitochondrial 
genome, X523992, or to Gallus gallus spadiceus mitochondrial genome: AP003321). The 
remaining 137 clones (29.4%) were selected for further analysis.  
 
 
137 clones are selected for further study 
The sequence analyses of the clones is summarized on Tables 4.I-II. BLAST searches 
revealed that of the total 137 clones, 39 (28.5%) have no homology to known genes in 
humans and of these, 7 (5% of the total) are not annotated in Gallus gallus. 
 
The 137 sequences were further analysed for the presence of a signal sequence using the 
SignalP 3.0 algorithm (hhttp://www.cbs.dtu.dk/services/SignalP/) (Bendtsen et al., 
2004; Nielsen et al., 1997a; Nielsen et al., 1997b). This revealed that less than 25% of the 
sequences (34/137) are known or predicted not to be secreted (Tables 4.I-II, last columns 
headed SP). These might have been survived the screen because of internal peptides that 
mimic signal sequences. The proportion of sequences without a signal peptide is very 
close to that obtained by others in similar screens (about 20%; E. Lavallie, personal 
communication), and apparently to be expected in this type of selection (Kaiser et al., 
1987). The presence or absence of a signal peptide (Y or N in column SP, Tables 4.I-II) are 
only predictions based on an algorithm for hydrophobic domains and are not absolute 
certainties of whether they contain a functional signal sequence (Bendtsen et al., 2004). 
 
 
 65 
An in situ screen revealed 23 sequences with spatio-temporally defined 
expression 
To assess whether the clones isolated are likely candidate players in neural induction, 
DIG-labelled RNA probes for the 137 clones were transcribed and in situ hybridization 
performed in chick embryos ranging from about stage 3 to stage 7/9 (in some cases older 
embryos). In situ analyses revealed that 107 sequences were ubiquitously expressed and 
23 sequences have a defined spatio-temporal expression. Their molecular homologies (if 
any) and expression patterns are summarised below.  
 
Nhbr7 (No similarity)  
Nhbr7 mRNA expression cannot be detected at early primitive streak stages (Fig 4.2 A-
B). At stages 4 and 4+ expression is confined to the prospective neural plate (Fig 4.2 C-D) 
and stops being detected by the time the first somite forms at stage 7 (Fig 4.2 E). 
 
Nhbr10, nhbr116, nhbw63, nhbw153 (Fatty acid elongase; ELOVL family 
member5, elongation of long chain fatty acids) 
Long chain fatty acids are major components of membrane and storage lipids in 
eukaryotes (Inagaki et al., 2002), mostly located in the Endoplasmic Reticulum or in its 
vicinity (Beaudoin et al., 2000; David et al., 1998; Karan et al., 2004; Michelsen et al., 2005; 
Toke and Martin, 1996; Tvrdik et al., 2000; Zhang et al., 2003). In terms of protein 
topology, all members of the elongase family have, or are predicted to have five or six 
transmembrane domains, due to the presence of large hydrophobic aminoacid stretches 
(Monne et al., 1999; Moore et al., 1995). Fatty acid elongases are enzymes involved in the 
biosynthesis and elongation of fatty acids in a process known as the fatty acid chain 
elongation system (FACES).  FACES has been found in many tissues including liver, 
brain, kidney, lung, adrenals, retina, testis, small intestine, blood cells (lymphocytes and 
neutrophils) and fibroblasts, with the exception of the heart, which has no measurable 
activity (Cinti et al., 1992). All the studies in fatty acid elongation have been carried out 
mainly with cell lines and no information is available on either fatty acid elongase 
expression or function during embryonic development. 
 
Detection of these clones by in situ hybridization was very difficult to achieve, given the 
low levels of expression in the embryonic region and strong staining of the inner third of 
the area opaca. Nevertheless for three of the clones (nhbr10, nhbr116 and nhbw63) 
consistent patterns were observed with embryonic expression in the prospective neural 
plate being detected at stage 4 (Fig. 4.3 A).  The weak expression is maintained 
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throughout the neural plate from stage 4+ to stage 8 (Fig 4.3 B-E), after which the 
expression in the area opaca is so strong that the embryos become completely stained (not 
shown). 
 
The remaining clone nhbw153, although also similar to fatty acid elongase, resulted in a 
different in situ hybridization pattern from the one described above. At stage 3+ the 
mRNA localizes to the anterior third of the primitive streak and the node as well as to the 
prospective neural plate (Fig. 4.21 A). At stage 4+ the primitive streak expression is 
extended posteriorly and there is also strong expression in the emerging head process 
(Fig 4.21 B). At stage 5, expression expands to the “mesodermal wings” and is 
maintained in the neural plate and head process (Fig 4.21 C). Similar expression is 
observed at stage 6, where the notochord is now well stained (Fig 4.21 D). By stage 7, 
expression is present in the entire neural plate, with the exception of the area 
surrounding the node and first formed somite; extraembryonic mesoderm also continues 
to express nhbw153 (Fig 4.21 E). Stage 10 embryos present strong expression in the blood 
islands and in the neural tube and borders of the posterior neural plate (Fig 4.21 F).  
 
Nhbr34 (Fibulin 2) 
Fibulin2 was first studied in the mouse. It is a matrix protein containing tandem arrays of 
calcium binding epidermal growth factor-like motifs (Argraves et al., 1990; Grassel et al., 
1999; Pan et al., 1993b). It is present in the stroma and in the basement membrane of 
many tissues and its expression pattern previously suggested a role in organogenesis, 
particularly in embryonic heart development (Zhang et al., 1995; Zhang et al., 1996). 
More recently it has been reported that some fibulins, and in particular fibulin1, is 
required for the directed migration and survival of cranial NCCs contributing to the 
development of pharyngeal glands, craniofacial skeleton, cranial nerves, aortic arch 
arteries, cardiac outflow tract and cephalic blood vessels (Cooley et al., 2008). 
 
Nhbr34 mRNA does not seem to be detected at early primitive streak stages (Fig. 4.4 A). 
There follows an upregulation of expression at stages 4-4+ (Fig 4.4B) in the primitive 
streak, neural plate and underlying mesoderm. Expression seems to decline completely 
by stage 6 (Fig 4.4C).  
 
Nhbr90 (No similarity) 
Nhbr90 mRNA is detected at stage 3/3+ at a low level in the prospective neural plate and 
strongly in the anterior primitive streak (Fig 4.5 A). The organizer expression is 
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maintained through the stages analysed (Fig 4.5 B-F); neural plate expression becomes 
stronger and restricted to regions anterior to the node at around stage 7 (Fig 4.5 D), with 
the formation of the first pair of somites; This pattern of expression is maintained, with 
its anterior boundary around the first somite and its posterior boundary just below the 
node (Fig 4.5 F).  
 
Nhbr91 (Similar to nuclear autoantigenic sperm protein, NASP) 
In the human testis, nuclear autoantigenic sperm protein (NASP) is localized 
predominantly in the nucleous of primary spermatocytes and round spermatids (Welch 
and O'Rand, 1990; Welch et al., 1990) and human spermatozoa contains NASP in the 
acrosomal region. NASP is hypothesised to play a role in regulating the early events of 
spermatogenesis (O'Rand et al., 1992). NASP has also been reported in somatic cells 
mouse embryonic cells, skin, neuroepithelium and mammary gland (Batova et al., 2000; 
Richardson et al., 2000) where it is coupled with the cell cycle, increasing its amounts 
when histones also increase. Because NASP has histone binding sites, it has been 
postulated that it may function in the transport and/or storage of histones (Richardson et 
al., 2000). In a recent study, Richardson and colleagues (Richardson et al., 2006) explored 
the role of NASP in cell cycle progression in cell lines and in mouse embryonic 
development. Their results indicate that, without sufficient NASP, both HeLa and U2OS 
cells fail to replicate their DNA and progress through the cell cycle; mouse NASP-/- null 
mutation is lethal due to failure in cell proliferation. NASP also seems to play a role in 
neuronal survival. In vitro studies of induced neuronal hypoxia have revealed that NASP 
is downregulated (Jin et al., 2004a; Jin et al., 2004b). 
 
Nhbr91 is expressed in the primitive streak and prospective neural plate at stage 4 (Fig 4.6 
A-B). At stage 6, expression continues to be detected in the primitive streak and head 
process and clears from the centre of the neural plate, forming a horseshoe shape 
including the border of the neural plate (Fig 4.6 C).  
 
Nhbr111 (Similar to hypothetical protein INO80 subunit B) 
INO80 belongs to the SWI/SNF family of chromatin-remodelling complex proteins 
(Peterson et al., 1994) with orthologues and homologues identified in yeast (Kobor et al., 
2004; Krogan et al., 2003; Mizuguchi et al., 2004; Shen et al., 2000), Drosophila (Klymenko 
et al., 2006; Kusch et al., 2004), plants (Deal et al., 2007; Fritsch et al., 2004) and mammals 
(Ikura et al., 2000; Jin et al., 2005; Ruhl et al., 2006), where INO80 has been shown to 
regulate gene expression directly  (Cai et al., 2007; Deal et al., 2007; Fritsch et al., 2004; 
Klymenko et al., 2006; Mizuguchi et al., 2004; Shen et al., 2000; Shimada et al., 2008; Wong 
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et al., 2007). Recent studies have also implicated INO80 in many other essential processes, 
including DNA repair (Fritsch et al., 2004; Kawashima et al., 2007; Morrison et al., 2004; 
van Attikum et al., 2007; Wu et al., 2007), checkpoint regulation (Morrison et al., 2007; 
Papamichos-Chronakis et al., 2006) DNA replication (Papamichos-Chronakis et al., 2006; 
Shimada et al., 2008; Vincent et al., 2008), telomere maintenance (Collins et al., 2007; Yu et 
al., 2007) and chromosome segregation (Ben-Aroya et al., 2008; Krogan et al., 2004; 
Measday et al., 2005; Morrison et al., 2004). There are no reported studies directly 
implicating INO80 in embryonic development.   
 
At stage 3, nhbr111 expression is detected in the entire area pellucida (Fig 4.7 A), becoming 
more restricted to the neural plate as the embryos reach stage 4 (Fig. 4.7 B). Although 
expression is quite widespread up to stage 7, later stages reveal a sharp expression in the 
neural plate   and in extraembryonic blood islands (Fig 4.7 D).  
 
Nhbr121 (Similar to Integrator Complex subunit 3) 
The Integrator Complex participates in the maintenance of genomic stability (Huang et 
al., 2009; Richard et al., 2008) and participates in the cellular DNA damage response 
(Skaar et al., 2009; Zhang et al., 2009). Specifically, INTS3 is a subunit of single-stranded 
DNA (ssDNA)-binding complexes involved in the maintenance of genome stability 
(Huang et al., 2009). INTS3 is also reported to associate with the C-terminal domain of 
RNA polymerase II large subunit and mediates 3’ end processing of small nuclear RNAs 
(Baillat et al., 2005). There are no reports on expression or roles of INTS3 during 
embryonic development and its existence in the chick is only predicted on the basis of 
genomic analyses.  
 
Nhbr121 is expressed in the stage 4 node and prospective neural plate (Fig 4.8 A). By 
stage 4+, expression in the node becomes stronger while clearing in the prospective 
neural plate surrounding the node (Fig 4.8 B). As development proceeds, expression is 
maintained in the node, asymmetrically at stage 6 with strong expression on the right 
side. Expression is also strong in the head process and in the “mesoderm wings” (Fig 4.8 
C). At stage 8- (Fig 4.8 D) expression appears to be in the neural plate and in the node. 
 
Nhbr225 (Similar to peptidyl-propyl isomerase G; Cyclophilin G) 
Peptidyl-propyl isomerases, also known as Cyclophilins, were first identified as the host 
cell receptors for the potent immunossupressive drug cyclosporin A and described as 
being ubiquitously distributed (Bukrinsky, 2002). They have also been shown to possess 
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peptidyl-prolyl cis–trans isomerase activity (Bukrinsky, 2002), which is thought to 
contribute to the proposed role of cyclophilins as mediators of protein folding and as 
chaperones (Ivery, 2000). Although most studies to date have focused on intracellular 
activities of cyclophilins, accumulating evidence suggests a role for these proteins as 
mediators of intercellular communication (Allain et al., 2002; Brazin et al., 2002; 
Carpentier et al., 2002; Gothel and Marahiel, 1999; Nagata et al., 2000; Sherry et al., 1992; 
Xu et al., 1992). There is no information on the role of these molecules during embryonic 
development. 
 
Nhbr225 transcripts are detected at stage 3 in the primitive streak and the prospective 
neural plate (Fig 4.9 A). By stage 4+ the expression in the primitive streak seems to have 
disappeared or is extremely weak. Expression is present in the node and emerging head 
process (Fig 4.9 B). At stage 7 the mRNA marks the entire neural plate, albeit stronger in 
the anterior part of the embryo (Fig 4.9 C). At stage 8- expression remains in the neural 
plate, although it seems to clear away from the area surrounding the remaining primitive 
streak, that, together with the node, seem to express the transcript by this stage (Fig 4.9 
D). In embryos at stage 11, expression is mainly present in the neural tube and anteriorly 
in the brain region (Fig 4.9 E); in the extraembryonic region at the same developmental 
stage, the blood islands are strongly stained (Fig 4.9 F).    
 
 
Nhbr231 (E3 ubiquitin protein ligase) 
Targeting proteins to degradation is an essential mechanism to ensure normal cellular 
function and the ubiquitination-dependent degradation of proteins involves the 
sequential activity of at least three types of enzymes: E1 ubiquitin-activating enzyme, E2 
ubiquitin-carrier enzyme and E3 ubiquitin-protein ligase (You and Pickart, 2001). E3 
ubiquitin ligases are responsible for the specificity of ubiquitin-mediated degradation, 
determining which target proteins are degraded and how efficiently that process is 
carried out (Pickart, 2001). The regulation of E3 ligases and, therefore, the efficiency of 
degradation of their target proteins can take place by several means. E3 ligases can be 
regulated by abundance, and in some instances autoubiquitination and degradation have 
been implicated in the regulation of these proteins (Canning et al., 2004; Wu et al., 2004). 
In addition, post-translational modifications such as phosphorylation, ubiquitination and 
modification by ubiquitin-like proteins have been demonstrated to play central roles in 
the regulation of E3 ligases (Hotton and Callis, 2008; Meek and Hupp; Moon et al., 2004; 
Parry and Estelle, 2004; Snyder, 2009; Xu et al., 2009). Malfunction and/or dysregulation 
of E3 ligase function has been implicated in various neurodegenerative disorders and in 
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cancer (Aplin et al., 2006; Boulton, 2006; Carnevale et al., 2007; Chen et al., 2006; Dawson, 
2006; Morris et al.; Polanowska et al., 2006). Interestingly, in the context of embryonic 
neural development, the E3 ubiquitin protein ligase seems to be responsible for Notch 
ubiquitination and degradation (Lai, 2002). 
 
 
Stage 4 embryos express nhbr231 in the prospective neural plate, stronger at the edge (Fig 
4.10 A). At stage 4+, expression continues to clear away from the central region of the 
neural plate, resulting in a horseshoe shaped expression domain (Fig 4.10 B). At stage 7-, 
expression is completely abolished in the midline and is strong in the anterior neural 
plate and mesoderm (Fig 4.10 C). By stage 12, nhbr231 transcripts are strongly localized in 
the brain and anterior neural tube. Expression is also strong in the blood islands (Fig 4.10 
D). 
 
 
Nhbr241 (HT7 antigen; Homo sapiens CD147/basigin) 
The HT7 antigen was first isolated in 1986 (Risau et al., 1986a; Risau et al., 1986b) as a 
highly glysosylated protein. The authors reported its expression in mouse as starting at 
E10 in endothelial cells of the brain capillaries, which form the blood-brain barrier. 
Additional expression is seen in erythroblasts and epithelial cells of kidney tubules, 
choroid plexus and retinal pigment layer (Albrecht et al., 1990; Risau et al., 1986a) and 
suggests that the HT7 protein may participate in transport processes in these cells. 
Another possible function of the HT7 protein may be in cell adhesion. Cultured brain 
endothelial cells have the antigen concentrated in areas of cell-cell contact (Albrecht et al., 
1990; Seulberger et al., 1990). Further evidence supporting this stems from the fact that 
HT7 antigen shares homology with the cell adhesion molecules N-CAM (Cunningham et 
al., 1987), ICAM-2 (Staunton et al., 1989) and carcinoembryonic antigen CEA (Benchimol 
et al., 1989), all of which are members of the immunoglobulin superfamily. 
CD147/basigin is a transmembrane protein belonging to the immunoglobulin 
superfamily (Biswas, 1982; Biswas et al., 1982). It is strongly related to cancer progression 
and highly expressed by various cancer cells including malignant melanoma cells, 
playing important roles in tumor invasiveness, metastasis, cellular proliferation, and in 
vascular endothelial growth factor production, tumour cell glycolysis, and multi-drug 
resistance (Kanekura and Chen; Li et al.; Lu et al.). Whilst increased expression of CD147 
occurs in many tumors, its expression is not confined to tumor cells (Bordador et al., 
2000; Muraoka et al., 1993; Polette et al., 1997; Sameshima et al., 2000) and it plays a 
critical role in fetal development and retinal function. CD147 has also been shown to play 
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a role in thymic T cell development and nervous system development (Muramatsu and 
Miyauchi, 2003) and is involved in spatial learning (Naruhashi et al., 1997) and 
Alzheimer’s amyloid plaque formation (Zhou et al., 2005; Zhou et al., 2007). 
 
 
At stage 3 expression of nhbr241 is very weak but starts to be detected in the primitive 
streak (Fig 4.11 A). By stage 4, expression becomes strong in the primitive streak, node 
and the entire embryonic region (Fig 4.11 B). At stage 4+ the node and primitive streak 
expression are very strong; transcripts are also strongly detected in the prospective 
neural plate (Fig 4.11 C).  By stage 6 the expression becomes very weak again and seems 
to be mainly detected in the neural plate (Fig 4.11 D).  
 
Nhbr251 (Similar to nociceptin-like receptor; Homo sapiens opiate receptor-like 
1, OPRL1) 
Nociceptin was first identified in 1995 as orphanin FQ/nociceptin (OFQ/N), a 
17aminoacid peptide and the ligand for the “orphan” opioid receptor ORC-1 (Boom et al., 
1999; Gouarderes et al., 1999). Nociceptin is present throughout the central nervous 
system, from the forebrain to the spinal cord (Neal et al., 1999a; Neal et al., 1999b). In 
terms of its function, it seems to act in a manner similar to that of opioid agonists by 
inhibiting adenylate cyclase and calcium currents and hyperpolarizing neurons by 
opening calcium channels (Moran et al., 2000). In the vast literature available, there are no 
reports on nociceptin distribution during embryonic development and all the functional 
studies explore its role in neural physiology rather than neural differentiation or 
induction. OPRL1 encodes a G protein-coupled receptor and all the published data 
results from studies done in either rats or humans and always in relation to substance 
abuse and addiction (Briant et al.; Homberg et al., 2009; Kuzmin et al., 2009; Rutten et al.; 
Rutten et al.; Xuei et al., 2008). 
 
 
Nhbr251 is expressed at stage 3+ in the entire embryonic region and strongly in the 
primitive streak and node (Fig 4.12 A). By stage 6 transcripts start to become restricted to 
the neural plate; stronger expression is observed in the head process and the sides of the 
primitive streak (Fig 4.12 B). Expression at stage 7 remains strong in the primitive streak 
and notochord; transcripts are also detected in the neural plate and posterior mesoderm 
(Fig 4.12 C). Stage 9 embryos reveal the presence of nhbr251 in the head, particularly in 
the head folds, the closing neural tube, posterior neural plate and in the remaining streak; 
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a strong patch of expression is present on the right side of the extraembryonic area opaca 
(Fig 4.12 D).  
 
Nhbr260 (No similarity) 
At stage 3, nhbr260 mRNA localizes strongly to the primitive streak and, more weakly, to 
the epiblast (Fig 4.13 A). At stage 4, expression remains similar and includes the node 
(Fig 4.13 B). Expression at stage 4+ is strong in the lateral sides of the primitive streak and 
node and in the mesoderm (Fig 4.13 C). Stage 8+ embryos present the transcript in the 
entire neural plate, stronger at the border, and in the posterior mesoderm. Some 
expression starts to be detected in what seem to be blood islands (Fig 4.13 D).  
 
Nhbr307: Similar to calreticulin 
Calreticulin, a highly conserved eukaryotic protein, is localized primarily to the 
endoplasmic reticulum (ER), but has also been reported to occur in many other locations, 
including the nucleus, the nuclear envelope, the cytosol and the outer surface of the 
plasma membrane (Michalak et al., 1991; Rauch et al., 2000). Initially it was identified as a 
high-affinity calcium-binding protein (Ostwald and MacLennan, 1974) and as an ER 
calcium storage molecule (Baksh et al., 1992). In the last few years, Calreticulin has 
become recognised as a multifunctional protein, which can act with a large number of 
proteins and is involved in a wide variety of different processes (Michalak et al., 1992), 
including regulation of steroid-dependent gene expression, regulation of integrin activity 
and interaction with extracelluar matrix proteins (White et al., 1995). During 
development, it has been shown that Calreticulin is essential for cardiac development 
(Mesaeli et al., 1999); mice mutant for calreticulin have heart, brain and body wall defects 
(Rauch et al., 2000). 
 
 
Nhbr307 transcripts are detected at very low levels throughout the embryonic and non 
embryonic regions at stage 3/3+ (Fig 4.14 A). Expression becomes localized at stage 4, 
weakly in the neural plate and very strong in the primitive streak and node (Fig 4.14 B). 
By stage 4+ the expression in the primitive streak seems to be downregulated (Fig 4.14 C). 
For the later developmental stages analysed, nhbr307 seems to maintain its expression 
restricted to neural structures, the neural plate and neural tube, and somites (Fig 4.14 D-
F). From stage 9+/10 the expression becomes ubiquitous (not shown).  
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Nhbr313 (Homo sapiens AF4/FMR2 family, member1; AFF1) 
AF4 is a cofactor of RNA polymerase II elongation and chromatin remodelling (Bitoun et 
al., 2007) and several studies have linked AF4 to infant leukemia (Bach et al., 2009; 
Mueller et al., 2009; Vogel and Gruss, 2009). In the mouse mutant, Purkinje cells start to 
degenerate soon after birth, leading to impaired motor coordination at 5 weeks. 
Progressive cell death occurs from week 8, affecting most severely the anterior lobes of 
the cerebellum. The mutant further displays general growth retardation, defects in T-cell 
maturation and cataract (Isaacs et al., 2003).  
 
Stage 3+-4 embryos express nhbr313 weakly throughout the embryonic region and 
strongly in the primitive streak and node (Fig 4.15 A and B). At stage 5 expression is 
difficult to detect but can be seen in the primitive streak and in the anterior neural plate 
(Fig. 4.15 C). By stage 7 the expression becomes more defined and clearly localizes to the 
neural plate and the remaining streak (Fig 4.15 D).   
 
Nhbr330 (Polyvirus receptor-related 1, isoform 2; nectin) 
Nectins are Ca2+-independent immunoglobulin (Ig)-like cell-cell adhesion molecules. 
Structurally they are transmembrane proteins with an extracellular region with three Ig-
like loops, a single transmembrane region and a cytoplasmic tail region (Takahashi et al., 
1999). Nectins contribute to the formation of a variety of cell-cell junctions, acting 
cooperatively with, or independently of, cadherins. In addition, nectins interact with 
nectin-like molecules (Necls), playing an important role cell adhesion, migration, and 
proliferation (Irie et al., 2004; Sakisaka and Takai, 2004). Nectins and Necls can also 
function as viral receptors and have been associated with human diseases (including 
cancer) when mutated or upregulated (Sakisaka and Takai, 2004). Nectins also play a role 
in intracellular signalling. They induce the activation of Cdc42 and Rac small G proteins 
through c-Src, which in turn regulates the formation of the cadherin-based adherens 
junctions through reorganization of the actin cytoskeleton (Izumi et al., 2004), gene 
expression through activation of a mitogen-activated protein cascade and cell 
polarization through cell polarity proteins (Shimizu and Takai, 2003; Takai et al., 2003). 
 
At stage 4, expression is detected in the posterior two thirds of the primitive streak and 
some weak expression may be seen in the epiblast (Fig 4.16 A). At stage 4+, nhbr330 
transcript is completely absent from the node but is otherwise strongly detected in the 
rest of the embryo (Fig 4.16 B). By stage 5 expression starts to become restricted to the 
neural plate, with the node and head process clear of transcript (Fig 4.16 C). At stage 8, 
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expression is present in the entire neural plate, being stronger at the anterior border (Fig 
4.16 D).  
 
Nhbw23 (Similar to receptor protein tyrosine phosphatase LAR) 
Receptor tyrosine phosphatases have been implicated in the regulation of axonal growth, 
promoting neurite outgrowth (Yang et al., 2003) and guiding vertebrate motor axons 
during development (Carulli et al., 2005). In the Drosophila compound eye, LAR is 
required for the proper connections between different photoreceptor neurons and their 
specific targets in the optic nerve (Clandinin et al., 2001). Similarly, in Xenopus, protein 
tyrosine phosphatases regulate retinal ganglion cell axon outgrowth in the developing 
visual system (Johnson et al., 2001). Frydman and colleagues (Frydman and Spradling, 
2001) have found that LAR is required for both epithelial planar polarity and for axis 
determination within the ovarian follicles in Drosophila. 
 
Nhbw23 is expressed in the prospective neural plate and is absent from the node (Fig 4.17 
A). Expression remains mostly restricted to the neural plate from stage 4+ (Fig 4.17 B) to 
stage 7+ (Fig 4.17 C).  
 
Nhbw 57 (Chemokine, C-X-C motif, ligand 1) 
CXC chemokines are heparin-binding proteins that display pleiotropic effects in 
immunity, regulating angiogenesis, and mediating organ-specific metastases of cancer 
(Strieter et al., 2005). The family has four highly conserved cysteine amino acid residues, 
with the first two cysteines separated by a non-conserved amino acid residue. A second 
structural domain dictates their functional activity. The NH2-terminus of several CXC 
chemokines contains three amino acid residues (Glu-Leu-Arg; ‘ELR’ motif), which 
immediately precedes the first cysteine amino acid residue (Belperio et al., 2000; Luster et 
al., 1998; Poppas et al., 1998; Strieter et al., 1995a; Strieter et al., 1995b). While the CXC 
chemokines with the ‘ELR’ motif (ELR+) promote angiogenesis, the CXC chemokines that 
lack the ELR motif (ELR-) inhibit angiogenesis (Strieter et al., 1995a). 
 
Before gastrulation, at stage XIII, transcripts are present in the entire epiblast (Fig 4.18 A). 
Stage 3+ embryos present expression in the entire epiblast, the node and primitive streak 
(Fig 4.18 B). By stage 4+ expression starts to become restricted to the prospective neural 
plate (Fig 4.18 C). In stage 6 embryos expression detected in the neural plate and in the 
forming notochord (Fig 4.18 D). Later, at stage 10, expression is strongly localized to the 
brain and closing neural tube and in the blood islands (Fig 4.18 E).  
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Nhbw87 (Calnexin) 
Calnexin is a conserved, abundant integral membrane phosphoprotein of the 
endoplasmic reticulum (ER) of eukaryotic cells, where it plays a important role in 
glycoprotein folding (Chevet et al., 2009) Immediately after sequencing the cDNA of 
Calnexin, it was recognized as a paralogue of Calreticulin (Wada et al., 1991). Similarly to 
Calreticulin, Calnexin recognizes the protein-folding status of client glycoproteins via 
their glycans (Michalak et al., 2009). The ER quality control machinery enables the 
retention of misfolded proteins within the ER lumen (Hebert and Molinari, 2007). While 
correctly folded glycoproteins transit the calnexin cycle relatively quickly, misfolded 
glycoproteins have a prolonged association with constituents of the calnexin cycle and 
subsequently, are targeted to the ER-associated degradation pathway for degradation by 
the proteasome (Helenius and Aebi, 2004; Pearse and Hebert; Schrag et al., 2003). 
 
It proved extremely difficult to produce clear in situ staining for nhbw87. It seems that by 
stage 3 there is some weak expression in the epiblast (Fig 4.19 A). Stage 7 embryos 
present expression in the neural plate, stronger in the head region (Fig 4.19 B). By stage 9, 
expression remains stronger in the head and in the neural tube and some expression 
remains in other parts of the neural plate (Fig 4.19 C).  
 
 
Nhbw95 (CD151) 
CD151 was first cloned in 1995 (Fitter et al., 1995) as a member of the tetraspanin 
superfamily (transmembrane 4 super family) of proteins. Tetraspanins form membrane 
complexes with integrin receptors and are implicated in integrin-mediated cell migration 
(Berditchevski and Odintsova, 1999; Sugiura and Berditchevski, 1999). In addition to cell 
motility, it seems that tetraspanins are involved in cell adhesion and metastasis as well as 
cell activation and signal transduction (Maecker et al., 1997). Immunohistochemical 
performed in adult human tissue specimens have demonstrated that CD151 is expressed 
in the epithelium, muscle and Schwann cells (Sincock et al., 1997). Within haematopoietic 
cells, CD151 is seems to be restricted to platelets and megakaryocytes, where it may be 
involved in recognition of the subendothelial matrix during thrombus formation and in 
trombopoiesis, respectively (Sincock et al., 1997). In cultured human umbilical vein 
endothelial cells CD151 is present on the plasma membrane and predominantly localises 
to regions of cell-cell contact (Sincock et al., 1999).  Anti-CD151 monoclonal antibody 
inhibits endothelial cell migration and modulates in vitro angiogenesis. CD151 associates 
with several integrins both on the plasma membrane and within intracellular vesicles, 
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suggesting a possible role in regulating integrin trafficking and/or function (Fitter et al., 
1999; Maecker et al., 1997; Sincock et al., 1999).  
 
Nhbw95 seems to be almost ubiquitous. However, it is absent from the area pellucida up to 
stage 3+ (Fig 4.20 A) and is more strongly expressed in the neural plate at stage 6 (Fig 4.20 
C). Stage 9 embryos present a distinct expression in the head, edge of the neural tube and 
the remnants of the streak in the posterior part of the embryo (Fig 4.20 D).  
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Discussion  
 
Advantages and Limitations of the Screen 
The YSST and conventional protein secretion 
Most eukaryotic secreted proteins (or those membrane bound) contain amino-terminal or 
internal signal peptides that direct their sorting to the endoplasmic reticulum (ER). From 
the ER, proteins are transported to the extracellular space or the plasma membrane 
through the ER-Golgi secretory pathway (Lee et al., 2004a; Osborne et al., 2005). 
 
The Yeast Signal Sequence Trap (YSST) is a genetic method developed to isolate and 
identify secreted proteins. The YSST uses a strain of Saccharomyces cerevisiae with a 
genomic deletion at the SCU2 locus (Klein et al., 1996); the SUC2-deficient yeast strain 
does not secrete invertase and, therefore, is unable to grow on sucrose or raffinose as the 
sole carbon source. The second component of the YSST is a vector with a SUC2 gene 
lacking the signal sequence and the start codon. Only if a partial cDNA provides these 
sequence elements is the fusion protein translocated into the secretion pathway.  All 
transformants carrying a secretion signal should be able to grow on sucrose or raffinose 
as their only source of carbon (Jacobs et al., 1997). 
 
The major advantage of performing a genetic screen in yeast, particularly the YSST, is 
that it is a rapid and relatively simple method for isolating large numbers of cDNAs 
putatively encoding  for secreted proteins. However, the screen also has two major 
limitations. First, it can yield false positives and second, it does not always identify 
known secreted molecules that should be present in the library.  
 
Among the sequences isolated, and after removing ribosomal and mitochondrial 
sequences, 34 (24.8%) were false positives, i.e., clones coding for proteins known, or 
predicted, not to be secreted. These false positives could contain sequences that mimic a 
signal peptide.  Kaiser and colleagues (Kaiser et al., 1987) have shown that amongst a 
large population of sequences, about 20% can work as signal sequences in yeast if an 
initiating methionine is provided and that many random sequences can functionally 
replace the secretion signal sequence of yeast invertase. 
 
It was expected from this screen that we would obtain some clones encoding well 
characterized molecules known to be expressed in the node at the developmental stage 
the RNA was extracted for the screen. Chordin, for example, is abundantly expressed in 
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the chick node at stage 3+ (Streit et al., 1998) and is a secreted protein (Piccolo et al., 1996; 
Sasai et al., 1994). Several hypothesis can be put forward as why chordin was not 
obtained. One possibility is that some cDNAs may not fuse appropriately in frame with 
the invertase and are therefore not selected. It could also be caused by failure of the yeast 
translational machinery to initiate for some heterologous mRNA sequences. In fact, it has 
been shown that some signal sequences, namely in human proteins, are not active in the 
yeast secretion machinery (Born et al., 1987). 
 
Non-conventional protein secretion 
Most eukaryotic secreted proteins are transported to the extracellular space or the plasma 
membrane through the ER-Golgi secretory pathway (Disatnik et al., 2004; Lee et al., 
2004a; Osborne et al., 2005). Even though this ER-Golgi secretory pathway is very 
efficient and is generally considered the most common mode of protein transport to the 
cell surface (Trombetta and Parodi, 2003), cytoplasmic, nuclear and even signal peptide 
containing proteins have been shown to reach the cell surface by non-conventional 
transport pathways – unconventional protein secretion (Nickel and Seedorf, 2008). Two 
distinct mechanisms seem to exist.  In one, proteins with a signal sequence reach the ER 
but are exported to the cell surface bypassing the Golgi apparatus. Examples of this are 
the heat shock protein 150 (HSP150) (Fatal et al., 2004), the cystic fibrosis transmenbrane 
conductance regulator (CFTR) (Yoo et al., 2002), the protein-tyrosine phosphatase CD45 
(Baldwin and Ostergaard, 2002) and the Drosophila melanogaster α integrin subunit 
(Juschke et al., 2005). The second nonconventional mechanism of protein secretion 
includes cytoplasmic and nuclear proteins that lack a signal peptide and exit the cell 
through a mechanism independent from both the ER and the Golgi. In this category, and 
relevant to developmental processes, are fibroblast growth factor2 (FGF2) (Engling et al., 
2002; Florkiewicz et al., 1995; Nickel, 2003; Schafer et al., 2004), β-galactosidase-specific 
lectins (Nickel, 2003), certain members of the interleukin family (Muesch et al., 1990; 
Rubartelli et al., 1990) and engrailed homeoprotein (Dupont et al., 2007; Joliot et al., 1998; 
Maizel et al., 2002), amongst others. The study of unconventional protein secretion is still 
in its early days and the transport of these proteins is triggered by unconventional means 
and through mechanisms still very poorly understood.  
 
It is conceivable that the presence of false positives, i.e., proteins lacking a signal 
sequence and that were selected in the screen belong to the category of proteins secreted 
through a mechanism of unconventional protein secretion. In fact, it has been suggested 
(Lee et al., 2006; Monteoliva et al., 2002) that the YSST is able to retrieve proteins secreted 
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through alternative secretion processes that are not based on the canonical secretion-
signal peptide (Nombela et al., 2006). 
 
The next three chapters deal with the cloning, molecular characterization and functional 
analyses of nhbr34, nhbr90 and nhbr307. The main selection criteria were, first, their 
spatiotemporal expression: all three clones are expressed quite strongly in the organizer 
at stage 3+/4 and produce clear expression patterns. Second, their molecular nature: 
nhbr34, homologue to Fibulin2 was never studied in connection with neural induction; 
nhbr307, homologue to Calreticulin, coding for a calcium binding protein, seemed 
particularly interesting, given the possible implications of calcium in neural induction 
(Leclerc et al., 1997; Leclerc and Duprat, 1995; Leclerc et al., 1999; Leclerc et al., 2003; 
Leclerc et al., 2001; Leclerc et al., 2000; Leclerc et al., 2008; Lee et al., 2009; Moreau et al., 
1994; Moreau et al., 2008); nhbr90 for being a completely novel and unusual sequence 
and, therefore, posing a great challenge.   
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Table 4.1.  Nhbr sequences and their homologies in Human (Homo sapiens) 
and in the Chick (Gallus gallus). 
 
Original	  
ID	  
Accession	  
ID	  
Gene	  
Symbol	  	  	  
(H	  sapiens)	  
Description	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(Homo	  sapiens)	  
Gene	  
Symbol	  (G	  
gallus)	  
Description	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(Gallus	  gallus)	  
SP	  
NHBR10	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  member	  
5,	  elongation	  of	  long	  chain	  fatty	  acids	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  232,	  e-­‐value	  
5e-­‐58	  
Y	  
NHBR111	   AJ719645	   N/A	   Homo	  sapiens	  INO80	  complex	  subunit	  
B	  (INO80B)	  
INO80B	   Similar	  to	  AJ719645,	  "Gallus	  gallus	  mRNA	  for	  
hypothetical	  protein,	  clone	  4o13",	  score	  199,	  
e-­‐value	  5e-­‐48	  
Y	  
NHBR116	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  member	  
5,	  elongation	  of	  long	  chain	  fatty	  acids	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  189,	  e-­‐value	  
7e-­‐45	  
Y	  
NHBR117	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  member	  
5,	  elongation	  of	  long	  chain	  fatty	  acids	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  308,	  e-­‐value	  
2e-­‐80	  
Y	  
NHBR121	   XM_428600	   INTS3	   Homo	  sapiens	  integrator	  complex	  
subunit	  3	  (INTS3)	  
Ints3	   Similar	  to	  XM_428600,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  Ints3	  protein	  (LOC431048),	  
mRNA",	  score	  175,	  e-­‐value	  1e-­‐40	  
N	  
NHBR125	   CR338931	   N/A	   N/A	   N/A	   Similar	  to	  CR338931,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST980a3",	  score	  341,	  e-­‐value	  
1e-­‐90	  
Y	  
NHBR130	   X07352	   CHRNA4	   Homo	  sapiens	  cholinergic	  receptor,	  
nicotinic,	  alpha	  4	  (CHRNA4)	  
CHRNA4	   Similar	  to	  X07352,	  "Chicken	  nicotinic	  
acetylcholine	  receptor	  alpha4	  gene	  exon	  5",	  
score	  260,	  e-­‐value	  2e-­‐66	  
Y	  
NHBR132	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  member	  
5,	  elongation	  of	  long	  chain	  fatty	  acids	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  123,	  e-­‐value	  
5e-­‐25	  
Y	  
NHBR133	   AC192754	   N/A	   N/A	   N/A	   Similar	  to	  AC192754,	  "Gallus	  gallus	  BAC	  clone	  
CH261-­‐87N12	  from	  chromosome	  z,	  complete	  
sequence",	  score	  119,	  e-­‐value	  7e-­‐24	  
N	  
NHBR135	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  member	  
5,	  elongation	  of	  long	  chain	  fatty	  acids	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  211,	  e-­‐value	  
2e-­‐51	  
Y	  
NHBR137	   NM_001012847	   ELL	   Homo	  sapiens	  elongation	  factor	  RNA	  
polymerase	  II	  (ELL)	  
ELL	   Similar	  to	  NM_001012847,	  "Gallus	  gallus	  
elongation	  factor	  RNA	  polymerase	  II	  (ELL),	  
mRNA	  >gi|53128621|emb|AJ719659.1|	  Gallus	  
gallus	  mRNA	  for	  hypothetical	  protein,	  clone	  
5a13",	  score	  266,	  e-­‐value	  4e-­‐68	  
N	  
NHBR140	   XR_026835	   N/A	   N/A	   LOC422070	   Similar	  to	  XR_026835,	  "PREDICTED:	  Gallus	  
gallus	  hypothetical	  LOC422070	  (LOC422070),	  
mRNA",	  score	  66,	  e-­‐value	  1e-­‐07	  
Y	  
NHBR148	   XM_426204	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  member	  
5,	  elongation	  of	  long	  chain	  fatty	  acids	  
ELOVL5	   Similar	  to	  XM_426204,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  Elongation	  of	  very	  long	  chain	  
fatty	  acids	  (FEN1/Elo2,	  SUR4/Elo3,	  yeast)-­‐like	  2	  
(LOC428646),	  mRNA",	  score	  115,	  e-­‐value	  1e-­‐22	  
Y	  
NHBR149	   XM_417693	   ARID1A	   Homo	  sapiens	  AT	  rich	  interactive	  
domain	  1A	  (SWI-­‐like)	  (ARID1A)	  
ARID1A	   Similar	  to	  XM_417693,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  AT	  rich	  interactive	  domain	  1A	  
(LOC419542),	  partial	  mRNA",	  score	  476,	  e-­‐
value	  8e-­‐131	  
Y	  
NHBR151	   NM_001030757	   N/A	   N/A	   ST13	   Similar	  to	  NM_001030757,	  "Gallus	  gallus	  
suppression	  of	  tumorigenicity	  13	  (colon	  
carcinoma)	  (Hsp70	  interacting	  protein)	  (ST13),	  
mRNA	  >gi|53130128|emb|AJ719784.1|	  Gallus	  
gallus	  mRNA	  for	  hypothetical	  protein,	  clone	  
6h13",	  score	  345,	  e-­‐value	  7e-­‐92	  
N	  
NHBR152	   XR_027128	   N/A	   N/A	   NXN	   Similar	  to	  XR_027128,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  red-­‐1	  (LOC417619),	  mRNA",	  
score	  678,	  e-­‐value	  8e-­‐192	  
N	  
NHBR166	   XM_001231865	   N/A	   N/A	   FBXO5	   Similar	  to	  XM_001231865,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  F-­‐box	  protein	  5,	  transcript	  
variant	  1	  (LOC421642),	  mRNA",	  score	  397,	  e-­‐
value	  3e-­‐107	  
Y	  
NHBR17	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  member	  
5,	  elongation	  of	  long	  chain	  fatty	  acids	  
ELOVL5	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  373,	  e-­‐value	  
4e-­‐100	  
Y	  
NHBR174	   CR406504	   N/A	   N/A	   CR406504	   Similar	  to	  CR406504,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST735g14",	  score	  106,	  e-­‐value	  
1e-­‐19	  
Y	  
NHBR179	   AC009104	   N/A	   N/A	   N/A	   Weakly	  similar	  to	  AC009104,	  "Homo	  sapiens	  
chromosome	  16	  clone	  RP11-­‐44L9,	  complete	  
sequence",	  score	  48,	  e-­‐value	  0.041	  
N	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NHBR193	   AC186532	   N/A	   N/A	   AC186532	   Similar	  to	  AC186532,	  "Gallus	  gallus	  BAC	  clone	  
CH261-­‐169B23	  from	  chromosome	  z,	  complete	  
sequence",	  score	  74,	  e-­‐value	  7e-­‐10	  
N	  
NHBR198	   NM_205518	   ACTB	   Homo	  sapiens	  actin,	  beta	  (ACTB)	   ACTB	   Similar	  to	  NM_205518,	  "Gallus	  gallus	  actin,	  
beta	  (ACTB),	  mRNA	  
>gi|211236|gb|L08165.1|CHKBACTN	  Gallus	  
gallus	  beta-­‐actin	  mRNA,	  complete	  cds",	  score	  
373,	  e-­‐value	  6e-­‐100	  
N	  
NHBR20	   CR385365	   RPL7A	   Homo	  sapiens	  ribosomal	  protein	  L7a	  
(RPL7A)	  
CR385365	   Similar	  to	  CR385365,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST418c10",	  score	  827,	  e-­‐value	  
2e-­‐236	  
Y	  
NHBR219	   NM_001031294	   GPR177	   Homo	  sapiens	  G	  protein-­‐coupled	  
receptor	  177	  (GPR177)	  
GPR177	   Similar	  to	  NM_001031294,	  "Gallus	  gallus	  G	  
protein-­‐coupled	  receptor	  177	  (GPR177),	  mRNA	  
>gi|53128766|emb|AJ719673.1|	  Gallus	  gallus	  
mRNA	  for	  hypothetical	  protein,	  clone	  5c7",	  
score	  502,	  e-­‐value	  7e-­‐139	  
Y	  
NHBR22	   NM_205518	   ACTB	   Homo	  sapiens	  actin,	  beta	  (ACTB)	   ACTB	   Similar	  to	  NM_205518,	  "Gallus	  gallus	  actin,	  
beta	  (ACTB),	  mRNA	  
>gi|211236|gb|L08165.1|CHKBACTN	  Gallus	  
gallus	  beta-­‐actin	  mRNA,	  complete	  cds",	  score	  
219,	  e-­‐value	  6e-­‐54	  
N	  
NHBR225	   XM_422008	   PPIG	   Homo	  sapiens	  peptidylprolyl	  
isomerase	  G	  (cyclophilin	  G)	  (PPIG)	  
PPIG	   Similar	  to	  XM_422008,	  "PREDICTED:	  Gallus	  
gallus	  peptidylprolyl	  isomerase	  G	  (cyclophilin	  
G)	  (PPIG),	  mRNA",	  score	  752,	  e-­‐value	  8e-­‐214	  
Y	  
NHBR231	   BC037687	   UBR5	   Homo	  sapiens	  ubiquitin	  protein	  ligase	  
E3	  component	  n-­‐recognin	  5	  (UBR5)	  
N/A	   Similar	  to	  BC037687,	  "Mus	  musculus	  E3	  
ubiquitin	  protein	  ligase,	  HECT	  domain	  
containing,	  1,	  mRNA	  (cDNA	  clone	  
IMAGE:3666455),	  containing	  frame-­‐shift	  
errors",	  score	  334,	  e-­‐value	  2e-­‐88	  
N	  
NHBR234	   BX934171	   C10orf119	   Homo	  sapiens	  chromosome	  10	  open	  
reading	  frame	  119	  (C10orf119)	  
BX934171	   Similar	  to	  BX934171,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST444n21",	  score	  647,	  e-­‐value	  
3e-­‐182	  
Y	  
NHBR237	   XM_416595	   TTF2	   Homo	  sapiens	  transcription	  
termination	  factor,	  RNA	  polymerase	  II	  
(TTF2)	  
TTF2	   Similar	  to	  XM_416595,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  MGC81081	  protein	  
(LOC418376),	  mRNA",	  score	  817,	  e-­‐value	  1e-­‐
233	  
Y	  
NHBR241	   X52751	   BSG	   Homo	  sapiens	  basigin	  (Ok	  blood	  
group)	  (BSG)	  
BSG	   Similar	  to	  X52751,	  "Chicken	  mRNA	  for	  HT7	  
antigen",	  score	  288,	  e-­‐value	  1e-­‐74	  
Y	  
NHBR243	   XM_418237	   UPF1	   Homo	  sapiens	  UPF1	  regulator	  of	  
nonsense	  transcripts	  homolog	  (yeast)	  
(UPF1)	  
UPF1	   Similar	  to	  XM_418237,	  "PREDICTED:	  Gallus	  
gallus	  UPF1	  regulator	  of	  nonsense	  transcripts	  
homolog	  (yeast)	  (UPF1),	  mRNA",	  score	  726,	  e-­‐
value	  4e-­‐206	  
N	  
NHBR249	   BX950486	   PVRL3	   Homo	  sapiens	  poliovirus	  receptor-­‐
related	  3	  (PVRL3)	  
PVRL3	   Similar	  to	  BX950486,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST539i24",	  score	  141,	  e-­‐value	  
3e-­‐30	  
Y	  
NHBR251	   XM_417424	   OPRL1	   Homo	  sapiens	  opiate	  receptor-­‐like	  1	  
(OPRL1)	  
OPRL1	   Similar	  to	  XM_417424,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  ORL1-­‐like	  opioid	  receptor	  
(LOC419251),	  mRNA",	  score	  496,	  e-­‐value	  4e-­‐
137	  
Y	  
NHBR259	   N/A	   N/A	   N/A	   N/A	   -­‐(not	  annotated)-­‐	   Y	  
NHBR260	   N/A	   N/A	   N/A	   N/A	   -­‐(not	  annotated)-­‐	   Y	  
NHBR267	   NM_205518	   ACTB	   Homo	  sapiens	  actin,	  beta	  (ACTB)	   ACTB	   Similar	  to	  NM_205518,	  "Gallus	  gallus	  actin,	  
beta	  (ACTB),	  mRNA	  
>gi|211236|gb|L08165.1|CHKBACTN	  Gallus	  
gallus	  beta-­‐actin	  mRNA,	  complete	  cds",	  score	  
653,	  e-­‐value	  4e-­‐184	  
N	  
NHBR271	   CR386508	   N/A	   N/A	   N/A	   Similar	  to	  CR386508,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST649o12",	  score	  264,	  e-­‐value	  
3e-­‐67	  
Y	  
NHBR276	   CR390811	   UBE2E1	   Homo	  sapiens	  ubiquitin-­‐conjugating	  
enzyme	  E2E	  1	  (UBC4/5	  homolog,	  
Yeast)	  (UBE2E1)	  
CR390811	   Similar	  to	  CR390811,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST460n14",	  score	  207,	  e-­‐value	  
3e-­‐50	  
Y	  
NHBR279	   XM_414529	   N/A	   N/A	   STK10	   Similar	  to	  XM_414529,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  protein	  kinase	  (LOC416204),	  
mRNA",	  score	  441,	  e-­‐value	  2e-­‐120	  
Y	  
NHBR28	   AF195629	   LOC100288871	   Homo	  sapiens	  similar	  to	  cytochrome	  
b	  (LOC100288871)	  
AF195629	   Similar	  to	  AF195629,	  "Gallus	  gallus	  haplotype	  C	  
cytochrome	  b	  gene,	  complete	  cds;	  
mitochondrial	  gene	  for	  mitochondrial	  
product",	  score	  756,	  e-­‐value	  5e-­‐215	  
Y	  
NHBR282	   	   N/A	   N/A	   N/A	   -­‐(not	  annotated)-­‐	   Y	  
NHBR285	   NM_001048076	   VIM	   Homo	  sapiens	  vimentin	  (VIM)	   VIM	   Similar	  to	  NM_001048076,	  "Gallus	  gallus	  
vimentin	  (VIM),	  mRNA",	  score	  234,	  e-­‐value	  2e-­‐
58	  
Y	  
NHBR29	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  member	  
5,	  elongation	  of	  long	  chain	  fatty	  acids	  
ELOVL5	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  205,	  e-­‐value	  
1e-­‐49	  
Y	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NHBR290	   NM_001006420	   NRBP1	   Homo	  sapiens	  nuclear	  receptor	  
binding	  protein	  1	  (NRBP1)	  
NRBP1	   Similar	  to	  NM_001006420,	  "Gallus	  gallus	  
nuclear	  receptor	  binding	  protein	  1	  (NRBP1),	  
mRNA	  >gi|53136891|emb|AJ721116.1|	  Gallus	  
gallus	  mRNA	  for	  hypothetical	  protein,	  clone	  
35j18",	  score	  669,	  e-­‐value	  7e-­‐189	  
N	  
NHBR298	   CR389017	   MEX3D	   Homo	  sapiens	  mex-­‐3	  homolog	  D	  (C.	  
elegans)	  (MEX3D)	  
CR389017	   Similar	  to	  CR389017,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST343d14",	  score	  292,	  e-­‐value	  
1e-­‐75	  
Y	  
NHBR299	   NM_001030620	   CANX	   Homo	  sapiens	  calnexin	  (CANX)	   CANX	   Similar	  to	  NM_001030620,	  "Gallus	  gallus	  
calnexin	  (CANX),	  mRNA	  
>gi|53127409|emb|AJ719429.1|	  Gallus	  gallus	  
mRNA	  for	  hypothetical	  protein,	  clone	  2d15",	  
score	  791,	  e-­‐value	  1e-­‐225	  
Y	  
NHBR30	   XM_415665	   ZNF207	   Homo	  sapiens	  zinc	  finger	  protein	  207	  
(ZNF207)	  
ZNF207	   Similar	  to	  XM_415665,	  "PREDICTED:	  Gallus	  
gallus	  zinc	  finger	  protein	  207	  (ZNF207),	  
mRNA",	  score	  385,	  e-­‐value	  8e-­‐104	  
N	  
NHBR307	   NM_001006495	   CALR	   Homo	  sapiens	  calreticulin	  (CALR)	   CALR	   Gallus	  gallus	  calreticulin	  (CALR)	   Y	  
NHBR308	   NM_205518	   ACTB	   Homo	  sapiens	  actin,	  beta	  (ACTB)	   ACTB	   Similar	  to	  NM_205518,	  "Gallus	  gallus	  actin,	  
beta	  (ACTB),	  mRNA	  
>gi|211236|gb|L08165.1|CHKBACTN	  Gallus	  
gallus	  beta-­‐actin	  mRNA,	  complete	  cds",	  score	  
425,	  e-­‐value	  1e-­‐115	  
N	  
NHBR313	   XM_420549	   AFF1	   Homo	  sapiens	  AF4/FMR2	  family,	  
member	  1	  (AFF1)	  
AFF1	   Similar	  to	  XM_420549,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  AF-­‐4	  (LOC422590),	  mRNA",	  
score	  621,	  e-­‐value	  1e-­‐174	  
Y	  
NHBR314	   XM_422300	   TPR	   Homo	  sapiens	  translocated	  promoter	  
region	  (to	  activated	  MET	  oncogene),	  
TPR	  
TPR	   Similar	  to	  XM_422300,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  translocated	  promoter	  region	  
(to	  activated	  MET	  oncogene)	  (LOC424457),	  
mRNA",	  score	  379,	  e-­‐value	  6e-­‐102	  
N	  
NHBR315	   M55660	   N/A	   N/A	   DSTN	   Similar	  to	  M55660,	  "Chicken	  (clones	  pCMA-­‐1	  
and	  pCMA-­‐8)	  depolymerizing	  factor	  (ADF)	  
mRNA,	  complete	  cds",	  score	  125,	  e-­‐value	  5e-­‐
26	  
N	  
NHBR330	   XM_417892	   PVRL1	   Homo	  sapiens	  poliovirus	  receptor-­‐
related	  1	  (herpesvirus	  entry	  mediator	  
C),	  (PVRL1)	  
TRIM29	   Similar	  to	  XM_417892,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  Tripartite	  motif-­‐containing	  29	  
(LOC419754),	  mRNA",	  score	  276,	  e-­‐value	  9e-­‐71	  
Y	  
NHBR331	   XM_416161	   PCTK2	   Homo	  sapiens	  PCTAIRE	  protein	  kinase	  
2	  (PCTK2)	  
PCTK2	   Similar	  to	  XM_416161,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  PCTAIRE	  protein	  kinase	  2	  
(LOC417920),	  mRNA",	  score	  268,	  e-­‐value	  9e-­‐69	  
N	  
NHBR334	   BX935775	   RPS24	   Homo	  sapiens	  ribosomal	  protein	  S24	  
(RPS24)	  
RPS24	   Similar	  to	  BX935775,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST1014f24",	  score	  361,	  e-­‐
value	  2e-­‐96	  
Y	  
NHBR34	   AC145911	   N/A	   Homo	  sapiens	  fibulin	  2	  (FBLN2)	   FBLN2	   Similar	  to	  AC145911,	  "Gallus	  gallus	  BAC	  clone	  
CH261-­‐47H12	  from	  chromosome	  unknown,	  
complete	  sequence",	  score	  805,	  e-­‐value	  5e-­‐
230	  
Y	  
NHBR37	   AJ719645	   N/A	   N/A	   WDR44	   Similar	  to	  AJ719645,	  "Gallus	  gallus	  mRNA	  for	  
hypothetical	  protein,	  clone	  4o13",	  score	  270,	  
e-­‐value	  2e-­‐69	  
N	  
NHBR4	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  member	  
5,	  elongation	  of	  long	  chain	  fatty	  acids	  
ELOVL5	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  238,	  e-­‐value	  
9e-­‐60	  
Y	  
NHBR42	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  member	  
5,	  elongation	  of	  long	  chain	  fatty	  acids	  
ELOVL5	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  90,	  e-­‐value	  
5e-­‐15	  
Y	  
NHBR47	   NM_205477	   MYH9	   Homo	  sapiens	  myosin,	  heavy	  chain	  9,	  
non-­‐muscle	  (MYH9)	  
MYH9	   Similar	  to	  NM_205477,	  "Gallus	  gallus	  myosin,	  
heavy	  chain	  9,	  non-­‐muscle	  (MYH9),	  mRNA	  
>gi|212382|gb|M26510.1|CHKMYHN	  Chicken	  
nonmuscle	  myosin	  heavy	  chain	  (MHC)	  gene,	  
complete	  cds",	  score	  492,	  e-­‐value	  7e-­‐136	  
N	  
NHBR48	   	   N/A	   N/A	   N/A	   -­‐(not	  annotated)-­‐	   Y	  
NHBR52	   XM_417443	   C20orf54	   Homo	  sapiens	  chromosome	  20	  open	  
reading	  frame	  54	  (C20orf54)	  
C20orf54	   Similar	  to	  XM_417443,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  chromosome	  20	  open	  reading	  
frame	  54	  (LOC419270),	  partial	  mRNA",	  score	  
349,	  e-­‐value	  4e-­‐93	  
N	  
NHBR55	   M81779	   CDH13	   Homo	  sapiens	  cadherin	  13,	  H-­‐
cadherin	  (heart)	  (CDH13)	  
CDH13	   Similar	  to	  M81779,	  "G.gallus	  T-­‐cadherin	  mRNA,	  
complete	  cds",	  score	  916,	  e-­‐value	  2e-­‐263	  
Y	  
NHBR58	   NM_001030620	   CANX	   Homo	  sapiens	  calnexin	  (CANX)	   CANX	   Similar	  to	  NM_001030620,	  "Gallus	  gallus	  
calnexin	  (CANX),	  mRNA	  
>gi|53127409|emb|AJ719429.1|	  Gallus	  gallus	  
mRNA	  for	  hypothetical	  protein,	  clone	  2d15",	  
score	  902,	  e-­‐value	  4e-­‐259	  
Y	  
NHBR59	   NM_001030620	   CANX	   Homo	  sapiens	  calnexin	  (CANX)	   CANX	   Similar	  to	  NM_001030620,	  "Gallus	  gallus	  
calnexin	  (CANX),	  mRNA	  
>gi|53127409|emb|AJ719429.1|	  Gallus	  gallus	  
mRNA	  for	  hypothetical	  protein,	  clone	  2d15",	  
score	  930,	  e-­‐value	  2e-­‐267	  
Y	  
NHBR65	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  member	  
5,	  elongation	  of	  long	  chain	  fatty	  acids	  
ELOVL5	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  419,	  e-­‐value	  
8e-­‐114	  
Y	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NHBR69	   XM_416106	   NAP1L1	   Homo	  sapiens	  nucleosome	  assembly	  
protein	  1-­‐like	  1	  (NAP1L1)	  
NAP1L1	   Similar	  to	  XM_416106,	  "PREDICTED:	  Gallus	  
gallus	  nucleosome	  assembly	  protein	  1-­‐like	  1	  
(NAP1L1),	  mRNA",	  score	  542,	  e-­‐value	  1e-­‐150	  
N	  
NHBR7	   CR387685	   N/A	   N/A	   CR387685	   Similar	  to	  CR387685,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST76p7",	  score	  115,	  e-­‐value	  
4e-­‐23	  
Y	  
NHBR70	   XM_416106	   NAP1L1	   Homo	  sapiens	  nucleosome	  assembly	  
protein	  1-­‐like	  1	  (NAP1L1)	  
NAP1L1	   Similar	  to	  XM_416106,	  "PREDICTED:	  Gallus	  
gallus	  nucleosome	  assembly	  protein	  1-­‐like	  1	  
(NAP1L1),	  mRNA",	  score	  653,	  e-­‐value	  6e-­‐184	  
N	  
NHBR72	   N/A	   N/A	   N/A	   N/A	   -­‐(not	  annotated)-­‐	   Y	  
NHBR73	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  member	  
5,	  elongation	  of	  long	  chain	  fatty	  acids	  
ELOVL5	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  203,	  e-­‐value	  
5e-­‐49	  
Y	  
NHBR76	   N/A	   N/A	   N/A	   N/A	   -­‐(not	  annotated)-­‐	   Y	  
NHBR77	   XR_026955	   MBTD1	   Homo	  sapiens	  mbt	  domain	  containing	  
1	  (MBTD1)	  
LOC417387	   Similar	  to	  XR_026955,	  "PREDICTED:	  Gallus	  
gallus	  hypothetical	  LOC417387	  (LOC417387),	  
mRNA",	  score	  300,	  e-­‐value	  3e-­‐78	  
Y	  
NHBR78	   BX931207	   MME	   Homo	  sapiens	  membrane	  metallo-­‐
endopeptidase	  (MME)	  
BX931207	   Similar	  to	  BX931207,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST1021m6",	  score	  966,	  e-­‐
value	  3e-­‐278	  
Y	  
NHBR8	   CR386843	   RPSA	   Homo	  sapiens	  ribosomal	  protein	  SA	  
(RPSA)	  
CR386843	   Similar	  to	  CR386843,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST38a1",	  score	  585,	  e-­‐value	  
9e-­‐164	  
Y	  
NHBR83	   CR386508	   N/A	   N/A	   CR386508	   Similar	  to	  CR386508,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST649o12",	  score	  328,	  e-­‐value	  
3e-­‐86	  
Y	  
NHBR89	   EU826449	   N/A	   N/A	   ATP8	   Similar	  to	  EU826449,	  "Gallus	  gallus	  ATP	  
synthase	  F0	  subunit	  8	  (ATP8)	  gene,	  partial	  cds;	  
and	  ATP	  synthase	  F0	  subunit	  6	  (ATP6)	  gene,	  
complete	  cds;	  mitochondrial",	  score	  266,	  e-­‐
value	  6e-­‐68	  
Y	  
NHBR90	   AF002986	   N/A	   N/A	   N/A	   Weakly	  similar	  to	  AF002986,	  "Homo	  sapiens	  
platelet	  activating	  receptor	  homolog	  (H963)	  
mRNA,	  complete	  cds",	  score	  46,	  e-­‐value	  0.035	  
Y	  
NHBR91	   XM_001235059	   N/A	   N/A	   NASP	   Similar	  to	  XM_001235059,	  "PREDICTED:	  Gallus	  
gallus	  nuclear	  autoantigenic	  sperm	  protein	  
(histone-­‐binding)	  (NASP),	  mRNA",	  score	  534,	  e-­‐
value	  2e-­‐148	  
N	  
NHBR95	   X52751	   BSG	   Homo	  sapiens	  basigin	  (Ok	  blood	  
group)	  (BSG)	  
BSG	   Similar	  to	  X52751,	  "Chicken	  mRNA	  for	  HT7	  
antigen",	  score	  234,	  e-­‐value	  1e-­‐58	  
Y	  
NHBR97	   CR352609	   YIPF3	   Homo	  sapiens	  Yip1	  domain	  family,	  
member	  3	  (YIPF3)	  
YIPF3	   Similar	  to	  CR352609,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST151l13",	  score	  379,	  e-­‐value	  
5e-­‐102	  
N	  
NHBR99	   N/A	   N/A	   N/A	   N/A	   -­‐(not	  annotated)-­‐	   Y	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Table 4.2.  Nhbw sequences and their homologies in Human (Homo 
sapiens) and in the Chick (Gallus gallus). 
 
Original	  
ID	  
Accession	  
ID	  
Gene	  
Symbol	  (H	  
Sapiens)	  
Description	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(Homo	  Sapiens)	  
Gene	  
Symbol	  (G	  
gallus)	  
Description	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
(Gallus	  gallus)	  
SP	  
NHBW100	   BX934439	   N/A	   N/A	   N/A	   Similar	  to	  BX934439,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST966n20",	  score	  262,	  e-­‐value	  
6e-­‐67	  
Y	  
NHBW105	   AC192748	   SEMA6A	   Homo	  sapiens	  sema	  domain,	  
transmembrane	  domain	  (TM),	  and	  
cytoplasmic	  domain,	  (semaphorin)	  
6A	  (SEMA6A)	  
N/A	   Similar	  to	  AC192748,	  "Gallus	  gallus	  BAC	  clone	  
CH261-­‐166H21	  from	  chromosome	  z,	  complete	  
sequence",	  score	  133,	  e-­‐value	  4e-­‐28	  
Y	  
NHBW12	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  
member	  5,	  elongation	  of	  long	  
chain	  fatty	  acids	  (FEN1/Elo2,	  
SUR4/Elo3-­‐like,	  yeast)	  (ELOVL5)	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  185,	  e-­‐value	  
1e-­‐43	  
Y	  
NHBW121	   CR391670	   N/A	   N/A	   N/A	   Similar	  to	  CR391670,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST158n2",	  score	  108,	  e-­‐value	  
1e-­‐20	  
Y	  
NHBW124	   NM_205518	   ACTB	   Homo	  sapiens	  actin,	  beta	  (ACTB)	   ACTB	   Similar	  to	  NM_205518,	  "Gallus	  gallus	  actin,	  
beta	  (ACTB),	  mRNA	  
>gi|211236|gb|L08165.1|CHKBACTN	  Gallus	  
gallus	  beta-­‐actin	  mRNA,	  complete	  cds",	  score	  
155,	  e-­‐value	  8e-­‐35	  
N	  
NHBW128	   L16770	   N/A	   N/A	   N/A	   Weakly	  similar	  to	  L16770,	  "Anas	  platyrhynchos	  
mitochondrial	  complete	  transfer	  RNA-­‐Glu,	  
transfer	  RNA-­‐Phe,	  transfer	  RNA-­‐Val,	  transfer	  
RNA-­‐Leu,	  12S	  ribosomal	  RNA,	  and	  16S	  
ribosomal	  RNA	  genes",	  score	  52,	  e-­‐value	  0.001	  
Y	  
NHBW13	   AY145522	   LOC100008588	   Homo	  sapiens	  18S	  ribosomal	  RNA	  
(LOC100008588),	  non-­‐coding	  RNA	  
N/A	   Similar	  to	  AY145522,	  "Rana	  chensinensis	  18S	  
ribosomal	  RNA	  gene,	  partial	  sequence",	  score	  
345,	  e-­‐value	  7e-­‐92	  
Y	  
NHBW138	   CR524036	   N/A	   N/A	   NOL5A	   Similar	  to	  CR524036,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST591p9",	  score	  127,	  e-­‐value	  
2e-­‐26	  
Y	  
NHBW148	   BX934736	   TUBA4A	   Homo	  sapiens	  tubulin,	  alpha	  4a	  
(TUBA4A)	  
N/A	   Similar	  to	  BX934736,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST559b14",	  score	  290,	  e-­‐value	  
6e-­‐75	  
N	  
NHBW15	   D38360	   LOC100008588	   Homo	  sapiens	  18S	  ribosomal	  RNA	  
(LOC100008588),	  non-­‐coding	  RNA	  
D38360	   Similar	  to	  D38360,	  "Gallus	  gallus	  gene	  for	  18S	  
rRNA,	  partial	  sequence",	  score	  153,	  e-­‐value	  6e-­‐
34	  
Y	  
NHBW153	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  
member	  5,	  elongation	  of	  long	  
chain	  fatty	  acids	  (FEN1/Elo2,	  
SUR4/Elo3-­‐like,	  yeast)	  (ELOVL5)	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  189,	  e-­‐value	  
8e-­‐45	  
Y	  
NHBW16	   CR352609	   YIPF3	   Homo	  sapiens	  Yip1	  domain	  family,	  
member	  3	  (YIPF3)	  
YIPF3	   Similar	  to	  CR352609,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST151l13",	  score	  429,	  e-­‐value	  
7e-­‐117	  
N	  
NHBW161	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  
member	  5,	  elongation	  of	  long	  
chain	  fatty	  acids	  (FEN1/Elo2,	  
SUR4/Elo3-­‐like,	  yeast)	  (ELOVL5)	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  135,	  e-­‐value	  
1e-­‐28	  
Y	  
NHBW175	   AC175394	   N/A	   N/A	   AC175394	   Similar	  to	  AC175394,	  "Gallus	  gallus	  BAC	  clone	  
TAM31-­‐49F22	  from	  chromosome	  w,	  complete	  
sequence",	  score	  185,	  e-­‐value	  2e-­‐43	  
Y	  
NHBW180	   NM_001006472	   CD151	   Homo	  sapiens	  CD151	  molecule	  
(Raph	  blood	  group)	  (CD151)	  
CD151	   Similar	  to	  NM_001006472,	  "Gallus	  gallus	  CD151	  
molecule	  (Raph	  blood	  group)	  (CD151),	  mRNA	  
>gi|53135765|emb|AJ720796.1|	  Gallus	  gallus	  
mRNA	  for	  hypothetical	  protein,	  clone	  25m21",	  
score	  714,	  e-­‐value	  1e-­‐202	  
Y	  
NHBW184	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  
member	  5,	  elongation	  of	  long	  
chain	  fatty	  acids	  (FEN1/Elo2,	  
SUR4/Elo3-­‐like,	  yeast)	  (ELOVL5)	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  171,	  e-­‐value	  
1e-­‐39	  
Y	  
NHBW190	   NM_001031023	   N/A	   N/A	   UBXN2B	   Similar	  to	  NM_001031023,	  "Gallus	  gallus	  UBX	  
domain	  protein	  2B	  (UBXN2B),	  mRNA	  
>gi|53129506|emb|AJ719732.1|	  Gallus	  gallus	  
mRNA	  for	  hypothetical	  protein,	  clone	  5m7",	  
score	  127,	  e-­‐value	  2e-­‐26	  
N	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NHBW201	   NM_001006219	   YWHAE	   Homo	  sapiens	  tyrosine	  3-­‐
monooxygenase/tryptophan	  5-­‐
monooxygenase	  activation	  
protein,	  epsilon	  polypeptide	  
(YWHAE)	  
YWHAE	   Similar	  to	  NM_001006219,	  "Gallus	  gallus	  
tyrosine	  3-­‐monooxygenase/tryptophan	  5-­‐
monooxygenase	  activation	  protein,	  epsilon	  
polypeptide	  (YWHAE),	  mRNA	  
>gi|53126522|emb|AJ719304.1|	  Gallus	  gallus	  
mRNA	  for	  hypothetical	  protein,	  clone	  1e8",	  
score	  169,	  e-­‐value	  4e-­‐39	  
N	  
NHBW203	   CR407495	   ATP6V0C	   Homo	  sapiens	  ATPase,	  H+	  
transporting,	  lysosomal	  16kDa,	  V0	  
subunit	  c	  (ATP6V0C)	  
ATP6V0C	  ///	  
TBC1D24	  
ATPase,	  H+	  transporting,	  lysosomal	  16kDa,	  V0	  
subunit	  c	  ///	  TBC1	  domain	  family,	  member	  24	  
Y	  
NHBW213	   XM_415612	   TNRC6C	   Homo	  sapiens	  trinucleotide	  repeat	  
containing	  6C	  (TNRC6C)	  
TNRC6C	   Weakly	  similar	  to	  XM_415612,	  "PREDICTED:	  
Gallus	  gallus	  trinucleotide	  repeat	  containing	  6C	  
(TNRC6C),	  mRNA",	  score	  50,	  e-­‐value	  0.004	  
Y	  
NHBW220	   BX934439	   EVPL	   Homo	  sapiens	  envoplakin	  (EVPL)	   N/A	   Similar	  to	  BX934439,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST966n20",	  score	  312,	  e-­‐value	  
8e-­‐82	  
Y	  
NHBW221	   BX934439	   EVPL	   Homo	  sapiens	  envoplakin	  (EVPL)	   N/A	   Similar	  to	  BX934439,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST966n20",	  score	  312,	  e-­‐value	  
8e-­‐82	  
Y	  
NHBW223	   NM_205518	   ACTB	   Homo	  sapiens	  actin,	  beta	  (ACTB)	   ACTB	   Similar	  to	  NM_205518,	  "Gallus	  gallus	  actin,	  
beta	  (ACTB),	  mRNA	  
>gi|211236|gb|L08165.1|CHKBACTN	  Gallus	  
gallus	  beta-­‐actin	  mRNA,	  complete	  cds",	  score	  
520,	  e-­‐value	  4e-­‐144	  
N	  
NHBW226	   CR352609	   YIPF3	   Homo	  sapiens	  Yip1	  domain	  family,	  
member	  3	  (YIPF3)	  
YIPF3	   Similar	  to	  CR352609,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST151l13",	  score	  441,	  e-­‐value	  
2e-­‐120	  
Y	  
NHBW23	   XM_001233493	   PTPRF	   Homo	  sapiens	  protein	  tyrosine	  
phosphatase,	  receptor	  type,	  F	  
(PTPRF)	  
PTPRF	   Similar	  to	  XM_001233493,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  receptor	  protein	  tyrosine	  
phosphatase	  LAR	  (LOC424568),	  mRNA",	  score	  
482,	  e-­‐value	  7e-­‐133	  
Y	  
NHBW237	   N/A	   N/A	   N/A	   N/A	   -­‐(not	  annotated)-­‐	   N	  
NHBW246	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  
member	  5,	  elongation	  of	  long	  
chain	  fatty	  acids	  (FEN1/Elo2,	  
SUR4/Elo3-­‐like,	  yeast)	  (ELOVL5)	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  80,	  e-­‐value	  
5e-­‐12	  
Y	  
NHBW252	   XM_424960	   SEMA6A	   Homo	  sapiens	  sema	  domain,	  
transmembrane	  domain	  (TM),	  and	  
cytoplasmic	  domain,	  (semaphorin)	  
6A	  (SEMA6A)	  
SEMA6A	   Similar	  to	  XM_424960,	  "PREDICTED:	  Gallus	  
gallus	  sema	  domain,	  transmembrane	  domain	  
(TM),	  and	  cytoplasmic	  domain,	  (semaphorin)	  
6A	  (SEMA6A),	  mRNA",	  score	  169,	  e-­‐value	  1e-­‐38	  
Y	  
NHBW256	   AJ721056	   DHX33	   Homo	  sapiens	  DEAH	  (Asp-­‐Glu-­‐Ala-­‐
His)	  box	  polypeptide	  33	  (DHX33)	  
DHX33	   Similar	  to	  AJ721056,	  "Gallus	  gallus	  mRNA	  for	  
hypothetical	  protein,	  clone	  33j19",	  score	  278,	  
e-­‐value	  1e-­‐71	  
N	  
NHBW258	   AJ721056	   DHX33	   Homo	  sapiens	  DEAH	  (Asp-­‐Glu-­‐Ala-­‐
His)	  box	  polypeptide	  33	  (DHX33)	  
DHX33	   Similar	  to	  AJ721056,	  "Gallus	  gallus	  mRNA	  for	  
hypothetical	  protein,	  clone	  33j19",	  score	  280,	  
e-­‐value	  3e-­‐72	  
N	  
NHBW260	   CU683875	   N/A	   N/A	   N/A	   Similar	  to	  CU683875,	  "Zebrafish	  DNA	  sequence	  
from	  clone	  CH73-­‐23L24	  in	  linkage	  group	  6,	  
complete	  sequence",	  score	  125,	  e-­‐value	  1e-­‐25	  
Y	  
NHBW263	   BC146737	   LOC730041	   Homo	  sapiens	  similar	  to	  small	  GTP	  
binding	  protein	  TC10	  (LOC730041)	  
BC146737	   Similar	  to	  BC146737,	  "Danio	  rerio	  zgc:165551,	  
mRNA	  (cDNA	  clone	  MGC:165551	  
IMAGE:7219026),	  complete	  cds",	  score	  377,	  e-­‐
value	  2e-­‐101	  
Y	  
NHBW264	   CU683875	   N/A	   N/A	   N/A	   Similar	  to	  CU683875,	  "Zebrafish	  DNA	  sequence	  
from	  clone	  CH73-­‐23L24	  in	  linkage	  group	  6,	  
complete	  sequence",	  score	  125,	  e-­‐value	  6e-­‐26	  
Y	  
NHBW266	   BC092921	   LYZL2	   Homo	  sapiens	  lysozyme-­‐like	  2	  
(LYZL2)	  
N/A	   Similar	  to	  BC092921,	  "Danio	  rerio	  cDNA	  clone	  
IMAGE:7160567",	  score	  716,	  e-­‐value	  3e-­‐203	  
Y	  
NHBW268	   CU683875	   N/A	   N/A	   N/A	   Similar	  to	  CU683875,	  "Zebrafish	  DNA	  sequence	  
from	  clone	  CH73-­‐23L24	  in	  linkage	  group	  6,	  
complete	  sequence",	  score	  125,	  e-­‐value	  6e-­‐26	  
Y	  
NHBW40	   XM_419518	   BPTF	   Homo	  sapiens	  bromodomain	  PHD	  
finger	  transcription	  factor	  (BPTF)	  
HEATR5B	   Similar	  to	  XM_419518,	  "PREDICTED:	  Gallus	  
gallus	  hypothetical	  LOC421469	  (LOC421469),	  
mRNA",	  score	  96,	  e-­‐value	  1e-­‐16	  
Y	  
NHBW45	   NM_001030620	   CANX	   Homo	  sapiens	  calnexin	  (CANX)	   CANX	   Similar	  to	  NM_001030620,	  "Gallus	  gallus	  
calnexin	  (CANX),	  mRNA	  
>gi|53127409|emb|AJ719429.1|	  Gallus	  gallus	  
mRNA	  for	  hypothetical	  protein,	  clone	  2d15",	  
score	  345,	  e-­‐value	  1e-­‐91	  
Y	  
NHBW49	   N/A	   N/A	   N/A	   N/A	   -­‐(not	  annotated)-­‐	   Y	  
NHBW51	   NM_001030620	   CANX	   Homo	  sapiens	  calnexin	  (CANX)	   CANX	   Similar	  to	  NM_001030620,	  "Gallus	  gallus	  
calnexin	  (CANX),	  mRNA	  
>gi|53127409|emb|AJ719429.1|	  Gallus	  gallus	  
mRNA	  for	  hypothetical	  protein,	  clone	  2d15",	  
score	  571,	  e-­‐value	  2e-­‐159	  
Y	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NHBW57	   BC037997	   CXCL2	   Homo	  sapiens	  chemokine	  (C-­‐X-­‐C	  
motif)	  ligand	  2	  (CXCL2)	  
CXCL2	   Similar	  to	  BC037997,	  "Mus	  musculus	  
chemokine	  (C-­‐X-­‐C	  motif)	  ligand	  1,	  mRNA	  (cDNA	  
clone	  IMAGE:5321155),	  partial	  cds",	  score	  351,	  
e-­‐value	  1e-­‐93	  
Y	  
NHBW62	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  
member	  5,	  elongation	  of	  long	  
chain	  fatty	  acids	  (FEN1/Elo2,	  
SUR4/Elo3-­‐like,	  yeast)	  (ELOVL5)	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  191,	  e-­‐value	  
2e-­‐45	  
Y	  
NHBW63	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  
member	  5,	  elongation	  of	  long	  
chain	  fatty	  acids	  (FEN1/Elo2,	  
SUR4/Elo3-­‐like,	  yeast)	  (ELOVL5)	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  189,	  e-­‐value	  
8e-­‐45	  
Y	  
NHBW64	   BX935106	   KCMF1	   Homo	  sapiens	  potassium	  channel	  
modulatory	  factor	  1	  (KCMF1)	  
N/A	   Similar	  to	  BX935106,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST70g5",	  score	  230,	  e-­‐value	  2e-­‐
57	  
Y	  
NHBW7	   BC037997	   CXCL2	   Homo	  sapiens	  chemokine	  (C-­‐X-­‐C	  
motif)	  ligand	  2	  (CXCL2)	  
CXCL2	   Similar	  to	  BC037997,	  "Mus	  musculus	  
chemokine	  (C-­‐X-­‐C	  motif)	  ligand	  1,	  mRNA	  (cDNA	  
clone	  IMAGE:5321155),	  partial	  cds",	  score	  349,	  
e-­‐value	  5e-­‐93	  
Y	  
NHBW73	   J04596	   CXCL2	   Homo	  sapiens	  chemokine	  (C-­‐X-­‐C	  
motif)	  ligand	  2	  (CXCL2)	  
N/A	   Similar	  to	  J04596,	  "Mouse	  platelet-­‐derived	  
growth	  factor-­‐inducible	  KC	  protein	  mRNA,	  
complete	  cds",	  score	  147,	  e-­‐value	  4e-­‐32	  
Y	  
NHBW74	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  
member	  5,	  elongation	  of	  long	  
chain	  fatty	  acids	  (FEN1/Elo2,	  
SUR4/Elo3-­‐like,	  yeast)	  (ELOVL5)	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  189,	  e-­‐value	  
8e-­‐45	  
Y	  
NHBW8	   BC037997	   CXCL2	   Homo	  sapiens	  chemokine	  (C-­‐X-­‐C	  
motif)	  ligand	  2	  (CXCL2)	  
N/A	   Similar	  to	  BC037997,	  "Mus	  musculus	  
chemokine	  (C-­‐X-­‐C	  motif)	  ligand	  1,	  mRNA	  (cDNA	  
clone	  IMAGE:5321155),	  partial	  cds",	  score	  351,	  
e-­‐value	  1e-­‐93	  
Y	  
NHBW82	   CR385946	   N/A	   N/A	   N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  171,	  e-­‐value	  
2e-­‐39	  
Y	  
NHBW85	   NM_001112806	   N/A	   N/A	   CKS1B	   Similar	  to	  NM_001112806,	  "Gallus	  gallus	  CDC28	  
protein	  kinase	  regulatory	  subunit	  1B	  (CKS1B),	  
mRNA	  >gi|41631786|emb|BX931258.1|	  Gallus	  
gallus	  finished	  cDNA,	  clone	  ChEST683j9",	  score	  
189,	  e-­‐value	  6e-­‐45	  
Y	  
NHBW87	   NM_001030620	   CANX	   Homo	  sapiens	  calnexin	  (CANX)	   CANX	   Similar	  to	  NM_001030620,	  "Gallus	  gallus	  
calnexin	  (CANX),	  mRNA	  
>gi|53127409|emb|AJ719429.1|	  Gallus	  gallus	  
mRNA	  for	  hypothetical	  protein,	  clone	  2d15",	  
score	  914,	  e-­‐value	  1e-­‐262	  
Y	  
NHBW90	   XM_417424	   OPRL1	   Homo	  sapiens	  opiate	  receptor-­‐like	  
1	  (OPRL1)	  
OPRL1	   Similar	  to	  XM_417424,	  "PREDICTED:	  Gallus	  
gallus	  similar	  to	  ORL1-­‐like	  opioid	  receptor	  
(LOC419251),	  mRNA",	  score	  472,	  e-­‐value	  6e-­‐
130	  
Y	  
NHBW94	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  
member	  5,	  elongation	  of	  long	  
chain	  fatty	  acids	  (FEN1/Elo2,	  
SUR4/Elo3-­‐like,	  yeast)	  (ELOVL5)	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  185,	  e-­‐value	  
1e-­‐43	  
Y	  
NHBW95	   NM_001006472	   CD151	   Homo	  sapiens	  CD151	  molecule	  
(Raph	  blood	  group)	  (CD151)	  
CD151	   Similar	  to	  NM_001006472,	  "Gallus	  gallus	  CD151	  
molecule	  (Raph	  blood	  group)	  (CD151),	  mRNA	  
>gi|53135765|emb|AJ720796.1|	  Gallus	  gallus	  
mRNA	  for	  hypothetical	  protein,	  clone	  25m21",	  
score	  732,	  e-­‐value	  6e-­‐208	  
Y	  
NHBW97	   CR385946	   ELOVL5	   Homo	  sapiens	  ELOVL	  family	  
member	  5,	  elongation	  of	  long	  
chain	  fatty	  acids	  (FEN1/Elo2,	  
SUR4/Elo3-­‐like,	  yeast)	  (ELOVL5)	  
N/A	   Similar	  to	  CR385946,	  "Gallus	  gallus	  finished	  
cDNA,	  clone	  ChEST154e23",	  score	  185,	  e-­‐value	  
1e-­‐43	  
Y	  
NHBW98	   N/A	   N/A	   N/A	   N/A	   -­‐(not	  annotated)-­‐	   Y	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Fig 4.1. Selection for molecules with a Signal Sequence. Nodes were dissected from 
Stage 3+/4 chick embryos; After RNA extraction and reverse transcription the clones were 
put through the secretion selection and the resulting sequences further screened by in 
situ hybridization. 
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Fig 4.2. Nhbr7 expression pattern. Strong expression is detected in the early neural 
plate at stage 4 (C) and 4+ (D) followed by a dramatic downregulation (E). 
 
 
 
 
 
 
 
 
Fig 4.3. Nhbr10, nhbr116 and nhbw63 expression pattern. Weak but consistent 
expression is detected in the neural plate form stage 4 (A) and this expression is 
maintained to at least stage 8 (B to E); There seems to be an increased expression in the 
node region at stages 4+ (B), 6 (C) and 7 (D) but this might be due to tissue thickening 
rather than expression amount. 
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Fig. 4.4. Nhbr34 expression pattern. Very dynamic expression is observed, with strong 
detection of transcripts, very transiently, at stage 4+ (B). Prior and after fully elongate 
primitive streak, no expression is detected (A,C). 
 
 
 
 
 
   
Fig 4.5. Nhbr90 expression pattern. Nhbr90 transcripts are first detected in the node at 
stage 3+ (A) and the node expression is maintained throughout the stages analysed (A-
F). 
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Fig 4.6. Nhbr91 expression pattern. Nhbr91 transcripts are detected in the anterior 
streak and node at stage 3+ (A) with low level of expression throughout the embryonic 
region. By stage 4, the expression becomes defined to the prospective neural plate and 
node (B) and reappears in the primitive streak at stage 5 (C). 
 
 
 
 
 
 
 
Fig 4.7. Nhbr111 expression pattern. Nhbr111 transcripts are present throughout the 
embryonic region at stage 3 (B) and become more defined to the prospective neural plate 
by stage 4 (B). Later stages reveal neural plate and blood islands expression (C and D). 
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 Fig 4.8. Nhbr121 expression pattern. Nhbr121 is expressed in the node and 
prospective neural plate at stages 4 (A) and 4+ (B). Transcripts continue to be detected in 
the neural plate and underlying mesoderm at later stages (C and D). 
 
 
 
 
 
Fig 4.10. Nhbr231 expression pattern. Stage 4 embryos express nhbr231 in the 
prospective neural plate, stronger at the border (A); Stage 4+ transcripts continue to clear 
away from the central region of the neural plate, resulting in a horseshoe shaped 
expression domain (B); At stage 7-, expression is completely abolished in the midline and 
is strong in the anterior neural plate and mesoderm (C); By stage 12, nhbr231 transcripts 
are strongly localized in the head region and anterior neural tube. Expression is also 
strong in the blood islands (D). 
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Fig 4.9. Nhbr225 expression pattern. Transcripts are detected at stage 3 in the 
primitive streak and the prospective neural plate (A); By stage 4+ the expression in the 
primitive streak seems to have disappeared or is extremely weak; Expression is present 
in the node and emerging head process (B); At stage 7 the nhbr225 mRNA is detected in 
the entire neural plate, albeit stronger in the anterior part of the embryo (C); At stage 8- 
expression remains in the neural plate, although it seems to clear away from the area 
surrounding the remaining primitive streak that, together with the node, seem to express 
the transcript by this stage (D); At stage 11, expression is mainly present in the neural 
tube and in the head region (E), as well as in the blood islands (F).    
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Fig 4.11. Nhbr241 expression pattern. Nhbr241 expression starts, very weakly, at stage 
3 and is detected in the primitive streak (A); By stage 4, expression stronger expression 
is detected in the primitive streak, node and the entire embryonic region (B); At stage 4+ 
the node and primitive streak expression is very strong; transcripts are also strongly 
detected in the prospective neural plate (C); By stage 6 the expression becomes very 
weak again and seems to be mainly detected in the neural plate (D).  
 
 
 
 
 
 
Fig 4.12. Nhbr151 expression pattern. At stage 3+ expression is detected in the entire 
embryonic region and strongly in the primitive streak and node (A); By stage 6 transcripts 
start to become restricted to the neural plate with stronger expression observed in the 
head process and the sides of the primitive streak (B); Expression at stage 7 remains 
strong in the primitive streak and notochord; transcripts are also detected in the neural 
plate and posterior mesoderm (C); At stage 9 expression is present in the head region, 
the closing neural tube, posterior neural plate and in the remaining streak; a strong patch 
of expression is present on the right side of the extraembryonic area opaca (D).  
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Fig 4.13. Nhbr260 expression pattern. At stage 3, nhbr260 is strongly expressed in the 
primitive streak and, more weakly, in the epiblast (A); At stage 4, expression remains 
similar and includes the node (B); Expression at stage 4+ is strong in the lateral sides of 
the primitive streak and node and in the mesoderm (C); Stage 8+ embryos present the 
transcript in the entire neural plate, stronger at the border, and in the posterior 
mesoderm. Some expression starts to be detected in what seem to be blood islands (D).  
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Fig 4.14. Nhbr307 expression pattern. Nhbr307 is expressed at very low levels 
throughout the embryonic and non embryonic regions at stage 3/3+ (A); Expression 
becomes localized at stage 4, weakly in the neural plate and very strong in the primitive 
streak and node (B); By stage 4+ the expression in the primitive streak seems to be 
downregulated (C). For the later developmental stages analysed, nhbr307 seems to 
maintain its expression restricted to neural structures, the neural plate and neural tube, 
and somites (D-F). 
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Fig 4.15. Nhbr313 expression pattern. Stage 3+-4 embryos express nhbr313 weakly 
throughout the embryonic region and strongly in the primitive streak and node (A and B); 
At stage 5 expression is difficult to detect but can be seen in the primitive streak and in 
the anterior neural plate (C); By stage 7 the expression becomes more defined and 
clearly localizes to the neural plate and the remaining streak (D).   
 
 
 
 
 
Fig 4.16. Nhbr330 expression pattern. At stage 4, nhbr330 expression is detected in 
the posterior two thirds of the primitive streak and some weak expression may be seen in 
the epiblast (A); At stage 4+, transcripts are completely absent from the node but are 
otherwise strongly detected in the rest of the embryo (B); By stage 5 expression starts to 
become restricted to the neural plate, with the node and head process not expressing the 
transcript (C);At stage 8, expression is present in the entire neural plate, being stronger at 
the anterior border (D).  
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Fig 4.17. Nhbw23 expression pattern. Transcripts are detected in the prospective 
neural plate and is absent from the node at stage 3+ (A). Expression remains mostly 
restricted to the neural plate from stage 4+ (B) to stage 7+ (C).  
 
 
 
 
 
 
Fig 4.18. Nhbw57 expression pattern. At stage XIII, transcripts are present in the entire 
epiblast (A); Stage 3+ embryos present expression in the entire epiblast, the node and 
primitive streak (B). By stage 4+, expression starts to become restricted to the prospective 
neural plate (C); In stage 6 embryos expression detected in the neural plate and in the 
forming notochord (D); Later, at stage 10, expression is strongly localized to the cephalic 
region and closing neural tube and in the blood islands (E).  
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Fig 4.19. Nhbw87 expression pattern. This in situ proved very difficult. By stage 3, there 
is some weak expression in the epiblast (A); Stage 7 embryos present expression in the 
neural plate, stronger in the head region (B); By stage 9, expression remains stronger in 
the head and in the neural tube and some expression remains in other parts of the neural 
plate (C).  
 
 
 
 
 
 
Fig 4.20. Nhbw95 expression pattern.  Expression seems almost ubiquitous, but it  is 
absent from the area pellucida up to stage 3+ (A) and is more strongly expressed in the 
neural plate at stage 6 (C). Stage 9 embryos present a distinct expression in the head, 
edge of the neural tube and the remnants of the streak in the posterior part of the embryo 
(D). 
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Fig. 4.21. Nhbw153 expression pattern. Expression is detected in the the anterior third 
of the primitive streak and the node as well as to the prospective neural plate (A); At 
stage 4+, ex expression in the primitive streak extended posteriorly and there is also strong 
expression in the emerging head process  (B); At stage 5, expression expands to the 
“mesodermal wings” and is maintained in the neural plate and head process (C); Similar 
expression is observed at stage 6, where the notochord is now well stained (D); By stage 
7, expression is present in the entire neural plate, with the exception of the area 
surrounding the node and first formed somite; the extraembryonic mesoderm also 
continues to express nhbw153 (E). Stage 10 embryos present strong expression in the 
blood islands and in the neural tube and borders of the posterior neural plate (F).  
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Chapter 5 
nhbr 34: Fibulin 2 
 
Introduction 
 
Fibulins are a family of extracellular matrix (ECM) proteins. Within a decade of the 
identification of the founding member of the family, Fibulin 1 (Argraves et al., 1989), 
several others were identified, mostly in mouse and humans, defining a family. These 
molecules are Fibulin 2 (Pan et al., 1993b), Fibulin 3 (Tran et al., 1997a), Fibulin 4 
(Gallagher et al., 2001; Giltay et al., 1999) and Fibulin 5 (Kowal et al., 1999a; Nakamura et 
al., 2002). A possible sixth member of the family – Fibulin 6 or Hemicentin – has been 
identified recently in the nematode (Vogel and Hedgecock, 2001). Because its inclusion in 
the fibulin family remains controversial, it will not be described further.  
 
Fibulin protein structure 
Fibulins vary greatly in size from 360 to about 1200 residues and all the family members 
can be modified further by alternative splicing (Argraves et al., 2003; Argraves et al., 
1990; Pan et al., 1993b; Timpl et al., 2003; Tran et al., 1997a).  Like most ECM proteins 
Fibulins have a distinct arrangement in modules, which can be grouped in domains 
classed as types I, II and III (Fig 5.1). 
 
Domain I of Fibulin 1, at the amino-terminus, consists of three anaphylatoxin-like (AT) 
modules (Huber et al., 1980). Domain II follows, with 9 epidermal growth factor (EGF)-
like modules, most of which can have a consensus sequence for calcium binding (also 
known as calcium-binding EGF-like modules). The carboxy-terminal domain III (FC 
module) is characteristic of fibulins and fibrillins (Giltay et al., 1999).  Fibulin 2 has an 
extra amino-terminal domain, which can be subdivided into a cysteine-rich segment (Na) 
and a cysteine-free segment (Nb) (Pan et al., 1993b). Fibulins 3, 4 and 5 are much shorter 
members of the family, lacking the AT modules, and characterized by only 5 EGF-like 
repeats (which can present modifications for calcium binding) (Gallagher et al., 1999; 
Giltay et al., 1999; Nakamura et al., 1999). All the Fibulins are secreted into the 
extracellular matrix and are synthesized from a precursor containing a signal peptide that 
is cleaved before secretion (Timpl et al., 2003). 
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Fibulin function 
All Fibulins are associated with basement membranes and elastic extracellular matrix 
fibres (Argraves et al, 2003) and are known to bind calcium as well as to interact with 
many other ECM proteins.  It has been hypothesised that they function as intramolecular 
bridges, stabilising the ECM structures, and that they modulate, to a certain extent, cell 
morphology, adhesion and motility (Gallagher WM et al, 2005). The next few paragraphs 
explore some possible roles of Fibulins in development and cellular interactions. 
 
Fibulins and heart development 
All the Fibulins isolated to date have been implicated in cardiovascular development 
(Argraves et al., 1990; Giltay et al., 1999; Kowal et al., 1999a; Kowal et al., 1999b; 
Nakamura et al., 1999; Pan et al., 1993a; Pan et al., 1993b; Timpl et al., 2003; Tran et al., 
1997a; Tran et al., 1995; Tran et al., 1997b) and most studies have focused on Fibulin1 and 
Fibulin2.  Immunostaining studies for Fibulin-1 revealed that in stage 15-22 quail 
embryos the protein is a constituent of most basement membranes, particularly in areas 
undergoing epithelial-mesenchymal transitions in the endocardial cushions, developing 
myotomes and neural crest. In the early heart, Fibulin expression is upregulated in the 
cardiac jelly at sites where endocardial cushion cells begin the migrations that lead to the 
formation of valvular and septal primordia (Spence et al., 1992). Avian studies have not 
been performed for fibulin-2. In the mouse, both fibulin-1 and fibulin-2 have been 
studied extensively. Both are expressed at sites of epithelial-mesenchymal transformation 
and cell migration during cardiac valvuloseptal and great vessel development (Tsuda et 
al., 2001; Zhang et al., 1995; Zhang et al., 1994), in zones lined by basement membrane 
and in adventitial layers (Miosge et al., 1996); both proteins remain as prominent 
components of adult valves (Miosge et al., 1998; Tsuda et al., 2001; Zhang et al., 1995). 
Targeted inactivation of the fibulin1 gene in mice leads to severe haemorrhages in the 
skin, muscle and perineural tissues. These defects are first evident at about midgestation 
and result in the death of almost all homozygous embryos at birth (Kostka et al., 2001). 
Targeted mutations of other Fibulin family members have not been reported.  
 
Fibulin3 is present in some capillaries, but not in large blood vessels whereas Fibulin4 is 
present in the medial layers of large veins and arteries and some small capillaries (Giltay 
et al., 1999). Fibulin5 seems to be restricted to the arterial vasculature and is 
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predominantly expressed in the vascular smooth muscle cells of adult blood vessels 
(Kowal et al., 1999a) and in the pulmonary artery endothelium  (Kuang et al., 2003). 
 
Fibulins in early development, including the nervous system 
Apart from reports of Fibulin1 and Fibulin2 expression in the neural crest in avian and 
murine embryos (Spence et al., 1992) there is very limited information pointing to a role 
of Fibulins in the development of neural structures. Another study assessed the 
expression patterns of fibulin1 and fibulin2 in human embryos of gestational weeks 4-10. 
Differences in staining patterns were observed in various neural structures. Fibulin-1 is 
prominent in the matrix of the leptomeningeal anlagen, in basement membranes of the 
neuroepithelium and in the perineurium of peripheral nerves. Fibulin-2 is detected 
primarily within the neuropithelium, spinal ganglia and peripheral nerves (Miosge et al., 
1996). Both fibulin1 and -2 are reported as being expressed in areas of epithelial-
mesenchymal interactions such as developing tooth and hair follicles (Zhang et al., 1995; 
Zhang et al., 1996); the early embryonic expression of both fibulins suggests that they 
function during organ development and, in particular, in the differentiation of heart, 
skeletal and neural structures (Miosge et al., 1996). 
 
Fibulins in gonadal morphogenesis 
Most developing organs are surrounded by an extracellular matrix (ECM), which must 
be remodelled to accommodate growth and morphogenesis. The role of ECM proteins in 
organogenesis is not yet clearly understood. However, experiments in Caenorhabditis 
elegans have started to explore the role of fibulin in gonad morphogenesis, where two 
secreted proteases, MIG-17 and GON-1, are required for gonad formation. Two 
independent recent studies (Hesselson et al., 2004; Kubota et al., 2004) have shown that 
Fibulin 1 can rescue gonadogenesis in the absence of these proteases. MIG-17 acts from 
outside the gonad to control the migration of gonadal distal tip cells (DTCs) that promote 
gonad morphogenesis. Kubota and coleagues (Kubota et al., 2004) have also shown that 
fibulin1 can bypass the requirement for MIG-17 activity in directing DTC migration. 
GON-1 regulates both elongation and shape of the developing gonad. Fibulin1 mutants 
have a wider than normal gonad as well as body size defects. Hesselson and coleagues  
(Hesselson et al., 2004) demonstrated that a fine balance between GON-1 and fibulin1 
levels is required for proper gonad formation. Studies in other species have not been 
performed, but it is likely that fibulins may be involved in similar processes during organ 
formation. 
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Fibulins in response to injury 
Fibulins have also been implicated in the responses to wound healing and inflammation. 
Fibulin 2 is upregulated in sun-damaged skin elastosis (Hunzelmann et al., 2001), and in 
some forms of kidney injuries (Wada et al., 2001). In wounds induced in mouse skin, 
there is a marked upregulation of fibulin2 mRNA expression, which declines to normal 
levels after completion of skin repair. Fibulin1 is present in normal skin but is not 
upregulated in the wounds during the healing process (Fassler et al., 1996; Raghunath et 
al., 1999). Fibulin5 expression is increased in the lung alveolar wall of mice with induced 
emphysema (Kuang et al., 2003), vascular smooth muscle cells in response to blood vessel 
injury (Kowal et al., 1999a; Kowal et al., 1999b), the lung vasculature in response to 
hyperoxia (Kuang et al., 2003; Kuang et al., 2006) and in atherosclerotic plaques (Kowal et 
al., 1999a). A study performed in rabbits has shown that overxexpression of fibulin5 in the 
injured skin accelerates the wound healing process (Lee et al., 2004b).  
 
This chapter presents the cloning, molecular characterization and possible implications in 
neural induction of a chick homologue of Fibulin 2 (Fbln2 short). Its expression in the 
chick starts in the epiblast prior to gastrulation and, as cells start to ingress, expression is 
seen in the forming mesoderm. Thereafter expression is concentrated in the notochord, 
intermediate mesoderm (Wolffian duct primordia) and derivatives of the somites as well 
as in branchial arches and diencephalic regions. Misexpression of Fbln2 short within and 
outside the prospective neural plate does not alter the normal expression of the early 
neural markers Sox3 and Sox2. It is also unable to induce Sox2 in the area opaca even in 
combination with FGF8. These experiments do not support the hypothesis that fibulin 
plays an important role in neural induction in the chick embryo.  
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Materials and methods 
 
Isolation of a full-length clone of chick fibulin2-short 
The original nhbr34 clone was used to transcribe a radiolabelled RNA probe which was 
used for library screening (details of the procedure can be found in Chapter 2). 
 
Northern Blots 
Northern blots were performed as described in Chapter 2 and the full length clone 
Fibulin2-short was used to transcribe a radiolabelled probe ([α-32P]dCTP) prior to 
hybridization. 
 
Database searches 
Homologous sequences from other species were obtained from GenBank. Alignments 
were performed using ClustalW software and phylogenetic trees built with TreeView. 
Tools within Prosite http://www.expasy.org/prosite/ allowed analysis of the protein 
motifs.  
 
In situ hybridisation 
The full length fibulin2 short was used to transcribe a digoxigenin-labelled RNA probe 
and hybridisation performed as described in Chapter 2.  
 
Electroporation construct 
cFbln2 short was cloned into pCAβ-IRES-GFP (a kind gift from A. Lumsden Lab). The pBS-
Fbln2 plasmid was cut with SpeI and the ends blunted with Klenow enzyme (Promega), 
followed by digestion with ClaI. The pCAβ-IRES-GFP vector was digested with BamHI, 
Klenow filled and cut with ClaI. After ligation, the resulting DNA was sequenced and 
used for electroporation at a concentration of 1.5 µg/µl. 
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Results 
Cloning of the full length nhbr34: chick fibulin2-short 
Searches of the chicken genome using the nhbr34 sequence revealed a predicted fibulin 2 
gene located on chromosome 12 (LOC427583). The sequence is 4803 bp long and codes 
for a putative 1600 amino acid protein. This sequence had been deposited in the NCBI 
database under accession number XM_425156.  
 
The nhbr34 clone was used to screen a chick stage 2-4 cDNA library, resulting in the 
isolation of a sequence containing a 1746bp long ORF, coding for a 581aa peptide.  When 
compared with the predicted fibulin 2 from the genome, the shorter isolated sequence is 
100% identical at the aminoacid level. It was therefore called fibulin2-short. Northern Blot 
analyses of RNA from chick embryos at stages 3, 5 and 7-8 reveal two bands of 4.7 and 
1.8-2Kb respectively (Fig 5.2 A). The larger band is likely to correspond to the predicted 
fibulin2 gene, whereas the size of the smaller band agrees with the predicted length of 
the shorter version of fibulin 2 which had been isolated.  The smaller fibulin 2 RNA is 
much more abundant than the larger transcript which may explain why it was not picked 
up during the library screening. Fig 5.2C shows the aminoacid sequence of chick Fibulin2 
short (cFbln2-short) with the underlined region where the nhbr34 clone aligns.  
 
Fibulin 2 is a conserved molecule 
From the time the first Fibulin 2 was isolated from mouse fibroblasts (Pan et al., 1993b), 
many other Fibulins have been isolated and characterised. The recent sequencing of the 
genomes of various species also provides a great tool to predict and compare sequences. 
ClustalW alignments were performed to compare the sequences of Fibulin2 short with 
the very well described mouse (NM_007992) and human (NM_001004019) sequences. 
Predicted sequences from chicken (XM_425156), rat (XM_232197) and chimpanzee 
(XM_516297) and a smaller version of human fibulin2 (hFBLN2 short) were also used. 
The resulting alignment  (Fig 5.3) highlights the conserved structure of fibulin2 amongst 
the sequences analyzed. Conservation is particularly evident in the characteristic 
domains of Fibulin2, namely the cystein-rich segment (Na; pink), the three anaphylatoxin 
modules (AT; green), the EGF-like modules (light blue and light blue and yellow when 
there is a consensus sequence for calcium binding) and in the carboxy-terminal domain 
(FC module; red). The signal peptide and the Cysteine-free segment (Nb), represented in 
dark blue and grey respectivelly, although not conserved at the amino acid level, share 
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the properties that the first has hydrophobic residues and the second lacks cysteines in all 
the sequences. Fig 5.3 B shows the modular structure of Fibulin2.  
 
The Fibulin family has many members 
Since the identification of Fibulin-1 (Argraves S, et al 1989), the founding member of the 
Fibulin family of proteins, four other members have been identified (Fibulin-2, -3, -5 and -
5), mostly in work performed with human and murine cell lines. To compare fibulin2-
short with other fibulin family members, sequence comparisons were performed with 
fibulin 2, fibulin 1 and fibulin 5.  Some of the sequences used were predicted from the 
available genome data. Given the large number of sequences available, only a few were 
selected for analyses. These were zebrafish fibulin1-D (zfFbln1-D; AF013751), chick 
Fibulin1 (cFbln1; NM_204165), predicted rat Fibulin1 (rFbln1; XM_243637), mouse 
Fibulin1 (mFbln1; NM_010180) human Fibulin1-C (hFBLN1-C; NM_001996), predicted 
chick Fibulin5 (cFbln5; XM_421323), rat Fibulin5 (rFbln5; NM_019153), mouse Fibulin5 
(mFbln5; NM_011812), human Fibulin5 (hBBLN5; NM_006329) and the fibulin 2 family 
member mentioned above. Trees resulting from the alignment are shown in Fig 5.2B and 
Fig 5.4. Homonymous family members were clustered and within each family, avian 
fibulins appear closer to their mammalian counterparts, which group together, than the 
corresponding fish sequences (eg. Fig 5.4).  Fibulin2 appears to have diverged earlier 
than the duplication that led to Fibulins 1 and 5. 
 
Expression pattern of fbln2 in the chick 
Whole mount in situ hybridisation was performed in chick embryos ranging from pre-
gastrula stages to about stage 20. Expression is first detected very weakly in the epiblast 
at stage 2-3 (not shown) and by stage 3+ expression covers the entire epiblast (Fig 5.5 A). 
At stage 4, expression is excluded from the primitive groove but is expressed in the 
primitive ridges and Hensen’s node (white arrowhead) (Fig 5.5 B). Thereafter, fbln2 is 
expressed in the mesodermal wings of the lateral plate (Fig 5.5 C) and emerging head 
process (Fig 5.5D and Fig 5.6A) and increasingly strongly in the notochord (white arrow, 
Fig 5.5 E-H; Fig 5.6 J, M-Q). From stage 6 onwards expression starts to clear from the 
anterior ectoderm, leaving a fringe of expressing cells at the anterior and lateral borders 
of the neural plate (Fig 5.5 E-G). From stage 7+ the expression completely clears from the 
neural plate and becomes restricted to the notochord, somites and border of the neural 
plate (Fig. 5.5 G). At stage 11 strong expression is observed in the anterior ectoderm and 
prosencephalon, notochord, somites and a dorsal domain of the intermediate mesoderm 
(Fig 5.5 H and Fig 5.6 J-S). Later in development fbln2-short is strongly expressed in the 
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diencephalon (perhaps including periocular neural crest), heart (Fig 5.6 L, M), branchial 
arches (red asterisks in Fig 5.5 I,J), lateral mesoderm and myotome (red arrows; Fig 5.5 I-
K). 
 
fbln2-short misexpression is unable to alter the expression of neural 
plate markers Sox3 and Sox2 
Because all fibulins are secreted proteins (Argraves et al., 2003) and fbln2-short is 
expressed in Hensen’s node at stages 3+-4 and in the axial mesoderm thereafter, it could 
play a role in neural induction. To investigate this further, pCAβ-fbln2-short-IRES-GFP 
was electroporated into the epiblast of stage 3+ chick embryos in a line extending from 
close to the node to the area opaca. This does not alter the expression of the early neural 
plate markers Sox3 (0/11; Fig 5.7 A-B) or Sox2 (0/14; Fig 5.7 F-G) in any of the embryos 
tested.  Control electroporations, where the pCAβ -IRES-GFP plasmid was used, had 
similar results  
 
Since misexpression of a line of Fbln2-short does not alter the expression of Sox3 and Sox2, 
it is unlikely to induce their expression in the area opaca. Nevertheless, to rule out this 
possibility, pCAβ-fbln2-short-IRES-GFP was electroporated in a discrete domain in the 
inner third of the area opaca of stage 3+ chick embryos. After overnight culture, no 
expression of Sox3 (0/6; not shown), Sox2 (0/8; Fig 5.7 C-E), or Brachyury (0/14) was 
observed in the electroporated region. Combining FGF8-soaked beads with pCAβ-fbln2-
short-IRES-GFP electroporation also resulted in no induction of Sox2 or of the 
mesodermal marker Brachyury in any of the embryos tested (0/12; Fig 5.7 H-J). 
 
These results do not implicate Fibulin2 in neural induction.   
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Discussion 
Alternative splicing vs truncated fibulins 
Alternative splicing has been reported for almost all fibulins studied. It was first 
demonstrated for domain III of human fibulin1 (Argraves et al., 1990; Tran et al., 1997a), 
which can vary from being completely eliminated (variant A) to being composed of 137 
residues in variant D. Fibulin 2 splicing usually occurs within the EGF-like domains (Pan 
et al., 1993b); splicing in other regions of fibulin is also detected, including partial or 
complete deletion of the amino terminal domain I (Gallagher et al., 2001). Descriptions of 
truncated fibulins are rare in the literature, but it has been reported that human fibulin3 
can have its amino terminal truncated to the extent of lacking the signal sequence and 
therefore presumed failure of secretion of the protein (Lecka-Czernik et al., 1995).  
 
Chick Fibulin2-short seems to be a truncated form of the predicted chick Fibulin2. They 
both locate to the same position on Chicken chromosome 12 and have identical amino-
acid composition. Based on the Northern blot results presented, it seems that fibulin2-
short transcripts are more abundant than the longer form (fibulin2) at these stages in the 
chick embryo and may explain why the latter was not isolated during the library 
screening. The functional significance of the two forms remains to be understood. 
 
Interestingly, by checking for other truncated fibulins within the human genome, a 
truncated form of fibulin2 was found. This human fibulin2-short seems to encode a much 
smaller protein, lacking the signal peptide, the fibulin2 domain N and domain I. The 
resulting peptide is identical to the carboxy-terminal half of hFibulin2. Whether these 
truncations are common in other fibulin family members or why they happen is unclear, 
as is the presence of alternatively spliced variants. It is conceivable that these 
modifications could affect binding ability to ECM proteins but this remains to be 
investigated. 
 
Fibulin2-short in neural induction 
No previous studies have explored the function of any fibulin in neural induction. There 
have been only a few studies of its expression in early embryos, which reported 
expression of fibulins in the neural crest (Spence et al., 1992), neuroepithelium, spinal 
ganglia and peripheral nerves (Miosge et al., 1996), but the functioal significance of these 
patterns was not assessed. In situ hybridisation for Fibulin2 short in chick embryos (this 
study) showed that the mRNA is present transiently in Hensen’s node and then strongly 
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in the axial mesoderm, as well as in a portion of the rostral neural tube and in 
intermediate mesoderm at later stages. Despite the finding that it is expressed in the node 
and its derivatives the head process and notochord, misexpression experiments gave 
negative results: neither fibulin2-short alone nor together with FGF8 is unable to induce 
neural markers in an ecopic, competent region. It is conceivable that a more complex 
combination of factors is required to reveal a function of fibulin in the modulation of 
expression of neural markers. It is therefore difficult to envisage its role as a direct 
signalling molecule that could act as a neural inducer. Furthermore, cell surface receptors 
for this protein have not been described; it is therefore impossible at this stage to 
speculate further on the likelihood that it may play a role in this process at these stages of 
development, and if it does signal, which tissue responds to such signals. 
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Fig 5.1. Modular structure of Fibulins.  Fibulins have a characteristic arrangement of 
matrix modules, grouped together as domains I, II and III.  The four variants of fibulin-1 
are shown, being identical in sequence up to the fibulin-type carboxy-terminal (FC) 
module.  Fibulin-2 is unique in that it contains an extra domain, Domain N, which can be 
subdivided into a cystein-rich segment (Na) and cystein-free segment (Nb). Fibulin-3, 
fibulin-4 and fibulin-5 have a modified calcium-binding (cb) epidermal growth factor 
(EGF)-like module at their amino terminus, the Domain I. AT, anaphylatoxin-like. 
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Fig 5.2. cFibulin2-short. Northern blots reveal that Fibulin2  is abundantly expressed in 
the early chick embryo (A). Dendogram resulting from the alignment of several Fibulin2 
proteins, including another short variant, found in humans (B). Fibulin2-short aminoacid 
sequence, reveals a characteristic modular structure (C). 
 
 
 112 
 
 
 
Fig 5.3. Fibulin 2 is a modular protein. Aminoacid alignment of several Fibulin2 
proteins , including a human Fibulin2-short (hFBN2_s), very similar with cFibulin2-short; 
The Fibulin Modules are color coded, both in the alighnment (A) and schematic domain 
structure (B). 
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Fig 5.4 Filogenetic tree of fibulin1, fibulin2 and fibulin5 present in various species. 
Fibulin2-short and other Fibulin 2 protein sequences were compared with other fibulin 
family members, Fibulin 1 and Fibulin 5. Only a few sequences were selected for the 
analyses and those were zebrafish fibulin1-D (zfFbln1-D), chick Fibulin1 (cFbln1) 
predicted rat Fibulin1 (rFbln1), mouse Fibulin1 (mFbln1), human Fibulin1-C (hFBLN1-C), 
predicted chick Fibulin5 (cFbln5), rat Fibulin5 (rFbln5), mouse Fibulin5 (mFbln5), human 
Fibulin5 (hBBLN5), mouse Fibulin 2 (mFbln2), human Fibulin 2 (hFBLN2 variant1), a 
human short version of Fibulin2 (hFBLN2short) and the predicted Fibulin 2 from chicken 
(cFbln2 predicted), rat (rFbln2predicted) and chimpanzee (pFbln2predicted). 
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Fig 5.5. Fibulin2 expression pattern in the developing chick embryo. At stage 3+ 
expression is detected in the epiblats epiblast (A); By stage 4, expression is excluded from the 
primitive groove but is present in the primitive ridges and Hensen’s node (B, white 
arrowhead); Fibulin 2 is then expressed in the mesodermal wings of the lateral plate (C), in the 
emerging head process (D) and in the notochord (E-H, white arrow). From stage 6 onwards 
expression starts to clear from the anterior ectoderm, leaving a fringe of expressing cells at 
the anterior and lateral borders of the neural plate (E-G). From stage 7+ the expression 
completely clears from the neural plate and becomes restricted to the notochord, somites and 
border of the neural plate (G). At stage 11 strong expression is observed in the anterior 
ectoderm and prosencephalon, notochord, somites and a dorsal domain of the intermediate 
mesoderm (H). Later in development fbln2 is strongly expressed in the branchial arches (red 
asterisks,I and J), lateral mesoderm and myotome (red arrows, I-K). 
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Fig 5.6. Expression of Fibulin2 in the chick embryo. Expression at stage 5 (A) and 
sections through the embryo (B-I); Expression at stage 11 (J) and respective sections 
(K-S).  
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Fig 5.7. Fibulin2-short is unable to induce the neural markers Sox3 and Sox2. When 
electroporated as a line extending from the embryo to the area opaca, fibulin2-short is 
unable to induce either Sox3 (A and B) or Sox2 (F and G).  Missexpression in the area 
opaca also results in no Sox2 induction (D and E), even when combined with FGF8b (I 
and J). No Brachyury is induced in the experiments (C-E and H-J). 
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Chapter 6 
nhbr307: Calreticulin 
 
 
Introduction 
 
Calreticulin was first isolated in mammals over thirty years ago (MacLennan et al., 1974; 
Ostwald and MacLennan, 1974), and this was followed by molecular cloning of the 
protein from rabbit skeletal muscle (Fliegel et al., 1989a; Fliegel et al., 1989b; Smith et al., 
1989). Subsequently, genes encoding Calreticulin were identified in several vertebrates 
(Liu et al., 1993; Mazzarella et al., 1992), invertebrates (Hawn et al., 1993; Huggins et al., 
1995; Jaworski et al., 1996; Khalife et al., 1993a; Khalife et al., 1993b; Labriola et al., 1999) 
and also in plants (Chen et al., 1994a; Crofts et al., 1998; Dresselhaus et al., 1996; 
Kwiatkowski et al., 1995) and protozoans (Labriola et al., 1999; Navazio et al., 1998), but 
no calreticulin gene has been found in yeast or prokaryotes. 
 
Molecularly, Calreticulin is a 40-46kDa protein with an N-terminal signal sequence and a 
C-terminal Endoplasmic Reticulum retrieval sequence (KDEL) (Denning et al., 1997; 
Fliegel et al., 1989a). Structural predictions suggest that the protein has three domains 
(Denning et al., 1997; Fliegel et al., 1989a; Michalak et al., 1992) (known as N-, P- and C-
domains). The N-domain is highly conserved amongst all known Calreticulin molecules. 
The P-domain is proline-rich, sharing similarity in aminoacid composition with the 
Calcium modulator proteins Calnexin and Calmegin (Michalak et al., 1999). This domain 
contains a high affinity, low capacity Ca2+-binding site (1 mol Ca2+/mol of protein, Kd ≈ 
1µM). The C-domain is rich in acidic aminoacids  (aspartic and glutamic acid) and 
contains a low-affinity/high capacity Ca2+-binding site (25 mol Ca2+/ mol protein Kd ≈ 
250µM) (Coppolino and Dedhar, 1998). 
 
The protein appears to fulfil many cellular functions, both within and outside of the ER. 
In the ER lumen it performs two major functions: chaperoning and regulation of Ca2+ 
homeostasis (Mery et al., 1996; Wada et al., 1994). Calreticuln is a highly versatile lectin-
like chaperone (Hebert et al., 1995; Peterson et al., 1995; Spiro et al., 1996) and it 
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participates in the synthesis of a variety of molecules, including ion channels, surface 
receptors, integrin and transporters. The protein also affects intracellular Ca2+ 
homeostasis by modulation of ER Ca2+ storage and transport. Upregulation of 
Calreticulin leads to numerous effects in different experimental models, including 
increased Ca2+ storage capacity of the ER (Mery et al., 1996), modulation of cell adhesion 
(Leung-Hagesteijn et al., 1994), modulation of store-operated Ca2+ influx (Mery et al., 
2005; Mery et al., 1996), increased propensity to apoptosis (Knee et al., 2003), modulation 
of steroid sensitive gene expression (Burns et al., 1994)  and modulation of the function of 
another ER calcium pump, SERCA2 (John et al., 1998). In cell culture, downregulation of 
Calreticulin causes changes in cell adhesion (Coppolino et al., 1997; Rauch et al., 2000), 
increased resistance to apoptosis (Nakamura et al., 2000), abnormal accumulation of 
misfolded proteins (Knee et al., 2003), modulation of Ca2+-dependent gene transcription 
(Mesaeli et al., 1999) and inhibition of agonist-dependent Ca2+ release from ER stores 
(Mesaeli et al., 1999).  
 
However, little is known about the functions of Calreticulin during development. Mouse 
mutants defective in calreticulin die at E14.5 (Mesaeli et al., 1999) with impaired cardiac 
development and problems in Ca2+-dependent transcriptional pathways (Guo et al., 2002; 
Mesaeli et al., 2001; Mesaeli et al., 1999). Mutant mice also present brain and body wall 
defects (Rauch et al., 2000). A zebrafish calreticulin homologue was first isolated in a 
screen for genes whose expression is dependent on Cyclops signalling (a Nodal 
homologue) but no function was assigned to it (Rubinstein et al., 2000). A subsequent 
study found that inhibition of the ER Calcium pump during early gastrulation induces 
cyclopia, phenocopying some of the defects seen in cyclops, squint, one-eyed pinhead and 
silberblick mutant embryos (which have defects in Nodal or Wnt signalling). By contrast, 
inhibition during mid-gastrulation induces tail defects similar to those observed in no-tail 
(brachyury) mutant embryos (Creton, 2004). However since these studies rely on 
pharmacological inhibition of the ER Ca2+ pump, there is no direct evidence that 
Calreticulin is involved in these processes. 
 
This Chapter reports the cloning, molecular and functional characterization of chick 
calreticulin (cCrt) during early development. cCrt is expressed in Hensen’s node and 
evidence is provided that its product can be secreted. When misexpressed alone or in 
combination with FGF8, Chd, Smad6 and/or Smad7 it is unable to induce the neural 
marker Sox2 in competent epiblat of the area opaca, although it can expand the neural 
ectoderm in a similar manner to that observed for BMP antagonists, raising the 
possibility that Calreticulin acts, directly or indirectly, as a BMP antagonist. 
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Materials and Methods 
 
Isolation of a full-length clone of chick calreticulin (cCrt) 
The original nhbr307 clone was used to transcribe the radiolabelled RNA probe used for 
library screening (for details on the procedure refer to Chapter 2). 
 
Database searches 
Homologous sequences from other species were obtained from GenBank. The sequence 
of fulllength chick calreticulin was BLASTed against a Database of Expressed Sequence 
Tags (dbEST) http://www.chick.umist.ac.uk/ and against the chicken genome 
using the Ensembl Genome Browser 
http://www.ensembl.org/Gallus_gallus/index.html. Alignments were 
performed using ClustalW software and Phylogenetic Trees constructed with TreeView. 
Tools within Prosite http://www.expasy.org/prosite/ were used to analyse 
motifs in the protein. 
 
Sub-cellular localisation in COS cells 
The open reading frame of calreticulin was cloned in pCDNA 3.1/Myc-His (Invitrogen), 
using the NotI and BamHI cloning sites. Inserts were generated by PCR using the primers 
GATCGCGGCCGCATGAGCCGCCTCTGCCTCCCG (adds a NotI restriction site prior to 
the start codon) and GATCGGATCCTCTTCCTCTCAGCCTCC (removes the stop codon 
from calreticulin and adds a BamHI restriction site) and pfuTaq polymerase (Promega) 
(94°C, 2 minutes; 42°C, 2 minutes; 72°C, 2 minutes; 30 cycles). After digestion of both the 
PCR fragment and the pCDNA vector with NotI and BamHI, the DNAs were gel purified 
using a gel extraction kit (Promega) and ligated with T4 ligase (Promega). The resulting 
plasmid (cCrt-Myc) was checked by sequencing. 
 
1x105 COS-1 cells were plated in a 35 mm cell culture dish, grown in DMEM containing 
10% new born calf serum and transfected with the cCrt-Myc construct using 
Lipofectamine Plus (Gibco). No DNA was used to produce the ”Mock transfected” 
control cells. After 48 hours in culture, the cells were rinsed in PBS and fixed in 4% 
paraformaldehyde for 30 minutes at room temperature. After washing again in PBS (3x10 
minutes), the cells were blocked in PBS containing 0.05% Triton X-100 and 1% goat serum 
for 30 minutes at room temperature and incubated in anti-myc monoclonal antibody 
supernatant (1:1 in blocking buffer) overnight at 4°C. The following day, cells were 
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washed with PBS (5x5 minutes) and incubated in anti-mouse IgG-HRP (Jackson; 1:2500 in 
blocking buffer) overnight at 4°C. After washing (5x15 minutes in PBS), the cells were 
rinsed twice with 100 mM Tris pH7.4 and incubated in 0.5 mg/ml DAB for 5 minutes. 
H2O2 was added (0.003%) and the colour developed in the dark. After stopping the 
reaction with tap water, the cells were fixed with 4% paraformaldeheyde and mounted 
on a slide. In some experiments anti-calreticulin antibody was used  (GαCrt; 1:2500, kind 
gift of Prof. Michal Michalak); cells were blocked in PBS containing 0.05% Triton X-100 
and 1% calf serum and immunoreactivity detected with rabbit anti-goat HRP (Invitrogen; 
1:5000). 
 
Western Blotting 
1.5x105 COS-1 cells were transfected with cCrt-Myc as described above. A BMP4 
expression construct (Liem et al., 1995) was used as a control. After 24 hours, the culture 
medium was changed to DMEM with no additives and the cells cultured for another 24 
hours. After culture the medium was collected (“secreted fraction”) and the cells rinsed 
twice with PBS and centrifuged at 1100rpm for 5 minutes. The supernatant was discarded 
and the pellet lysed in PBS with 1mM EDTA, 0.1% Triton X-100, 40 µg/ml PMSF, 5 
µg/ml Leupeptin and 1 µg/ml Pepstatin for 30 minutes at 4°C. 1 µl of DNAse was then 
added for 10 minutes, at room temperature, and the lysis product centrifuged at 10,000 
rpm for 10 minutes at 4°C. The supernatant was collected (“lysate”). 
 
20 µl of secreted fraction or lysate were boiled at 95°C with 2x SDS-PAGE loading buffer 
(260 mM Tris pH6.8, 12% w/v SDS, 20% v/v 2-mercaptoethanol, 40% v/v glycerol) for 3 
minutes and then centrifuged at 13000 rpm for 3 minutes. The samples were run on 15% 
SDS-PAGE gels under denaturing and reducing conditions (SDS-running buffer: 0.303% 
w/v Trizma base, 1.44% w/v glycine, 0.1% w/v SDS). Proteins were transferred onto 
nitrocellulose membranes (Amersham) and blocked for 2 hours in 4% milk powder in 
TBST. The membranes were incubated in the primary antibody overnight at 4°C, washed 
in TBST (3x10 minutes) and incubated in the secondary antibody, goat anti-mouse IgG-
HRP (1:2500) overnight at 4°C. The membranes were washed again with TBST (3 x 10 
minutes) and detected by chemoluminescence. 
  
Chick in situ hybridisation 
The full-length clone of calreticulin was used to transcribe a digoxigenin-labelled RNA 
probe. The procedure followed is given in Chapter 2. 
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Zebrafish embryo collection and in situ hybridisation 
Breeding fish were maintained at 28.5°C on a 14 hour light/10 hour dark cycle in the 
UCL Anatomy fish facility (Masa Tada kindly provided the fish). Embryos were collected 
from the colony by natural spawning, raised in 10% Hank’s saline (137 mM NaCl, 5.4 
mM KCl, 1.3 mM CaCl2, 1.0 mM MgSO4, 0.25 mM Na2HPO4, 4.2 mM NaHCO3) at 28°C 
and staged. Embryos were fixed in 4% paraformaldehyde in PBS, either overnight at 4°C 
or for 2 hours at room temperature. After removal of the chorion, the embryos were 
stored in 100% methanol at –20°C. 
 
In situ hybridisation was performed according to protocols in current use in the Wilson 
lab. Embryos were rehydrated through 75%, 50% and 25% methanol in PTW (PBS/0.1% 
Tween-20), washed  (4x 5 minutes) in PTW at room temperature, treated for 20 minutes 
with proteinase K (10 µg/ml) and re-fixed in 4% paraformaldeheyde for 20 minutes. 
After washing five times with PTW (5 minutes), the embryos were preincubated in 
hybridization mix (50% formamide, 5x SSC pH 6.0, 50 µg/ml yeast RNA, 50 µg/ml 
heparin, 0.1%Tween-20) at 65°C for 2 hours and then hybridised overnight in fresh 
hybridisation mix containing 100 ng of digoxigenin-labelled RNA. 
 
Following hybridisation, the embryos were washed (3x 10 minutes) with 25% 
hybridisation mix in 2xSSC, once in 2xSSC and twice with 0.2xSSC (30 minutes each 
wash) at 65°C. The following washes were performed at room temperature and consisted 
of 5 minutes each in 75%, 50%, 25% 0.2x SSC in PTW and then PTW. After blocking for 2 
hours at room temperature in PTW containing 2% sheep serum and 2 mg/ml BSA, the 
embryos were incubated overnight in anti-DIG-AP antibody (Roche) 1:5000 (in the same 
blocking solution). The next day, embryos were rinsed in PTW and washed 6-10 times for 
15 minutes in PTW with gentle agitation. This was followed by three 5-minute washes in 
alkaline phosphatase reaction buffer (0.1 M Tris/HCl, pH 9.5, 50 mM MgCl2, 0.1 M NaCl, 
0.1% Tween-20). The colour reaction was carried out with NBT/BCIP as described for the 
chick in situ protocol (Chapter 2). The embryos were mounted in 70% glycerol. 
 
Whole mount immunocytochemistry 
Embryos were collected in PBS and fixed overnight in 4% paraformaldeheyde containing 
2 mM EGTA at 4°C. Embryos were then washed in PTW (3 x 30 minutes) and blocked in 
TBST containing 5% heat inactivated calf serum and 1mg/ml bovine serum albumin 
prior to incubation overnight at 4°C in goat anti-Calreticulin (1:2500). Embryos were then 
washed in PTW (3x 1 hour) and incubated overnight at 4°C in the secondary antibody 
rabbit anti-goat HRP (Invitrogen; 1:5000). Following 3 washes (one hour each) the 
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embryos were rinsed with 100mM Tris pH7.4 and incubated in 0.5 mg/ml DAB for 10 
minutes, H2O2 (0.003%) added and the embryos fixed and stored as described above. 
 
Electroporation constructs 
The coding region of chick calreticulin (cCrt) was cloned in pCAβ-IRES-GFP (a kind gift 
from A. Lumsden Lab) between the ClaI and BamHI cloning sites. Zebrafish calreticulin 
(fCrt) (Rubinstein et al., 2000) was cloned in pCAβ-IRES-GFP between the BsmBI and 
BamHI cloning sites. The BMP4 and Smad6 constructs in pCAβ-IRES-GFP were as 
described in Chapter 3. 
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Results 
Cloning of the full length nhbr307:  chick calreticulin  (cCrt) 
The nhbr307 clone did not contain an entire open reading frame (ORF). Screening a chick 
stage 2-4 whole embryo cDNA library led to the isolation of a 1162 base pair sequence 
containing a 1116 bp ORF, a 40 bp long 5‘ Untranslated Region (UTR). Fig 6.1A shows the 
predicted ORF and corresponding translation into a 381aa protein. This sequence is 
identical at the aminoacid level (differing by only two nucleotides) to “chick Calreticulin“ 
deposited in current databases (Genbank accession number AY393845, Uniprot Q6EE32) 
except that the 3‘ 69 nucleotides (C-terminal 23 aminoacids) of the latter are missing, and 
both sequences lack the characteristic KDEL sequence found in Calreticulin family 
members in other species (Fig 6.1). 
 
When comparing Calreticulin with other related calcium binding proteins Calnexin 
(NM_0010309620) and Calmegin (Predicted, XM_420413) it was found that although 
there is considerable divergence in the amino- and carboxy-termini between the proteins, 
the central P domain is very conserved. The P domain of Calreticulin is 59% identical to 
that of Calnexin and 52% identical to the Calmegin central region (not shown). 
 
Northern blot analyses of RNA isolated from chick embryos at stages 3, 5 and 7 reveal the 
presence of a major transcript of about 1.3 Kb and two larger minor bands (~1.9 and 3.5 
Kb) (Fig 6.1 B). However there is no published evidence of alternative splicing for 
calreticulin (Michalak et al., 1999) nor are any splice variants apparent from analysis of the 
intron-exon structure.  
 
The predicted 404 aminoacid (Uniprot Q6EE32) protein sequence was run through 
several databases all of which pointed to Calreticulin: Prosite BLOCK, Prints and Pfam 
databases identified the sequence as belonging to the Calreticulin family, with the 
characteristic amino terminal signal sequence, the Calreticulin family signature 1 
(KHEQNIDCGGGYVKLF), the Calreticulin family signature 2 (IHFGODICG) and the 
characteristic family repeats A (PXXIXDPDAXKPEDWDE) and B (GXWXPPXIXNPXYX). 
In terms of secondary structure, the protein is divided into three domains, N-domain, P-
domain and C-domain (Fig 6.1 A and C, in blue, red and green, respectively).  
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Calreticulin is a conserved molecule 
Since it was first isolated from rabbit skeletal muscle (Fliegel et al., 1989a; Smith et al., 
1988), many other calreticulin genes have been isolated and characterised. To compare 
chick Calreticulin (cCrt) with Calreticulin proteins from other species, ClustalW 
alignments were performed. Given the large number of sequences in the NCBI database, 
only a few were chosen for this comparison: human Calreticulin (hCALR, NM_004343), 
mouse Calreticulin (mCalr, NM_007591), rat Calreticulin (rCalr, NM_022399), Xenopus 
Calreticulin (xCalr, BC046699), zebrafish Calreticulin (zCalr, NM_131047) and Drosophila 
Calreticulin (dCrt, NM_079569). The alignments reveal a high homology between the 
sequences analysed, particularly within the Calreticulin family signature 1, signature 2 
and the characteristic family repeats A and B  (Fig 6.2 A). A dendogram obtained from 
these sequences is shown in Fig. 6.2 B. 
 
Chicken related sequences 
Although Uniprot, Genbank and EBI databases contain entries for chick calreticulin, no 
corresponding sequence can be found, at the present date (February 2011), in the chick 
genome database (www.ensembl.org). A portion of the sequence (91 nucleotides 
long) can be found in an “unassigned” (Un) chromosome but this region has not been 
assembled completely and the sequence lies at the end of a contig which is followed by a 
gap. However, other related sequences can be found in chomosome 4 (Calmegin; 
ENSGALT00000015978), chromosome 13 (Calnexin; ENSGALT00000009563) and 
chromosome 28 (3625650-3664309) which share some similarity with cCrt (not shown). 
 
Calreticulin protein localises to the endoplasmic reticulum, but can also 
be secreted 
The cellular localisation of the protein was predicted using Psort software (Horton and 
Nakai, 1997) http://www.psort.org/. This reveals a probability of 0.667 of secretion 
to the extracellular space, whereas the probabilities of being located in the cytoplasm, 
vacuoles or endoplasmic reticulum were of 0.111 in each case. The SOSOI prediction of 
transmembrane regions in a protein, 
http://sosui.proteome.bio.tuat.ac.jp/sosuiframe0.html, predicts cCrt to be a 
soluble protein, with an average of hydrophobicity of  -0.974394. However, Calreticulin 
has been reported in other species as an endoplasmic reticulum resident protein 
(Gelebart et al., 2005). In fact Calreticulin characteristically ends with a KDEL ER retrieval 
sequence (reported in all but Oncocera volvulus Calreticulin). 
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Because prediction analyses suggest it to be a secreted protein, whereas published data 
point to ER localisation, myc tagged cCrt was transfected into COS-1 cells and the 
accumulation of the produced protein detected using either anti-myc or anti-Calreticulin 
antibodies. In both cases, signal is detected in perinuclear granules (Fig 6.3 A and C). 
Western blots were also performed from the transfected COS cells; the culture medium 
and cell lysate were collected separately. Calreticulin was found in both fractions (Fig 6.9 
A), confirming that it can indeed be secreted from cells. 
 
Expression pattern of Calreticulin (cCrt) in the chick  
To assess the expression of calreticulin at early stages of development in normal chick 
embryos, both whole mount in situ hybridisation, using the full length cCrt clone, and 
whole mount antibody staining were performed. At the mRNA level (Fig 6.4 A-F), 
transcripts are first detected at stage 3-3+ (Fig 6.4 A) and the signal is strongest in the 
anterior half to one-third of the primitive streak. At stages 4+-5 expression becomes 
concentrated in Hensen’s node, with a lower level of expression seen in the anterior 
epiblast (Fig 6.4 B, C). Expression is maintained in the node and from stage 7 onwards it 
is markedly asymmetric, with expression on the right side (Fig 6.4 D-E; inset D‘). At this 
stage expression begins in the neural plate, always more pronounced anteriorly (Fig 6.4 
E-F); this increases at stage 9. From stage 10 onwards, expression becomes ubiquitous 
(not shown). 
 
Antibody staining only produces a weak signal, but also reveals accumulation of 
Calreticulin protein in the primitive streak from stage 3+ (Fig 6.4 G-J) as well as the 
asymmetry in the node at stages 7 and 8 (Fig 6.4 I and J; inset J‘).  
 
Expression pattern of Calreticulin (fCrt) in Zebrafish 
For comparison, in situ hybridisation was also performed in zebrafish using the full-
length zebrafish clone. At shield stage expression is present in the shield (Fig 6.5 A1). 
Expression persists at the midline and most anterior part of the embryo through epiboly 
and tail bud stages (Fig 6.5 B-D). By the 3 somite stage, expression starts to become 
ubiquitous, although remaining stronger anteriorly (Fig 6.5 E1 and E2). Therefore 
expression of this gene in zebrafish embryos is comparable to the results obtained for the 
chick. 
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Misexpression of Calreticulin expands the neural plate 
Since calreticulin is expressed in Hensen’s node during gastrulation and appears to be 
secreted, can it induce ectopic expression of neural markers? To answer this, pCAβ-cCrt-
IRES-GFP was electroporated into the epiblast of stage 3+ chick embryos in a line 
extending from the node to the area opaca (Fig 6.6 A). cCrt overexpression causes an 
expansion of expression of neural plate markers into the non-neural ectoderm in 7/15 
(46.7%) of embryos stained for Sox3 (Fig 6.6 D-E) and 9/20 (45%) of embryos tested for 
Sox2 (Fig 6.6 F-G). In addition to neural plate markers, the expression of neural plate 
border markers was also analysed. msx1 was expanded in 5/12 (41.7%) cases (Fig 6.6 H-J) 
as was Dlx5 in 6/12 (50%; Fig 6.6 J-K), Pax7 in 6/10 (60%; Fig 6.6 L-M) and BMP4 in 5/11 
(45%; Fig 6.6 B-C). However, Slug is mainly downregulated, especially posteriorly (3/7 - 
43%; Fig 6.6 N-O). Notably, in all of the embryos showing an expansion of neural plate or 
border markers, this effect never extended to the area opaca.  
 
Since the cCrt clone lacks the C-terminal sequence including the KDEL domain, the 
zebrafish orthologue fCrt, which includes a terminal KDEL domain, was used in the same 
experiment. Similar results were obtained. fCrt overexpression caused an expansion in 
the expression of Sox3 in 5/9 (55%) and Sox2 in 4/10 (40%) embryos tested (not shown). 
 
Therefore, ectopic cCrt can expand the neural plate including its border. This is 
reminiscent of the action of the BMP inhibitors Chordin, Noggin, Smad6 and Smad7 when 
misexpressed in a similar way (see Chapter 3 and (de Almeida et al., 2008; Linker et al., 
2009; Linker and Stern, 2004; Streit and Stern, 1999a{de Almeida, 2008 #2383). 
 
Misexpression of Calreticulin cannot induce neural markers in the area 
opaca 
To test whether Calreticulin missexpression can induce the competent epiblast of the area 
opaca to acquire expression of neural markers, pCAβ-cCrt-IRES-GFP was electroporated 
into a discrete domain within the inner third of the area opaca of stage 3+ chick embryos, 
at approximately the level of Hensen’s node (Fig 6.7A). After incubation for 15-20hrs, no 
expression of Sox3 (0/5, not shown) or Sox2 (0/8; Fig 6.7 C-D) was observed in the 
electroporated region. As a control, similar electroporations were performed using the 
pCAβ-IRES-GFP without an insert, resulting in no effect on Sox3 (0/5) or on Sox2 (0/4) 
expression (not shown). 
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FGF signalling is required for initial induction of Sox3 as well as for cells to respond to 
BMP antagonists, which maintain Sox3 expression (Streit et al., 2000a; Streit et al., 1998; 
Wilson et al., 2000). However, although FGF in combination with BMP antagonists can 
maintain Sox3 expression, it does not induce Sox2 (Linker and Stern, 2004; Streit et al., 
1998). Misexpression of FGF8 with cCrt also fails to induce Sox2 in the area opaca in all the 
embryos tested (0/10; Fig 6.7 E-F‘). However, Calreticulin did not maintain FGF-induced 
Sox3 expression (0/14; not shown). Calreticulin was also unable to induce Sox2 in the 
presence of both Chordin and FGF8 (0/10; Fig 6.7 G-H‘). Even a combination of FGF8 and 
Calreticulin, together with BMP antagonists Chordin (Streit et al., 1998), Smad6 (Imamura 
et al., 1997) and Smad7 (which inhibits both BMP and activin/nodal-related signals; 
(Casellas and Brivanlou, 1998) is unable to induce Sox2 (0/14; Fig 6.7 I-J‘) in competent 
epiblast. These results show that Calreticulin, either alone or in combination with FGF and 
BMP inhibitors, is unable to induce Sox2 in a domain isolated from the host’s neural 
plate. 
 
Calreticulin may inhibit BMP signalling 
The results presented above raise the possibility that cCrt may be acting by inhibiting 
BMP signals. When BMP4 is misexpressed by electroporation in the prospective neural 
ectoderm of the chick embryo at stage 3+, both Sox3 and Sox2 are downregulated after 
overnight culture (Linker and Stern, 2004). To test whether cCrt could rescue the effects of 
BMP4 overexpression, the two constructs were co-electroporated into prospective neural 
ectoderm adjacent to the node at stage 3+ (Fig 6.8 A). A DNA pool with a minimum 
concentration of 0.7µg/µl of pCAβ-BMP4-IRES-GFP was needed to inhibit Sox3 in all the 
embryos tested (11/11; Fig 6.8 B-C). 2.5µg/µl of cCrt plasmid was required to rescue this 
phenotype in 55% of the embryos (11/20, Fig 6.8 H-I). Smad6 was used as a control BMP 
inhibitor; 2 µg/µl of this are able to rescue the BMP4 effect in 58% of the embryos 
analysed (7/12; Fig 6.8 D-E). These results are consistent with the hypothesis that cCrt 
might act as a BMP inhibitor. 
 
 
Calreticulin secreted by COS cells expands the neural plate 
It has been reported that Calreticulin localizes mainly to the ER, but a fraction of the 
protein is secreted (Fig 6.9 A). This conclusion is supported by the results of Western 
blots presented above. However, these experiments do not address whether the secreted 
Calreticulin is biologically active in the assays described above, which suggested some 
BMP inhibiting activity. To test whether extracellular Calreticulin could account for the 
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above results, myc-tagged cCrt was used to transfect COS cells and pellets of these grafted 
adjacent to the non-neural epiblast next to the prospective neural plate of stage 3+ chick 
embryos, a region where misexpression of BMP inhibitors can expand the neural plate 
(see Chapter 3). In 3/11 (27%) embryos tested, an expansion of Sox2 expression was 
detected in the epiblast above the grafted cells (Fig 6.9 C-C‘); no expansion of the neural 
plate was seen when mock-transfected cells were implanted (0/6; Fig 6.9 B-B‘).  This 
result suggests that extracellularly presented Calreticulin can expand the neural plate 
into the non-neural ectoderm but the effect is weaker than with Chordin (Streit et al., 
1998), consistent with the conclusion that Calreticulin may act, directly or indirectly, as a 
weak BMP antagonist. 
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Discussion 
 
Calreticulin fullfils the criteria of the screen 
Calreticulin was cloned from a screen for secreted factors from the chick organiser at stage 
3+-4 (Chapter 4).  In situ hybridisation performed with the full-length clone shows that it 
is expressed in the chick node. In situs performed in zebrafish with the fish homologue 
confirm the expression of calreticulin in the node. Moreover, because the protein has a 
sequence likely to function as a signal peptide at its amino terminal, prediction analyses 
pointed to it being secreted and both Western blots and the results of implantation of 
transfected COS cells strongly suggest that the protein is secreted. Therefore, Calreticulin 
fullfils the criteria of the screen. 
 
Calreticulin and the border of the neural plate 
Calreticulin is expressed at the right time and in the right place to be a neural inducer. 
Furthermore, a fraction of the protein is secreted. But is it a neural inducer? The 
misexpression experiments performed led to expansion of the neural plate into the 
adjacent non-neural epiblast of the area pellucida, together with expansion of the neural 
plate border markers msx1, Dlx5, Pax7 and Slug. The normal domains of expression of 
these border markers overlaps to a large extent with the domain of expression of BMP4 at 
stages 5-7, and it has previously been suggested that both msx1 and Dlx1, as well as Slug 
and Pax7 are induced by a threshold of BMP signalling (Streit and Stern, 1999a; Tribulo et 
al., 2003). These results suggest that Calreticulin may be modulating BMP signals, 
perhaps contributing with other endogenous BMP antagonists in establishing the 
interface between the neural and the non-neural ectoderm and thus, positioning the 
neural plate border.  
 
Calreticulin is not an early neural inducer 
When grafted into the inner third of the area opaca the organiser can induce a full cascade 
of events that culminate in formation of an ectopic neural plate. Many studies have been 
performed in order to dissect the molecular components of this cascade, with FGF having 
been put forward as the initial step (Alvarez et al., 1998; Kim and Nishida, 2001; 
Minokawa et al., 2001; Storey et al., 1998; Streit et al., 2000a). BMP inhibition has also been 
widely reported as being the mechanism by which neural is achieved (the Default model 
is discussed in Chapter 1). Like other BMP antagonists when misexpressed in this region 
 130 
(see Chapter 3), Calreticulin is unable to mimic the effects of a node graft in the area opaca 
either alone or in combination with FGFs and even with the BMP antagonists Chd and 
Smad 6 and Smad7 (the latter also inhibits activin/nodal-related signals). Therefore 
although Calreticulin is not a sufficient neural inducer, the present results suggest that it 
may be able to act as a relatively weak BMP antagonist, which might contribute, along 
with other BMP antagonists produced by the node, to the maintenance and/or 
stabilisation of early-induced markers and perhaps to positioning the border between 
neural and non-neural territories. 
 
Calcium homeostasis may play a role neural induction 
In addition to the more widely studied roles of BMP antagonists, FGF and more recently 
Wnt inhibition, a few studies point to an involvement of Calcium signalling, perhaps 
through L-type channels, in neural induction (Leclerc et al., 2000; Lee et al., 2009; Moreau 
et al., 1994)(references). However neither the mechanism of action nor the relationships 
between this type of signalling and the others mentioned above have been explored in 
detail, and it is probably fair to say that this mechanism has very largely been ignored. In 
particular, if Calcium signalling is indeed involved in neural induction, some important 
questions that have never been addressed include: how would Calcium be conveyed 
from the organizer to the responding tissue? What mechanisms might regulate the L-type 
channels in a non-cell autonomous manner? As a main intracellular function of 
Calreticulin is as a regulator of Ca2+ homeostasis regulator (Groenendyk et al., 2004), it is 
not improbable that it may function in a similar way upon secretion, perhaps as a 
“presenter” of Calcium to L-channels in the responding cells.  
 
The evidence implicating Ca2+ signalling during neural induction in Xenopus is plentiful 
but rather indirect. At least two genes reported to be involved in early neural 
development can be activated by high intracellular levels of Ca2+: (high [Ca2+i]): Zic3 
(Batut et al., 2003; Leclerc et al., 2003; Leclerc et al., 2000; Nakata et al., 1998) and xMPL 
(Batut et al., 2003). Zic3 is a member of the Odd-paired domain family shown to be 
involved in neural determination in Xenopus (Marchal et al., 2009; Moreau et al., 1994; 
Moreau et al., 2008; Nakata et al.; Nakata et al.). When either intact Xenopus embryos or 
explants are treated with L-type channel inhibitors, the expression of Zic3 is blocked 
(Batut et al., 2005; Moreau et al., 1994; Moreau et al., 2008). xMPL is expressed in the 
presumptive neural plate in Xenopus and encodes a substrate for protein kinase C (PKC). 
Its expression is activated by high [Ca2+i] and can be induced by noggin overexpression 
(Batut et al., 2003). Noggin has been proposed to activate L-type channels (Leclerc et al., 
1999). It has been proposed that an increase in [Ca2+i] can neuralise animal cap ectoderm 
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(Leclerc et al., 2003); a mechanism for this has been proposed (Batut et al., 2005). 
According to the authors, neural inducing molecules including noggin could induce 
increase [Ca2+i] via activation of L-type channels in the dorsal ectoderm. This in turn 
would initiate a cascade of events where BMP signals may be inhibited, the early neural 
precursor Zic3 is induced and culminates with the stable expression of neural genes (En2, 
neurogenin and NCAM). However, the proposed mechanism by which [Ca2+i] might 
regulate BMP signalling have not been elucidated, and since Noggin is known to bind 
BMPs directly in the extracellular space (Furthauer et al., 1999; Holley et al., 1996a; 
McMahon et al., 1998) it is difficult to understand why Calcium signalling might be 
needed to account for BMP inhibition. 
 
The present results do provide a novel link between Calcium signalling and BMP 
inhibition, as well as revealing a source of the signals: the organiser itself, since the data 
obained here strongly suggest that calreticulin is expressed in the node and that a fraction 
of the protein is secreted. It could be that, when missexpressed, the secreted calreticulin 
binds to calcium and presents it to the L-type Ca2+ channel, leading to the increase in 
intercellular Ca2+ concentration. According to the model of Batut and colleagues (Batut et 
al., 2005), this would lead to expansion of the neural plate (which was indeed observed in 
the present experiments). 
 
Could calreticulin play an additional role in the activation of L-type channels? An 
opportunity to answer this question arose serendipitously in the laboratory when a 
different screen, designed to identify early responses to signals from Hensen’s node in 
the chick (the same screen that led to the identification of ERNI; see Chapter 1) identified 
one such gene, named Calfacilitin, which encodes a protein with features suggestive of it 
being an L-type Calcium channel itself. This gene is expressed in the very early neural 
plate, raising the exciting possibility that a Calcium-presenting protein (Calreticulin) is 
secreted by the organiser while a L-type Calcium channel is induced in the responding 
tissue. To assess whether Calfacilitin might be such a Calcium channel, we started a 
collaboration with the laboratory of Prof. Tuck Wah Song in Singapore.  Preliminary 
results indicate that: (a) while Calfacilitin does not by itself function as a Calcium-
channel, it does appear to prolong the “open” time of endogenous L-type Calcium 
channels in the presence of Calcium, and (b) co-expression of Calreticulin with 
Calfacilitin seems to slightly prolong the “open” time even further.  Although these 
experiments are still in progress, they provide a plausible mechanism to explain the 
elusive source of L-type activating signals during neural induction. 
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Calreticulin variants 
It is important to note here that almost all of the experiments presented in this Chapter 
were performed using the chick calreticulin gene. Because Calreticulin is characterised, 
amongst other domains, by a carboxy-terminal KDEL sequence, and the chick cDNA that 
was isolated in his study lacks this domain, it is likely that the gene used here may 
represent a truncated version. Although the full-length zebrafish sequence can also 
expand the domains of Sox3 and Sox2 when overexpressed, it is crucial to repeat the 
BMP4 rescue experiment using the full length zebrafish calreticulin gene.  
 
A role for Calreticulin in embryonic left-right asymmetry? 
Asymmetry in the node starts early in development with the asymmetric expression of 
genes encoding Activin Receptor type IIA, the transcription factor HNF3β, and the 
signalling proteins Shh and Nodal (Levin et al., 1995; Lohr et al., 1997). Left-right 
asymmetry during development is crucial to correctly position the internal organs of the 
embryo. Here, Calreticulin was found to be expressed asymmetrically in the node from 
around stage 6-7 onwards, both at the RNA and protein levels. This is about the same 
stage at which Nodal is first expressed in the lateral plate mesoderm. It was mentioned 
above that calcium transients in Xenopous induce expression of the early neural marker 
Zic3 (Leclerc et al., 2003), and it is tantalising to relate this to the finding that Zic3 is 
involved in left-right specification (Kitaguchi et al., 2002; Kitaguchi et al., 2000). Although 
the present results do not reveal a specific role for Calreticulin in left-right specification, 
this is an interesting possibility worthy of further exploration. 
 
Conclusion 
Chick calreticulin is highly conserved across species.  In the chick it is expressed in the 
node and is secreted. Although it is unable by itself to induce neural markers in 
competent epiblast of the chick area opaca, either alone or in combination with FGF 
and/or BMP antagonists, it is able to modulate the expression of neural plate border in a 
manner similar to that observed when BMP signals are attenuated. Furthermore, 
Calreticulin can partly rescue the effects of BMP overexpression. We propose that 
Calreticulin may act as a relatively weak BMP antagonist by a mechanism that remains to 
be elucidated, but which could provide the missing link between Calcium signalling and 
BMP inhibition.  
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Fig 6.1. Gallus gallus Calreticulin (cCrt). Amino acid sequence for cCrt revealing the 
16aa signal sequence (orange) and the functional domains  N-domain (blue), P-domain 
(red) and C-domain(green); underlined (blak) is the original nhbr307 sequence (A). 
Northern blot for stages HH3, HH5 and HH7 reveals a band of about 1.2kb. Although two 
other bands (1.9 Kb and 3.5 Kb) are present, there is no evidence for alternative splicing 
of the calreticulin mRNA (B). Domain structure of the protein based on the human 
calreticulin showing the same functional domains and the characteristic A repeats (yellow 
triangles) and B repeats (purple triangles) as well as the C-terminal KDEL endoplasmic 
reticulum (ER) retrieval sequence (C). Chicken calreticulin lacks the KDEL sequence. 
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Fig 6.3. Calreticulin sub-cellular localization. Antibody staining of Cos cells transfected 
with calreticulin reveals its abundance in granules around the nucleus (red arrows), 
corresponding to the endoplasmic reticulum (A and C). In the control Mock transfected 
cells no protein is detected (B). The scheme (D) shows calreticulin proteins present at the 
cell surface, in the endoplasmic reticulum, CTL granules and in the nucleus and its 
interactions with integrins, calcium stores, nascent polypeptide chains, perforin and 
steroid hormone receptors. Dotted arrows indicate possible routes of calreticulin 
trafficking (Adapted from Coppolino M, 1998). 
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Fig 6.4. Calreticulin (cCrt) expression in the chick embryo. At the mRNA level, 
transcripts are detected at stage 3-3+ (A) and the signal is strongest in the anterior part of 
the primitive streak. At stages 4+-5 expression becomes concentrated in Hensen’s node, 
with a lower level of expression seen in the anterior epiblast (B and C). Expression is 
maintained in the node and, from stage 7 onwards, it is asymmetric and on the right side 
(D, E and D‘). From this stage, expression can be detected in the neural plate (D, E and 
F). At the protein level, antibody staining reveals the accumulation of Calreticulin protein 
in the primitive streak from stage 3+ (G-J) as well as the asymmetry in the node at stages 
7 and 8 (I, J and J‘).  
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6.6. Calreticulin overexpression extends the border of the neural plate. pCAβ-cCrt-
IRES-GFP was electroporated into the epiblast of stage 3+ chick embryos in a line 
extending from the node to the area opaca (A). cCrt overexpression causes an expansion 
of expression of neural plate markers Sox3 (D-E) and Sox2 (F-G). The neural plate 
domain was expanded together with the lateral shift of expression of the border markers 
msx1 (H and I), Dlx5 (J and K), Pax7 (L and M), Slug (N and O) and BMP4 (B and C). 
The expansion of neural plate or border markers was never extended to the area opaca.  
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Fig 6.8. Calreticulin can rescue the effects of BMP4 overexpression in the neural 
plate. BMP4 (0.7µg/µl) missexpred by electroporation in the prospective neural plate at 
stage 3+ results in the downregulation of Sox3 after O/N culture (A and B). Smad6, a 
BMP antagonist, can rescue the effect of BMP4 overexpression on Sox3 at a 
concentration of 2µg/µl (C and D). Calreticulin can also rescue the effect of BMP 
overexpression, but at a higher concentration of 2.5µg/µl (G and H). 
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Fig 6.9. Calreticulin, secreted by transfected COS, cells can expand the neural plate 
domain.  Western blots using both the lysate and the supernatant of Cos transfected 
cells reveal that Calreticulin protein can be secreted (supernatant fraction); Chordin was 
used as a control (A). Pellets of Calreticulin transfected cells were placed in the border of 
the prospective neural plate at stage 3+, resulting in the expansion of the Sox2 domain of 
expression (C). Mock transfected cells have no effect on Sox2 expression (B). 
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Chapter7 
Nhbr90: A long non-coding RNA 
 
 
Introduction 
 
Nhbr90 was isolated as a putative secreted factor from the organizer. Given that its 
transcript is always present in the node and the fact that nhbr90 has no known 
homologies, it was decided it would be an interesting molecule to study further. 
 
This chapter deals with the cloning, expression and study of nhbr90 in the context of 
neural induction. We report that it is indeed always expressed in the organizer; in fact, 
nhbr90 starts before primitive streak formation, in the hypoblast. Later expression 
coincides with embryonic regions of neurogenesis activity, namely the branchial arches 
and Dorsal Root Ganglia (DRGs).  
 
Nhbr90 does not seem to be translated, but rather be a long non-coding RNA (ncRNA). 
Overexpression of nhbr90 reveals that it induces both Sox3 and Sox2 in the competent 
epiblast of the area opaca through a mechanism yet to be understood. 
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Materials and methods 
 
Isolation of a full-length clone of chick nhbr90 
The original nhbr90 clone was used to transcribe a radiolabelled RNA probe, which was 
used for library screening (details of the procedure can be found in Chapter 2). 
 
Northern Blots 
Northern blots were performed as described in Chapter 2 and the full length clone nhbr90 
was used to transcribe a radiolabelled probe ([α-32P]dCTP) prior to hybridization. 
 
RNA analyses and structure prediction 
RNA prediction analyses and secondary structure was carried out using free software 
UNAfolf and mfold3.5 (Kuker et al., 1999; Rouillard et al., 2003) from the RNA Institute at 
the University of Albany, USA. RNA analyser (Burge and Karlin, 1997; Lowe and Eddy, 
1997) from the Department of Bioinformatics at the University of Würzburg was also 
used. The RNA analyses work was done in collaboration with Mario dos Reis (a fromer 
member of the Stern Lab) and Fabrice Jossinet at the Institut de Biologie Moléculaire et 
Cellulaire du CNRS, Université Louis Pasteur. 
 
 
In situ hybridisation 
The full length nhbr90 was used to transcribe a digoxigenin-labelled RNA probe and 
hybridisation was performed as described in Chapter 2. Further probes were transcribed 
with smaller fragments of the nhbr90 clone, including a 506 bp probe obtained by cutting 
the nhbr90 with ClaI and AseI (ClaI/AseI riboprobe), and a 1573bp probe obtained from 
the Ase/BamHI digestion (AseI/BamHI riboprobe) (Fig 7.1B). 
 
Electroporation constructs 
Nhbr90 was cloned into pCAβ-IRES-GFP (a kind gift from A. Lumsden Lab). The pBS-
nhbr90 plasmid was cut with ClaI and BamHI and inserted into pCAβ-IRES-GFP. The 
resulting DNA was sequenced and used for electroporation at a concentration of 1.5 
µg/µl. Further electroporation constructs were made using fragments from the full 
length nhbr90 clone (2079bp), namely a 1573 bp insert, obtained by digesting the pBS-
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nhbr90 with AseI and BamHI  and a 1312bp insert, obtained by digesting the the pBS-
nhbr90 with ClaI and XhoI (Fig 7.1C). 
 
Expressing nhbr90 in COS cells 
The full length nhbr90 sequence (2079bp) was cloned into in pCDNA 3.1/Myc-His 
(Invitrogen). pBS-nhbr90  was cut with ClaI, Klenow filled in (resulting in a blunted end) 
and then cut with BamHI. Similarly, the pCDNA 3.1/Myc-His vector was cut with NotI, 
Klenow filled in and subsequently cut with BamHI. The vector and nhbr90 were ligated 
and the resulting DNA sequenced and used to transfect COS cells to form pellets of 
nhbr90 expressing cells (explained in Chapter 2). 
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Results  
 
Cloning of the full length nhbr90: nhbr90 doesn’t get translated and 
seems to function as a non-coding RNA 
The original 276bp nhbr90 clone (Fig 7.2 A, underlined in red) was used to transcribe a 
radiolabelled RNA probe, which was used to screen a chick stage 2-4 whole embryo 
cDNA library, resulting in the isolation of 13 clones. Sequencing the clones revealed they 
were all identical in nucleotide sequence and 2079bp in length  (Fig 7.2 A).   
 
No long Open Reading Frame (ORF) was detected in the 2Kb clone, raising the possibility 
that, perhaps the, full length clone wasn’t isolated. To test this, Northern Blots were 
performed, in triplicate, using RNA isolated from chick embryos at stages 3, 5 and 7. The 
results were consistently the same and reveal the presence of a unique 2Kb transcript (Fig 
7.2 B). This indicates that the sequence obtained from library screening is the full length 
of the nhbr90 clone. 
 
Further searches were performed using Ensemble. The nhbr90 sequence spans 2 contigs 
present in Gallus gallus Chromosome 5. In one location the there’s a 97.51 percentage 
identity spanning 1367bp; another hit reveals a 96.84 percentage identity spanning 
1392bp. Although not ideal, the fact that the 2KB sequence is not found in its entirety in 
the chick Genome is not altogether surprising. Given that the sequence spans two contigs, 
it might be the case that they haven’t been properly assembled or that, indeed, some 
sequencing is missing. 
 
The puzzling fact that a 2KB sequence with no long ORF raised the possibility that, 
perhaps, we could be dealing with a sequence that never gets to be transcribed. Using 
RNA prediction software, both my analyses and that of a collaborator, Mario dos Reis, 
predict that nhbr90 can fold as a long non-coding RNA (ncRNA) (Fig 7.2 C). Another 
collaborator, Fabrice Jossinet, predicts that a small sub-sequence in the putative 3'-UTR of 
the nhbr90 clone is complementary to the 5' stem of a putative miRNA precursor from 
Gallus gallus (not shown). This prediction wasn’t further explored. 
 
 
Despite not having a long ORF, the sequence has, however, 13 small putative ORFs when 
analysed in all the six frames. And these are, in descending order of size:  
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Frame From (bp) To (bp) Length (bp) 
Length 
(aa) 
-3 701 1045 345 114 
+2 35 334 300 99 
-2 1473 1655 183 60 
-1 1357 1527 171 56 
+3 750 896 147 48 
+1 745 888 144 47 
-1 343 483 141 46 
+1 1654 1785 132 43 
+3 1740 1868 129 42 
-3 1616 1741 126 41 
-1 1642 1764 123 40 
+2 1544 1663 120 39 
+3 405 518 114 37 
 
Further tests are necessary to access if of the small putative ORFs is transcribed and/or 
functional. 
 
 
 
Nhbr90 is expressed in the node and in areas of neurogenic activity 
To assess the expression of nhbr90 at early stages of development in normal chick 
embryos, whole mount in situ hybridization was performed.  Because of the presence of 
the several putative ORFs in the clone, three different probes were transcribed, spanning 
different regions in the sequence. We used a full length 2079bp riboprobe (Riboprobe 1) 
and two smaller ones of 506bp and 10573 bp (Riboprobe 2 and Riboprobe 3, respectively) 
(Fig 7.1 B). The three riboprobes resulted in identical expression pattern (not shown) 
clearly indicating that the nhbr90 sequence is part of one single transcript.  
 
Expression starts at pre-streak stages, in the hypoblast (Fig 7.3 A) and, by the time the 
streak is formed and fully elongated at stage 3+/4, expression is strongly localized in the 
 150 
node (Fig 4.3 B and C). By stage 4+ the expression persists in the node and starts to 
appear in the prospective neural plate, just anteriorly to the node (Fig 7.3 D). The 
expression of nhbr90 is maintained in the node as it regresses and transcripts start to be 
detected in the notochord, as it’s laid down (not shown).  At stage 7, expression localizes 
to the presomitic mesoderm and the anterior boundary of expression overlaps with the 
first pair of somites formed (not shown). This somite region and presomitic mesoderm 
expression persists during somite formation. Also maintained is the expression in the 
node and notochord (Fig 7.3 E). Later on, at stages 10 (not shown) and 11, with the neural 
tube being closed, expression is detected in the neural tube, with its anterior boundary of 
expression coinciding with the first pair of somites formed. Expression is also detected in 
the caudal neural plate (Fig 7.3 F). 
 
Given the dynamic expression of nhbr90 and the fact that transcripts are always present 
in the node, a signalling centre, we decided to examine what happens to the expression at 
later stages in development. In embryos developed to stage 18, the nhbr90 transcripts 
accumulate in the cranial ganglia at the level of the hindbrain and pharyngeal arches 
(white arrow heads, Fig 7.4 A, B and C), the dorsal neural tube (Fig 7.4 D) and the dorsal 
root ganglia (red arrows, Fig 7.4 A, D and D’).  These are areas of active nerve formation 
and maturation of neurons. This later expression further emphasises the role nhbr90 may 
be playing not only in neural induction, but also in neurogenesis. 
 
In sum, nhbr90 is expressed before node formation, in the hypoblast cells that will 
contribute to the node. It then strongly localises to the node, and mostly the node up to 
stage 4. The hypoblast and node expression during the time neural induction is taking 
place, makes nhbr90 a very strong candidate to be a neural inducing molecule.  
 
 
 
Nhbr90 overexpression results in Sox3 and Sox2 induction 
Nhbr 90 is expressed in the node, being a very good candidate to act as a neural inducer. 
It does not contain a long ORF and predictions suggest that can function as a ncRNA. To 
test if it is indeed functional in our neural induction essay, full length nhbr90 was 
overexpressed, by electroporation, in stage 3+/4 chick embryos in a line spanning from 
the node to the area opaca (Fig 7.5 A).  Results revealed that, indeed, nbbr90 is able to 
induce both Sox3 in almost all the embryos tested (20/20; Fig 7.5 B, C) and Sox2 (23/25; 
Fig 7.5 D, E) and that this induction extends to the area opaca. To note that the 3 embryos 
that failed to express Sox2 ectopically had a very small amount of cells electroporated and 
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the results might have been due to insufficient missexpression of the construct. The 
induction of neural markers is not an artefact of electroporation as no induction was 
observed (0/9 Sox3; 0/10 Sox2) when control electroporations were performed (Fig 7.5 F-
J). 
 
Could this induction into the area opaca be a result of continuous cell communication 
from the neural plate? To test this, a discrete patch of cells was electroporated directly 
into the anterior inner third of the area opaca (Fig 7.5 K), resulting in remarkable 
induction of the neural markers Sox3 (12/13; Fig 7.5 L, M) and Sox2 (16/20 Fig 7.5 N, O). 
No induction was observed in control electroporations  (0/6 Sox3 and 0/8 Sox2; Fig 7.5 
P-T). 
 
These results could be due to some of the small ORFs present in the clone being 
translated and functional. To test this, two smaller fragments of nhbr90 (Fig 7.1 C) were 
inserted into the pCAB-IRES-GFP and electroporated into the area opaca. Neither of the 
constructs resulted in Sox2 induction (0/12 for AseI/BamHI nhbr90; 0/7 for ClaI/XhoI 
nhbr90). Crucially, when both were electroporated together, no neural markers were 
induced (0/15) (not shown).  
 
This last experiment is a further indication that a full nhbr90 sequence is necessary for it 
to function as a neural inducer as it provides overexpression of all the putative small 
ORFs at once, without inducing Sox2. Only when the full length nhbr90 sequence is 
missexpressed, Sox2 is induced and, as it does not contain a long ORF, it may be acting as 
a ncRNA. 
 
 
The embryo looses its competence to respond to neural inducing signals 
In normal embryonic development, the competence of the epiblast to respond to neural 
inducing signals is restricted in early development, rapidly disappearing around or after 
stage 6 (Dias and Schoenwolf, 1990; Gallera, 1965; Storey et al., 1992; Streit et al., 1995; 
Streit et al., 1996; Streit and Stern, 1997a; Woodside, 1937). 
 
In order to ascertain the ability of nhbr90 to signal as a neural inducer in normal chick 
development and to which extent the embryo maintains its competence to respond to the 
signals, the following experiment was carried out:  Embryos ranging from stage 3+ to 
stage 7/8- were electroporated with pCAB-nhbr90-IRES-GFP in a patch area of the inner 
third of the area opaca and left to grow O/N. When missexpression is carried out at stage 
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3+, Sox2 induction is seen in 77% of the embryos (17/22; Fig 7.6 A, B and C). Experiments 
performed at stage 4+ resulted in 70% induction of the neural marker (7/10; Fig 7.6 A); at 
stage 5/6 only 27% the embryos showed Sox2 induction and, by stage 7/8-, the embryos 
had completely lost their ability to respond to the neural induction ability of the nhbr90 
construct (0/12; Fig 7.6 A). Control experiments, where electroporations were performed 
with the pCAB-GFP vector, no induction of Sox2 was observed (0/14 at stage 3+; 0/5 at 
stage 4+; 0/5 at satge 5/6; 0/6 at stage 7/8-; Fig 7.6 A, D and E). 
 
The timing necessary for induction of neural markers by nhbr90 mimics 
that of the node 
When a node graft is performed in a chick embryo at stage 3+, it takes approximately 5-6 
hours for Sox3 to be induced in the host embryo, and about 9 hours for Sox2 induction. 
Does nhbr90 mimics this timing for induction of neural markers? To test this, nhbr90 was 
electroporated in a small region either in the epiblast adjacent to the future neural plate at 
stage 3/3+ (Fig 7.7 A) or in the inner third of the area opaca at the same developmental 
stage (Fig 7.7 B).  After 6 hours, Sox3 is induced in all the embryos tested in the proximity 
to the neural plate (8/8, Fig 7.7 B and C) and in 93%  (13/14, Fig 7.7 G and H) of those 
tested in the area opaca. No induction of Sox2 was observed after 6 hours (0/8 in the area 
pellucida; 0/8 area opaca, not shown). In control embryos, where GFP alone was 
electroporated, no Sox3 (0/6 in the area opacca; 0/5 area pellucida, not shown) or Sox2 
(0/5 in the area opacca; 0/4 area pellucida, not shown) were induced. 
A minimum of 8 to 9 hours are required for nhbr90 to induce Sox2 expression both in the 
area adjacent to the neural plate (13/14, Fig 7.7 D and E; 0/6 for the control, not shown) 
and in the area opaca (15/15, Fig 7.7 I and J; 0/5 for the control, not shown).  
These results confirm that nhbr90 mimics the node in terms of the timing required for 
induction of neural markers.  
 
 
 Nhbr90 acts in a non cell autonomous manner 
The nhbr90 clone seems to act as a neural inducer but, as a non coding RNA, if its effect is 
direct, then it will be cell autonomous, as RNAs are not known to leave the cell.  To test if 
the effect of nhbr90 is direct we took two different approaches: First, by missexpressing 
nhbr90 into the inner third of the area opaca of stage 3+ embryos. This set up results in 
induction of Sox2 expression in over 90% of the embryos tested (previous sections and 
Fig 7.8 A, B and B’). When embryos were processed for GFP staining, it was clearly 
revealed that Sox2 expressing cells are not exclusively the ones electroporated and that, 
 153 
not all the electroporated cells express Sox2. It seems, therefore, that the effect of nhbr90 is 
non-cell autonomous. To further test this idea we took a second approach: nhbr90 was 
expressed in COS cells and these grafted in stage 3+ chick embryos, also in the inner third 
of the area opaca. In this case there was also induction of Sox2 in all the embryos tested 
(8/8; Fig 7.8 C and C’). 
 
These results indicate that, by whatever mechanism nhbr90 working to induce Sox2, the 
effect is not direct and the neural inducing factor is secreted. As there is no evidence of a 
long non-coding RNA being secreted we speculate that nhbr90 might be inducing some 
secreted factor by the expressing cells and this factor will then induce the neural marker 
Sox2. 
 
Nhbr90 is involved in ERNI and Geminin regulation 
In a recent paper (Papanayotou et al., 2008) it was beautifully demonstrated the 
mechanism by which Sox2 is activated. ERNI is expressed early in the hypoblast and 
prospective neural plate (Streit et al., 2000b) and needs to be downregulated for neural 
induction to take place. ERNI interacts with Geminin, inhibiting Sox2 in the early neural 
plate. At around stage 4, Bert is expressed and disrupts the interaction between Geminin 
and ERNI, allowing the activation of Sox2.  
 
Geminin is a coiled-coiled protein expressed in the early prospective neural plate. When 
misexpressed in a line extending laterally from the neural plate, Geminin strongly induces 
ectopic Sox2. Geminin can also induce Sox2 expression when introduced into the 
extraembryonic epiblast (Papanayotou et al., 2008). These results resemble the effect of 
nhbr90 misexpression. Could there be a relation between nhbr90 and the three genes, 
ERNI, Bert and Geminin, central to Sox2 regulation? To test this, nhbr90 was electroporated 
in line extending from the prospective neural plate and into the extraembryonic ectoderm 
(Fig 7.9 F). This results in the extension of the normal domain of expression of Geminin 
(5/5; Fig 7.9 I and J; 7 more embryos were processed, all with induction of Geminin, but 
were not taken into account given their abnormal growth). Furthermore, nhbr90 
overexpression downregulates the endogenous ERNI expression while extending the 
prospective neural plate domain. (6/8; Fig 7.9 G and H).  The effect of nhbr90 in Bert 
expression could not be accessed due to intense background staining and therefore the 
impossibility to differentiate between induction (if any) and endogenous expression (10 
embryos electroporated, not shown). 
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In control electroporations, no effect was seen in either ERNI (0/4; not shown) or Geminin 
(0/6; not shown). Control electroporations in the 6 embryos probed with Bert resulted in 
high levels of background (not shown). 
 
This result extend previous observations that, in order to become neural, cells must first 
express ERNI, forming a pre-neural state, and that ERNI needs to be downregulated for 
the proper neural plate to form and express Sox2 (Papanayotou et al., 2008). It is 
conceivable that nhbr90 is able to induce Sox2 by both downregulating ERNI and 
upregulating Geminin by a mechanism yet to be elucidated.  
 
 
Nhbr90 induced Sox2 cells are prevented to gastrulate though the streak  
Activation of the transcription factor Sox2 is strongly correlated with the establishment of 
the  
embryonic neural plate and studies have revealed that, amongst a number or enhancers 
regulating Sox2, enhancer N1 is responsible for Sox2 activation in the caudally extending 
neural plate (Takemoto et al., 2006; Uchikawa et al., 2003). It is further revealed that 
enhancer N1 becomes inactive in the mesodermal precursors that have ingressed through 
the primitive streak, indicative of the release from this cell population from a neural fate 
(Takemoto et al., 2006). Our studies have revealed that nhbr90 robustly induced Sox2. 
What happens to gastrulation, and therefore cell ingression and mesodermal formation if 
cells are induced to prematurely express Sox2? To answer this question, nhbr90 was 
electroporated close to the primitive streak at stage 3 (Fig 7.9 A; some embryos were even 
slightly younger than stage 3) and the embryos allowed to grow. These resulted in all the 
embryos expressing Sox2 in the electroporated area (5/6; Fig 7.9 B and D) and also in 
impaired cell ingression through the streak, as revealed by downregulation of Brachyury 
expression (8/8; Fig 7.9 D and E).  Control electroporation revealed no induction of Sox2 
(0/5; not shown) and normal expression of Brachyury (6/6; not shown). 
 
To further examine what happens to the cells that ectopically express Sox2 during 
gastrulation, the effect of nhbr90 electroporation was examined. Embryos were 
electroporated with  nhbr90 at stage 3+ in a patch close to the most anterior primitive 
streak (Fig 7.10 A). All embryos electroporated revealed ectopic expression of Sox2 after 
8-9 hrs hours (6/6; Fig 7.10 B and C). And sections reveal that, although not all the 
electroporated cells induce Sox2, no Sox2 expressing cells have ingressed through the 
streak (Fig 7.10 A and E). When embryos were allowed to grow for 17 hours, it is still 
observed that not all the electroporated cells ectopically express Sox2 (Fig 7.10 H and I). 
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However, cells that are induced to express Sox2, fail to ingress and accumulate at the 
“gastrulation edge” (4/5; Fig 7.10 F, H and G, white arrowheads).  
 
No studies on the N1 enhancer were carried out. However, the results presented here are 
in agreement with recently published data supporting that cells that do ingress through 
the streak are “released” from their neural fate (Takemoto et al., 2006) or, in other means, 
the cells  adopt either mesodermal or neural character. 
 
 
 
Neural induction in the Caudal Neural Plate: FGF induces proneural 
genes and also nhbr90. 
The caudal neural plate (CNP), from which the chick posterior hindbrain and spinal cord 
are derived, is a unique embryonic region, regressing alongside the primitive streak to 
the tail end of the embryo (Brown and Storey, 2000; Schoenwolf et al., 1992). CNP cells 
are distinguished by the expression of a number of genes including the proneural gene 
homologue, cash4 (Henrique et al., 1997) and the homeobox-containing gene Sax1 (Spann 
et al., 1994). It has been shown that these caudal neural genes are induced continuously 
by the regressing node and that this node activity can be mimicked by FGF signaling 
(Henrique et al., 1997; Storey et al., 1998), a well established inducer of caudal neural 
character (reviewed by (Doniach, 1995; Ribisi et al., 2000). FGF signals also limit the 
posterior boundary of the transcription factor Pax6 expression (Pituello et al., 1999). 
Given that nhbr90 continues to be expressed in the node, at the level of the caudal neural 
plate we decided to investigate its possible role in regulating caudal neural genes. 
 
We started by examining the expression pattern, at the level of the caudal neural plate of 
stage 10 chick embryos of Fgf8, Pax6, Sax1, Cash4 and nhbr90. We focused on the posterior 
expression of these genes, at the level of the caudal neural plate up to the two newly 
formed somites.  
 
Fgf8 transcription is restricted to the caudal region of the embryo being very strong at the 
level of the primitive streak and Hensen’s node and displaying a decreasing caudo-
rostral gradient in the presomitic mesoderm (Fig 7.12 A’). 
 
Pax6 expression in the neural tube coincides with the onset of somitogenesis (Pituello et 
al., 1999). At the level of the caudal neural plate, Pax6 transcripts are only present at the 
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level of the somites and completely absent in the pre-somitic mesoderm and remaining 
CNP (Fig 7.12 B’). 
 
Sax1 (Spann et al., 1994) is expressed only in the spinal part of the neural plate. The 
anterior border of Sax1 expression is the transverse plane separating the youngest somite 
from the yet unsegmented mesodermal plate. The posterior border of Sax1 expression 
coincides with the posterior end of the neural plate (Fig 7.12 C’). 
 
Cash4 is expressed in the caudal neural plate and excluded from the somitic region 
(Henrique et al., 1997) (Fig 7.12 D’).  
 
Nhbr90 is expressed in the anterior half of the CNP and in the neural tube (Fig 7.12 E’). 
 
FGF8 has been shown to mimic the node in inducing both Cash4 (Henrique et al., 1997) 
and Sax1 (Storey et al., 1998) and to downregulate Pax6 (Bertrand et al., 2000). We 
decided to revisit these results and examine if FGF could also regulate nhbr90.  FGF8  (or 
PBS soaked beads, in the controls) soaked beads were placed adjacent and just posterior 
to the node in stage 5/6 chick embryos and the embryos allowed to grow for about 18/20 
hours (Fig 7.13 A). FGF8 does indeed downregulate the expression of Pax6 (7/7; Fig 7.13 
B) and upregulates Cash4 (4/6; Fig 7.13 C) and Sax1 (8/8; Fig 7.13 D). FGF8 also induces 
expression of nhbr90 in almost half of the embryos tested (3/7; Fig 7.13 E). Control 
experiments had no effect on the genes tested (0/5 for Pax6, Fig 7.13 F; 0/6 for Cash4, Fig 
7.13 G; 0/6 for Sax1, Fig 7.13 H; 0/4 for nhbr90, Fig 7.13 I).  
 
These results extend the previously published observations that FGF, expressed in the 
caudal neural plate, regulates the expression of Cash4 and Sax1. Surprisingly, Fgf8 can 
also, to a certain extent, induce nhbr90. Given the low percentage of upregulation of 
nhbr90 by FGF (43%), it is likely that FGF might not be the main mechanism of nhbr90 
regulation.  
 
Nhbr90 induce neural tissue but doesn’t seem involved in 
anteriorposterior patterning 
There is very little evidence for the existence of a general neuralized cell state that lacks 
regional character in the embryo (Streit et al., 1995); rather, it seems that early chick 
neural plate has anterior identity and needs further signals to acquire posterior identity 
(Muhr et al., 1999. This ‘anterior’ neural tissue expresses forebrain, markers (for example, 
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Otx2, {Bally-Cuif, 1995 #137), but does not express ‘posterior’ markers, such as En2 
(midbrain and hindbrain rhombomere 1, (Hidalgo-Sanchez et al., 1999), Krox20 
(hindbrain rhombomeres 3 and 5, (Marin and Charnay, 2000a; Marin and Charnay, 
2000b; Saldivar et al., 1997)) and Hoxb9 (spinal cord). 
 
Nhbr90 induces neural tissue. Does it also have a function on anterior posterior 
patterning? To address this question, nhbr90 was overexpressed, by electroporation, in 
the extraembryonic area opaca of stage 5 embryos (Fig 7.13 A). After O/N culture, the 
embryos were accessed for the expression of various markers. Sox2 was induced in 33% 
of the embryos (4/12; Fig 7.13 A and C). No induction was seen for the anterior marker 
Otx2 (0/7; not shown) or the posterior marker Hoxb9 (0/10; Fig 7.13 D and E). Similarly, 
no induction was detected for the caudal neural plate genes Sax1 (0/9; Fig 7.13 F and G) 
or Cash4 (0/10; Fig 7.13 H and I). Control electroporations, for all the genes tested had no 
effect (not shown; 0/5 for Sox2; 0/6 for Hoxb9; 0/3 for Otx2; 0/6 for Sax1; 0/4 for Cash4). 
 
These results suggest that, in the area opaca, nhbr90 is able to induce the neural marker 
Sox2, but unable to pattern the neural tissue. What happens if a similar experiment takes 
place in anterior exptraembryonic epiblast of the area pellucida? nhbr90 was 
electroporated in this region, at stage 5, and the embryos grown O/N (Fig 7.14 A). 
Surprisingly, of all the embryos tested, 50% still revealed induction of Sox2 (albeit very 
weak, when compared to previous experiments; 4/8; Fig 7.14 B and C). The caudal 
neural marker Cash4 was induced in 37.5% of the embryos, again very weakly, but 
noticeably  (3/8; Fig 7.14 J and K). No effect was observed for Fgf8 (0/7; Fig 7.14 D and 
E), Hoxb9 (0/10; Fig 7.14 F and G) or Sax1 (0/8; Fig 7.14 H and I).  Control 
electroporations had no effect on all the markers tested (not shown; 0/8 for Sox2; 0/5 for 
Fgf8; 0/9 for Hoxb9; 0/8 for Sax1; 0/8 for Cash4). The results obtained strongly suggest 
that nhbr90 is not involved in the anterior-posterior patterning of the neural tissue. 
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Discussion 
 
Nhbr90 appears to be a long non-codding RNA (lnc RNA) 
The accepted role of the RNA in the cell has been considered mostly in the context of 
protein gene expression, limiting its functions as mRNA, tRNA, and rRNA. The 
discovery, in the last few years, of a vast array of transcripts that are not translated to 
proteins but rather function as RNAs has changed this view profoundly. And it is 
becoming clear that non-coding RNAs are involved in a variety of processes, including 
modulation of transcription and gene regulation (He and Hannon, 2004; Mattick, 2005; 
Mimouni et al., 2009; Umlauf et al., 2008; Yano et al., 2004), maturation of mRNAs, 
rRNAs, and tRNAs, or X-chromossome inactivation (Gontan et al., 2011; Lee, 2009; 
Malecova and Morris, 2010; Tian et al., 2010) and even serving as precursors of smaller 
RNAs (Borden et al.; Grinchuk et al.; Mattick and Makunin, 2006) 
 
Recent studies have identified a variety of regulator paradigms for how long ncRNA 
function. Transcription by an upstream non coding promoter can affect the expression of 
a downstream gene by inhibiting RNA polymerase II recruitment (Bernard et al., 2010; 
Dye et al., 2006; Espinoza et al., 2007) or inducing chromatin remodelling (De Lucia and 
Dean, 2010; Turner and Morris, 2010). An antisense transcript is able to hybridize to the 
overlapping sense transcript (Gelfand et al., 2011; Lardenois et al., 2011) and with this, 
block recognition of the splice sites by the spliceossome, resulting in an alternatively 
spliced transcript. Alternatively, hybridization of the sense and antisense transcripts can 
allow Dicer to generate endogenous siRNAs (Murphy et al., 2008). By binding to specific 
protein partners, a non-coding transcript can modulate the activity of the protein, serve 
as structural component that allows a larger RNA-protein complex to form, or alter 
where the protein localizes in the cell. Long RNAs can be processed to yield small RNAs, 
such as miRNAs and piRNAs (Pauli et al., 2011). 
 
Isolation of a new RNA species with no significant ORF is not sufficient evidence of a 
new ncRNA gene. There should be evidence of specific and temporal expression, of 
function, either by computational means (e.g., sequence or structure conservation) or 
experimental means (e.g., genetic phenotype). There should also be evidence that the 
RNA does not code for a small protein (Eddy, 2002). 
 
In the context of nhbr90, it is important to add that many transcripts are classified as 
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noncoding on the basis of not having ORFs longer than 50–100 amino acids (Pauli et al.). 
However, the Drosophila tarsal-less (tal) gene provides a good example of the importance 
of validating these bioinformatic predictions. The tal gene expresses a 1.5-kb transcript 
that contains only ORFs smaller than 50 amino acids and was, therefore, originally 
classified as a long ncRNA. However, it was found that several 33-nt ORFs within the tal 
gene are translated into 11-amino-acid-long peptides that control tissue morphogenesis 
and pattern formation events during Drosophila development (Galindo et al., 2007; Kondo 
et al., 2007; Pueyo and Couso, 2008). Due to practical and statistical reasons, ORFs as 
short as these in tal are generally eliminated from gene annotations but, as the tal gene 
exemplifies, clearly need to be considered when addressing the function of an 
unannotated transcript. Additionally, some ncRNA genes, such as SRA (Steroid receptor 
RNA activator), seem to produce multiple RNA isoforms, some of which can be 
translated, allowing the gene to have functions carried out by both RNA and protein 
(Leygue, 2007). 
 
To make sure that the nhbr90 effect wasn’t due to some of its translated putative ORFs, 
several constructs were produced. Interestingly, only the full length clone resulted in the 
induction of Sox2. Even if several clones were co-electroporated (spanning the entirety of 
the full length clone), the resulting embryos had no Sox3 or Sox2 induction. This result 
suggests that, in fact, the effect seem with nhbr90 overexpression is not due to any of its 
putative ORFs being translated but rather that the it codes for a functional, non coding 
RNA. 
 
 
Nhbr90 is expressed in the right place, and at the right time to function 
as a neural inducer 
The Hensen’s node is able to induce a complete secondary axis when grafted to an 
ectopic position and the extent to which the axes are induced depends, amongst other 
factors, on the age of both the host epiblast and the age of the grafted node (Galler 1971; 
Niewkoop, 1985) (see Chapter I).  Storey and colleagues (Storey et al., 1992) identified the 
time frame during which neural inducing signals are present in the Hensen’s node and 
the node age related ability to pattern the neural tissue: nodes at stage 3+/4 have the most 
neural inducing ability; young nodes, from stage 2 to 4, induce both anterior and 
posterior central nervous system; older nodes, from about stage 5/6, have a reduced 
inducing ability and progressively generate more posterior structures (Dias and 
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Schoenwolf, 1990; Gallera, 1970b; Storey et al., 1992; Streit et al., 1997b; Tsung et al., 1965; 
Vakaet, 1965).  
 
The nhbr90 transcript is strongly localized in the node at stage 3+/4, the age the node 
exhibits its maximum inducing ability (Storey et al., 1992), making it a candidate to play a 
role in neural induction. 
 
 Furthermore, the late expression of nhbr90 in areas of neurogenic activity, suggests that 
the role of nhbr90 goes beyond neural induction and might, perhaps, include 
neurogenesis. Nhbr90 is expressed, at stage 19, in the branchial arches and the dorsal root 
ganglia (DRGs), both regions of active neural crest cell migration and neurogenesis 
(Lefcort and George, 2007; Noden, 1993; Noden and Trainor, 2005). 
 
The neural crest of vertebrate embryos gives rise to a wide variety of adult cell types, 
including neurons and glial cells of the peripheral nervous system, pigment cells and 
various endocrine cells and skeletal elements (Le Douarin, 1980). 
 
When it comes to the pharyngeal arches, the cranial neural crest migrates in three 
streams. The first stream of migration, trigeminal stream, emanates from the midbrain, 
rhombomeres 1 and 2. It migrates into the upper jaw primordia, underneath the eye, and 
into the first pharyngeal arch, which forms the lower jaw; The second stream, hyoid 
stream, from rhombomere 4, migrates into the second pharyngeal arch, forming the jaw 
support; The third stream, post-otic stream, emerges from rhombomeres 6 and 7 and 
populates the caudal pharyngeal arches, of which there are three in the chick embryo 
(Graham et al., 2004).  
 
In the chick dorsal root ganglia (DRGs) there are two waves of neurogenesis (Lefcort and 
George, 2007). The first wave takes place between stages 15 and 18 and is generated from 
neural crest cells (NCCs) that migrate ipsilaterally and differentiate in the inner core of 
what will be the DRG. The second wave, from stages 19 to 26, is derived from NCCs that 
migrate both ipsilaterally and contrallaterally (between stages 19 and 22). The cells that 
migrate ipsilaterally, delaminate from the more lateral regions of the dorsal neural tube 
and tend to migrate directly into the inner core of the DRG. A second population, that 
tends to delaminate from the very medial region of the dorsal neural tube, includes cells 
that migrate both ipsilaterally and contralaterally. This medially-derived population of 
NCCs localize to the DRG perimeter where they remain in the cell cycle and become the 
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major source of mitotically-active progenitor cells for the second wave of neurogenesis 
and for glial cells in the DRG (Lefcort and George, 2007). 
 
 
Nhbr90 might still play a role as a neural inducer in the Caudal Neural 
Plate (CNP)  
Caudal Neural Plate (CNP) cells express of a number of genes, including the proneural 
gene homologue, cash4 (Henrique et al., 1997) and the homeobox-containing gene Sax1 
(Spann et al., 1994). Previous studies have shown that these caudal neural genes are 
induced continuously by the regressing node and that this node activity can be mimicked 
by FGF signals (Henrique et al., 1997; Storey et al., 1998). Furthermore, Cash4 
misexpression, both in Xenopus and Drosophila, promote neural cell fates (Henrique et al., 
1997). 
 
By misexpressing cash4 in fly and frog embryos it has also been shown that this gene 
promotes neural cell fates (Henrique et al., 1997) and the cellular context in which it is 
expressed in the chick suggests that cash4 mediates neural specification steps within the 
CNP (Brown and Storey, 2000). Furthermore, cells derived from the CNP region, but now 
located above the node, all contribute to the neural tube (Brown and Storey, 2000; Mathis 
et al., 2001; Selleck and Bronner-Fraser, 1995; Storey et al., 1995). This seems to mean that 
cells in the CNP may be specified, but not yet committed to a neural fate and, consistent 
with this, express early neural genes, such as Sox3 and Sox2 (Streit et al., 1997b). 
  
cash4 and Sax1 persist in the CNP, but are both down regulated as cells form the neural 
plate/neural tube above the level of the primitive streak (Henrique et al., 1997; Spann et 
al., 1994) and it is here that the first neurons in the caudal nervous system are born 
(Sechrist and Bronner-Fraser, 1991). The results presented in this study show that nhbr90 
is expressed in the anterior half of the caudal neural plate and is able to induce Cash4. It is 
also able to induce Sox2 at the level of the CNP, suggesting that its neural inducing role 
continues beyond the early neural induction at stage 3+/4.  
 
Protein interactions and Sox2 activation 
A recent paper (Papanayotou et al., 2008) has elucidated the role of three coiled-coiled 
domain proteins Geminin, ERNI and Bert in the regulation of the neural marker Sox2. 
Geminin is shown to bind to the chromatin remodelling factor Brahma, displacing the 
HP1α transcriptional repressor from its binding site and allowing the SWI/SNF 
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chromatin remodelling complex to act as an activator and drive transcription of Sox2. 
However, ERNI interacts with Geminin and recruits onto the complex HP1γ, another 
transcriptional repressor, thus inhibiting Sox2 transcription in the earlier neural plate. At 
the end of gastrulation, BERT starts to be expressed in the neural plate, disrupting the 
interaction between Geminin and ERNI, displacing HP1 from the SWI/SNF chromatin 
remodelling complex and allowing it to activate the transcription of Sox2.  
 
Papanayotou’s studies (Papanayotou et al., 2008) and that of others (Streit et al., 2000a) 
reveal that FGF signaling activates ERNI as well as Sox3 and Geminin expression in the 
epiblast. However, FGF does not induce BERT, whose expression is also not regulated by 
BMP antagonists or any combination of known factors implicated in neural induction to 
date (Papanayotou, unpublished data). Future work will detertmine if nhbr90 plays a role 
in regulating BERT. 
 
The work presented here show that nhbr90 overexpression induces Sox2 expression in the 
extraembryonic epiblast of the area opaca. Our analyses further indicate that nhbr90 does 
not get transcribed and seems to function as a long non-coding RNA, and plays a role in 
the regulation of Geminin and ERNI. In fact, non-coding RNAs seem to be involved in the 
modulation of transcription and gene regulation (He and Hannon, 2004; Mattick, 2005; 
Mimouni et al., 2009; Umlauf et al., 2008; Yano et al., 2004) by inhibiting RNA polymerase 
II recruitment (Bernard et al, 2010; Dye et al., 2006; Espinoza et al., 2007; Goodrich and 
Kugel) or inducing chromatin remodelling (De Lucia and Dean, 2010; Turner and Morris, 
2010). In this context, it is interesting to add that it is possible that nhbr90 RNA might 
interact with the chromatin complexes that lead to the activation of Sox2.  
 
 
The non-cell autonomous effect of nhbr90 
It was shown in the results section that nhbr90 induces Sox2 in a non-cell autonomous 
manner when overexpressed by electroporation or when introduced as pellets of 
expressing cells (Fig 7.8 and Fig 7.10).  This non-cell autonomous effect is very puzzling 
as the vast majority of the literature refers to the cell autonomous nature of long non-
coding RNAs.  
 
The non-cell autonomous effect observed when nhbr90 is overexpressed could be 
explained by either of the following hypotheses: 
1. nhbr90 is regulating an intermediary secreted or membrane bound molecule 
which, in turn, exerts its effect on neighbouring cells; 
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2. nhbr90 can be secreted. 
For the first hypothesis it is interesting to note that very recent work being carried out by 
others in the lab has revealed the presence of Tetraspanin18 (Tspn18) upstream of nhbr90 
and that this genomic organization is conserved across different vertebrate classes 
(unpublished data, not shown). Tspn18 encodes for a transmembrane protein previously 
shown to be expressed in the chick embryonic nervous system but not yet studied in 
relation to embryonic development.  
  
To test the hypothesis that nhbr90 is exerting its effect via Tspn18, it will be necessary to 
both access if nbbr90 overexpression can regulate Tspn18 expression and if Tspn18 itself is 
involved in the regulation of Sox2.   
 
The second hypothesis, with the idea of RNA being exported to the extracellular space, is 
starting to gain some interest.  The possibility of RNA being exported was first reported 
almost 40 years ago (Kolodny et al., 1972) and received very little attention until 
relatively recently, where it was found a mechanism, involving microparticles, for  RNA  
transport to the extracellular space and possible intake by other cells (Chen et al., 2009; 
Hunter et al., 2008; Rosell et al., 2009; Taylor and Gercel-Taylor, 2008; Valadi et al., 2007).  
Many long non-coding RNAs are processed to yield small RNAs, such as miRNAs or 
siRNAs (Eddy, 2002; Pauli et al., 2011) and it is the small RNA particles that can be 
exported via microparticles (Hunter et al., 2008; Valadi et al., 2007).  
 
Microparticles are lipid vesicles that are <1mm in diameter and are secreted by many cell 
types (Aharon et al., 2009; Castellana et al., 2009; Chironi et al., 2009; Huttner et al., 2008; 
Shet, 2008) and provide a way of RNA export. Unlike cellular RNAs, these secreted 
RNAs are mainly small RNAs or RNAs greater than 500 nt. This suggests that secretion 
of RNAs is not a random cellular process but a selective process that targets small RNAs 
such as miRNAs and, most possibly, other small non-coding RNAs, but not the more 
abundant intact mRNAs or ribosomal RNAs present in cells (Mattick and Makunin, 
2005). 
In this context of RNA secretion, it is important to access if nhbr90 serves as precursor of 
smaller ncRNAs and if the smaller particles can be secreted. And if that is the case, how 
do the smaller ncRNAs regulate Sox2. 
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Fig 7.1. Schematic representation of the nhbr90 clone and constructs used in the 
present study.  The nhbr90 clone is 2079bp long and contains two putative ORFs : 
ORF1 (99aa) and ORF2 (114aa) (A). In situ hybridizations were performed using the full-
length clone (Riboprobe1) and also smaller fragments  (Riboprobes 2 and 3) (B). 
Constructs for overexpression of nhbr90 were made using either the full-length clone 
(pCAB full-length nhbr90 insert) or smaller fragments (pCAB AseI/BamHI nhbr90 insert 
and pCAB ClaI/XhoI nhbr90 insert) (C). 
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Fig7.2. Nhbr90 is a 2079bp sequence and can fold as a RNA.  Nucleotide sequence of 
nhbr90; Underlined in red is the original fragment obtained from the screen (A). Northern 
blots reveal the presence of a single nhbr90 transcript of 2Kb (B).  nhbr90 can assume s 
secondary structure characteristic of long non-coding RNAs (C).  
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Fig 7.3. Nhbr90 expression pattern. Nhbr90 is detected first in the hypoblast (A) and 
then strongly localises to the Hensen’s node (B, C and D). Later expression reveals the 
presence of the transcript in the neural plate (E) and neural tube (F). 
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Fig 7.4. Nhbr90 is expressed in areas of neurogenic activity. Stage 18 embryos 
express  nhbr90 in the cranial ganglia at the level of the hindbrain and pharyngeal arches 
(white arrow heads, A, B and C), the dorsal neural tube (D) and the dorsal root ganglia 
(red arrows, A, D and D’). 
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Fig 7.5. Nhbr90 is able to induce both Sox3 and Sox2.  Nhbr90 overexpression in a 
line spanning from the node to the area opaca  (A) results in the expansion of the domain 
of expression of Sox3 (B and C)  and Sox2 (D and E); nhbr90 electroporated to the inner 
third of the area opaca (K) induces the expression of the neural markers Sox3 (L and M) 
and Sox2 (N and O). Control electroporations have no effect on the neural markers tested 
(F- J and P- T). 
 169 
 
 
 
Fig 7.6. The embryo loses the competence to respond to nhbr90 neural inducing 
ability after stage 4+.  Graphic representation of the decrease in embryonic competence 
to respond to nhbr90 (A); Example of an embryo electroporated with nhbr90 in the area 
opaca at stage 3+ with Sox2 induction (B and C); Control electroporations have no effect 
on Sox2 expression (D and E). 
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Fig 7.8. The effect of nhbr90 is non cell autonomous. nhbr90 overexpression by either 
electroporation (A, B and B’) or by grafts of expressing cells ( C and C’) results in Sox2 
induction in the neighbouring cells (B’) or in the epiblast underlying the graft (as revealed 
through an histological section in C’).   
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Fig 7.10. Cells induced to express Sox2 are prevented to ingress through the 
primitive streak. Nhbr90 overexpression in a line parallel to the posterior streak at stage 
3+ (A) results in the induction of Sox2 within 9 hours (B and C) and the induced cells 
remain in the epiblast  (D and E). After 17 hours (F and H), and as gastrulation proceeds, 
the induced Sox2 cells accumulate at the “gastrulating edge” of the streak but do not 
ingress (G, white arrowheads); Not all the electroporated cells express Sox2 and those 
are able to ingress (I). 
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Fig 7.11. Expression profiles of Fgf8, Pax6, Sax1, Cash4 and nhbr90 in the Caudal 
Neural Plate (CNP). Pax6 is excluded from the CNP (B and B’) and its expression is 
complementary to that of Fgf8 (A and A’); nhbr90 seems to occupy a more anterior 
domain of the CNP (E and E’), followed by Sax1 (C and C’); Cash4 expression expands 
to the most posterior part of the CNP (D and D’).  
 
 
Fig 7.12. FGF8 induces proneural genes and also nhbr90. A bead of Fgf8 placed 
posterior to the node at stage 6 (A) downregulates Pax6 (B) and upregulates the 
proneural genes Cash4 (C) and Sax1 (D) and also nhbr90 (E); Control beads have no 
effect (F-I).  
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Fig 7.13.Overexpression of nhbr90 in the area opaca has no effect on the proneural 
markers Sax1 and Cash4. Electroporation of nhbr90 in the area opaca at stage 5 (A) 
results in the induction of Sox2 in some of the embryos tested (B and C) but has no effect 
in the posterior marker HoxB9 (D and E) or the proneural markers Sax1 (F and G) and 
Cash4 (H and I).  
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Fig 7.14.Overexpression of nhbr90 in the area pellucida induces neural markers but 
has no effect in patterning. Electroporation of nhbr90 in a patch adjacent to posterior 
end of the streak at stage 5 (A) results in the induction of Sox2 (B and C) and Cash4 (J 
and K) in some of the embryos tested but has no effect on Fgf8 (D and E), the posterior 
marker HoxB9 (F and G), or the proneural gene Sax1 (H and I). 
 177 
 
Chapter 8 
General Conclusion 
 
 
The work presented in this study starts by re-evaluating the role of BMP antagonism in 
neural induction in the chick embryo. We find that, even though BMP inhibition is a 
required step during neural induction, it is not sufficient to elicit the expression of the 
neural plate markers Sox3 or Sox2.  Even combinations of BMP inhibitors, together with 
FGF and Wnt inhibition, is not sufficient to induce neural markers. We do find, however, 
that non-neural ectoderm can be neuralised by BMP inhibition, but only when the BMP-
inhibited cells form a continuous trail from the neural plate or its border. 
 
To uncover novel neural inducing molecules produced by the organizer, a screen to 
isolate cDNAs encoding for secreted proteins was carried out. 441 clones were obtained 
and, after sequence analyses, 133 were selected and put through an in situ hybridization 
screen, narrowing down the number of candidate molecules to 21. Based on their 
expression in the node and/or anterior primitive streak, 3 genes were studied further.  
 
Fibulin2, a secreted extracellular matrix protein, revealed not to be directly involved in 
inducing neural markers;  
 
Calreticulin is shown to be secreted and acts like a BMP inhibitor, extending the border of 
the neural plate. However, it is unable to induce neural character in the competent 
extraembryonic ectoderm of the area opaca. By a mechanism yet to be elucidated, 
Calreticulin, known as an intracelular Calcium regulator, might provide a link between 
Calcium concentration and neural induction. 
 
Nhbr90, a novel molecule, seems not to be translated but act as a long non-coding RNA. 
Crutialy, nhbr90 has the ability to induce Sox2 by a mechanism that is yet to be 
elucidated.  
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The work presented in this Thesis emphasises the complexity of the neural induction 
process. Some new players have been identified and many more molecules from the 
screen are yet to be analysed.  
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